26.08.2013 Views

Recommended offer by Investec plc for The Evolution Group Plc to ...

Recommended offer by Investec plc for The Evolution Group Plc to ...

Recommended offer by Investec plc for The Evolution Group Plc to ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. Part II (Explana<strong>to</strong>ry Statement) of this document comprises<br />

an explana<strong>to</strong>ry statement in compliance with Section 897 of the Companies Act 2006. <strong>The</strong> document relates <strong>to</strong> an <strong>offer</strong> which, if implemented,<br />

will result in the cancellation of the listing of <strong>Evolution</strong> Shares on the Official List and of trading of <strong>Evolution</strong> Shares on the London S<strong>to</strong>ck<br />

Exchange’s Main Market <strong>for</strong> listed securities. If you are in any doubt as <strong>to</strong> the action you should take, you should consult your s<strong>to</strong>ckbroker,<br />

bank manager, solici<strong>to</strong>r, accountant or other professional adviser authorised under the Financial Services and Markets Act 2000 if you are<br />

in the UK or, if not, from another appropriately independent financial adviser.<br />

If you have sold or otherwise transferred all of your <strong>Evolution</strong> Shares, you should send this document, and the accompanying Forms of Proxy,<br />

as soon as possible <strong>to</strong> the purchaser or transferee, or <strong>to</strong> the s<strong>to</strong>ckbroker, bank or other agent through whom the sale or transfer was<br />

effected <strong>for</strong> delivery <strong>to</strong> the purchaser or transferee.<br />

However, the distribution of this document in<strong>to</strong> jurisdictions other than the United Kingdom may be restricted <strong>by</strong> law. <strong>The</strong>re<strong>for</strong>e persons in<strong>to</strong> whose<br />

possession this document and any accompanying documents come should in<strong>for</strong>m themselves about and observe any such restrictions. Any failure <strong>to</strong><br />

comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. In particular, such documents should not be<br />

distributed in, <strong>for</strong>warded <strong>to</strong> or transmitted in or in<strong>to</strong> any Restricted Jurisdiction or in<strong>to</strong> any jurisdiction where <strong>offer</strong>ing the New <strong>Investec</strong> Shares or making<br />

them available <strong>for</strong> subscription or purchase would breach any applicable law. If you have sold or otherwise transferred part of your holding of <strong>Evolution</strong><br />

Shares, please consult the bank, s<strong>to</strong>ckbroker or other agent through whom the sale or transfer was effected.<br />

<strong>The</strong> enclosed Forms of Proxy are personalised. If you have recently purchased or been transferred <strong>Evolution</strong> Shares and notwithstanding the instructions<br />

above, receive the Forms of Proxy from the transferor of such shares, you should contact <strong>Evolution</strong>’s Registrar, Capita, on the telephone numbers set out<br />

on page 7 of this document, <strong>to</strong> obtain replacements of these documents.<br />

(Registered in England and Wales – No. 3359425)<br />

<strong>Recommended</strong> <strong>offer</strong> <strong>by</strong><br />

<strong>Investec</strong> <strong>plc</strong><br />

<strong>for</strong><br />

<strong>The</strong> <strong>Evolution</strong> <strong>Group</strong> <strong>Plc</strong><br />

<strong>to</strong> be effected <strong>by</strong> means of a Scheme of Arrangement under<br />

Part 26 of the Companies Act 2006<br />

You should read the whole of this document (including any documents incorporated in<strong>to</strong> it <strong>by</strong> reference) and the accompanying Forms of Proxy. This<br />

document is also available on the websites of <strong>Evolution</strong> and <strong>Investec</strong> at www.evg<strong>plc</strong>.com and www.investec.com respectively. Your attention is drawn <strong>to</strong><br />

the letter from the Chairman of <strong>Evolution</strong> which is set out in Part I (Letter from the Chairman of <strong>The</strong> <strong>Evolution</strong> <strong>Group</strong> <strong>Plc</strong>) of this document and which<br />

recommends that you vote in favour of the Resolutions <strong>to</strong> be proposed at the Shareholder Meetings. A letter from Credit Suisse explaining the Scheme<br />

appears in Part II (Explana<strong>to</strong>ry Statement) of this document.<br />

Notices of the Court Meeting and the General Meeting, both <strong>to</strong> be held at the offices of Jones Day at 21 Tudor Street, London EC4Y 0DJ on<br />

27 Oc<strong>to</strong>ber 2011, are set out at Parts IX and X of this document respectively. <strong>The</strong> Court Meeting will start at 11.00 a.m. and the General<br />

Meeting at 11.05 a.m. (or as soon thereafter as the Court Meeting has concluded or been adjourned).<br />

<strong>The</strong> action <strong>to</strong> be taken in respect of the Shareholder Meetings is set out on pages 6 and 7 of this document. Shareholders will find enclosed with this<br />

document a BLUE Form of Proxy <strong>for</strong> use in connection with the Court Meeting and a WHITE Form of Proxy <strong>for</strong> use in connection with the General Meeting.<br />

Whether or not you intend <strong>to</strong> attend the Shareholder Meetings in person, please complete and sign each of the enclosed Forms of Proxy in accordance<br />

with the instructions printed on them and return them <strong>to</strong> the Company’s Registrar, Capita, of PXS, <strong>The</strong> Registry, 34 Beckenham Road, Beckenham, Kent<br />

BR3 4TU, as soon as possible and, in any event, so as <strong>to</strong> be received <strong>by</strong> the deadline set out on the relevant <strong>for</strong>m. If the BLUE Form of Proxy <strong>for</strong> the Court<br />

Meeting is not returned <strong>by</strong> the specified time, it may be handed <strong>to</strong> representatives of Capita or the Chairman of the Court Meeting be<strong>for</strong>e the start of that<br />

Meeting and will still be valid. However, in the case of the General Meeting, unless the WHITE Form of Proxy is returned <strong>by</strong> the time mentioned in the<br />

instructions printed on it, it will be invalid.<br />

If you hold your <strong>Evolution</strong> Shares in uncertificated <strong>for</strong>m (i.e. in CREST) you may vote using the CREST Proxy Voting Service in accordance with the<br />

procedures set out in the CREST manual (please also refer <strong>to</strong> the accompanying notes <strong>to</strong> the Notice of the General Meeting set out at the end of this<br />

document). Proxies submitted via CREST (under CREST participant ID RA10) must be received <strong>by</strong> Capita, PXS, <strong>The</strong> Registry, 34 Beckenham Road,<br />

Beckenham, Kent BR3 4TU not later than 11.00 a.m. on 25 Oc<strong>to</strong>ber 2011 in the case of the Court Meeting and <strong>by</strong> 11.05 a.m. on 25 Oc<strong>to</strong>ber 2011 in<br />

the case of the General Meeting or, in the case of any adjournment, not later than 48 hours be<strong>for</strong>e the time fixed <strong>for</strong> the holding of the adjourned meeting.<br />

Shareholders entitled <strong>to</strong> attend and vote at the Shareholder Meetings may appoint a proxy electronically <strong>by</strong> logging on <strong>to</strong> the website of Capita at www.<br />

capitashareportal.com and entering the voting ID, task ID and shareholder reference number shown on their Forms of Proxy. Full details of the procedure <strong>to</strong><br />

be followed <strong>to</strong> appoint a proxy electronically are given on the website. Further in<strong>for</strong>mation is also included in the instructions included on the Forms of Proxy.<br />

<strong>The</strong> completion and return of a Form of Proxy or the appointment of a proxy or proxies electronically or through CREST shall not prevent a Shareholder<br />

from attending and voting in person at either Shareholder Meeting or any adjournment thereof, if you so wish and are so certified.<br />

1


<strong>The</strong> New <strong>Investec</strong> Shares have not been, and will not be, registered under the US Securities Act, or under the securities laws of any State<br />

or other jurisdiction of the United States. Accordingly, the New <strong>Investec</strong> Shares may not be <strong>offer</strong>ed, sold, resold, delivered, distributed<br />

or otherwise transferred, directly or indirectly, in or in<strong>to</strong> the United States absent registration under the Securities Act or an exemption<br />

therefrom. <strong>The</strong> New <strong>Investec</strong> Shares are expected <strong>to</strong> be <strong>offer</strong>ed in the United States in reliance upon the exemption from the registration<br />

requirements of the Securities Act provided <strong>by</strong> Section 3(a)(10) thereof. <strong>Evolution</strong> Shareholders who are affiliates of <strong>Investec</strong> or <strong>Evolution</strong><br />

prior <strong>to</strong> the Effective Date will be subject <strong>to</strong> certain US transfer restrictions relating <strong>to</strong> the New <strong>Investec</strong> Shares received pursuant <strong>to</strong> the<br />

Scheme. For a description of these and certain further restrictions on <strong>offer</strong>s, sales and transfers of the New <strong>Investec</strong> Shares and the<br />

distribution of this document, see paragraph 17 of Part II (Explana<strong>to</strong>ry Statement).<br />

None of the securities referred <strong>to</strong> in this document have been approved or disapproved <strong>by</strong> the US Securities and Exchange Commission,<br />

any state securities commission in the United States or any other US regula<strong>to</strong>ry authority, nor have such authorities passed upon or<br />

determined the adequacy or accuracy of this document. Any representation <strong>to</strong> the contrary is a criminal offence in the United States.<br />

You should also read the rest of this document and consult an independent financial adviser. If you have any further questions, including<br />

in relation <strong>to</strong> the completion and return of the Forms of Proxy, please call the Shareholder Helpline on 0871 664 0300 from within the<br />

UK or on +44 20 8639 3399 if calling from outside the UK. Calls <strong>to</strong> the 0871 664 0300 number cost 10 pence per minute plus network<br />

extras. Lines are open 8.30 am <strong>to</strong> 5.30 pm (London time) Monday <strong>to</strong> Friday (except UK public holidays). Calls <strong>to</strong> the helpline from outside<br />

the UK will be charged at the applicable international rate. Different charges may apply <strong>to</strong> calls from mobile telephones and calls may<br />

be recorded and randomly moni<strong>to</strong>red <strong>for</strong> security and training purposes. <strong>The</strong> helpline cannot provide advice on the merits of the Offer<br />

nor give any financial, legal or tax advice.<br />

Applications will be made <strong>by</strong> <strong>Investec</strong> <strong>to</strong> the FSA <strong>for</strong> all the New <strong>Investec</strong> Shares <strong>to</strong> be admitted <strong>to</strong> the Official List and <strong>to</strong> the London<br />

S<strong>to</strong>ck Exchange <strong>for</strong> the New <strong>Investec</strong> Shares <strong>to</strong> be admitted <strong>to</strong> trading on the London S<strong>to</strong>ck Exchange’s market <strong>for</strong> listed securities. On<br />

the basis of current expectations as <strong>to</strong> the timing of regula<strong>to</strong>ry approvals and Court availability, it is expected that Admission will become<br />

effective and unconditional dealings in the New <strong>Investec</strong> Shares on the London S<strong>to</strong>ck Exchange’s market will commence in December<br />

2011. Application will also be made <strong>to</strong> the JSE <strong>for</strong> the New <strong>Investec</strong> Shares <strong>to</strong> be admitted, <strong>by</strong> way of a secondary listing, <strong>to</strong> the JSE.<br />

<strong>Investec</strong> Investment Banking, a division of <strong>Investec</strong> Bank <strong>plc</strong>, which is authorised and regulated in the UK <strong>by</strong> the FSA, is acting <strong>for</strong><br />

<strong>Investec</strong> in connection with the Offer and <strong>for</strong> no-one else and will not be responsible <strong>to</strong> anyone other than <strong>Investec</strong> <strong>for</strong> providing the<br />

protections af<strong>for</strong>ded <strong>to</strong> their respective clients nor <strong>for</strong> providing any advice in relation <strong>to</strong> the Offer or the contents of this document or<br />

any transaction, arrangement or matter referred <strong>to</strong> in this document.<br />

Credit Suisse, which is authorised and regulated in the UK <strong>by</strong> the FSA, is acting exclusively <strong>for</strong> <strong>Evolution</strong> and <strong>for</strong> no one else in connection<br />

with the Offer and this document and will not be responsible <strong>to</strong> anyone other than <strong>Evolution</strong> <strong>for</strong> providing the protections af<strong>for</strong>ded <strong>to</strong><br />

clients of Credit Suisse or <strong>for</strong> providing advice in connection with the Offer or the contents of this document or any transaction,<br />

arrangement or matter referred <strong>to</strong> in this document.<br />

<strong>The</strong> contents of this document are not <strong>to</strong> be construed as legal, business, financial or tax advice. If you are in any doubt about the<br />

contents of this document you should consult your own legal adviser, financial adviser or tax adviser <strong>for</strong> legal, business, financial or tax<br />

advice.<br />

This document does not constitute, and may not be used <strong>for</strong> the purposes of, an <strong>offer</strong> <strong>to</strong> sell or an invitation or the solicitation of an <strong>offer</strong><br />

<strong>to</strong> subscribe <strong>for</strong> or buy, any New <strong>Investec</strong> Shares <strong>by</strong> any person in any jurisdiction: (i) in which such <strong>offer</strong> or invitation is not authorised;<br />

(ii) in which the person making such <strong>offer</strong> or invitation is not qualified <strong>to</strong> do so; or (iii) in which, or <strong>to</strong> any person <strong>to</strong> whom, it is unlawful<br />

<strong>to</strong> make such <strong>offer</strong>, solicitation or invitation or would impose any unfulfilled registration, publication or approval requirements on<br />

<strong>Evolution</strong>, <strong>Investec</strong> or any of their respective, direc<strong>to</strong>rs, officers, agents and advisers. No action has been taken nor will be taken in any<br />

jurisdiction <strong>by</strong> any such person that would permit a public <strong>offer</strong>ing of the New <strong>Investec</strong> Shares in any jurisdiction where action <strong>for</strong> that<br />

purpose is required, nor has any such action been taken with respect <strong>to</strong> the possession or distribution of this document other than in<br />

any jurisdiction where action <strong>for</strong> that purpose is required. Neither <strong>Evolution</strong>, <strong>Investec</strong> nor their respective direc<strong>to</strong>rs, officers, agents or<br />

advisers accept any responsibility <strong>for</strong> any violation of any of these restrictions <strong>by</strong> any other person.<br />

General Notice <strong>to</strong> Overseas Shareholders<br />

<strong>The</strong> Offer will not be made, directly or indirectly, in or in<strong>to</strong> or <strong>by</strong> the use of the mails of, or <strong>by</strong> any other means (including, without<br />

limitation, electronic mail, facsimile transmission, telex, telephone, internet or other <strong>for</strong>ms of electronic communication) of interstate or<br />

<strong>for</strong>eign commerce of, or any facility of a national securities exchange of, any jurisdiction where <strong>to</strong> do so, under local laws or regulations,<br />

may result in a significant risk of civil, regula<strong>to</strong>ry or criminal exposure. Accordingly, unless otherwise determined <strong>by</strong> <strong>Investec</strong> and<br />

<strong>Evolution</strong>, copies of this document and any documentation relating <strong>to</strong> the Offer are not being, and must not be, directly or indirectly,<br />

mailed or otherwise <strong>for</strong>warded, distributed or sent in or in<strong>to</strong> or from any Restricted Jurisdiction and persons receiving such documents<br />

(including cus<strong>to</strong>dians, nominees and trustees) must not mail or otherwise <strong>for</strong>ward, distribute or send any such documents in or in<strong>to</strong> or<br />

from any such Restricted Jurisdiction. Any person (including, without limitation, cus<strong>to</strong>dians, nominees and trustees) who would, or<br />

otherwise intends <strong>to</strong>, or who may have a contractual or legal obligation <strong>to</strong>, <strong>for</strong>ward this document and/or any other documentation<br />

relating <strong>to</strong> the Offer <strong>to</strong> any jurisdiction outside the United Kingdom should in<strong>for</strong>m themselves of, and observe, any applicable legal or<br />

regula<strong>to</strong>ry requirements of any relevant jurisdiction.<br />

None of <strong>Evolution</strong>, <strong>Investec</strong> or their respective direc<strong>to</strong>rs, officers, agents and advisers is making any representation <strong>to</strong> any <strong>offer</strong>ee or<br />

purchaser of the New <strong>Investec</strong> Shares <strong>offer</strong>ed here<strong>by</strong> regarding the legality of an investment <strong>by</strong> such <strong>offer</strong>ee or purchaser under<br />

appropriate investment or similar laws. Each prospective inves<strong>to</strong>r should consult with his, her or its own advisers as <strong>to</strong> the legal, tax,<br />

business, financial and related aspects of purchase of or subscription <strong>for</strong> the New <strong>Investec</strong> Shares.<br />

2


TABLE OF CONTENTS<br />

NOTE ON FORWARD LOOKING STATEMENTS 4<br />

DISCLOSURE REQUIREMENTS OF THE CODE 4<br />

EXPECTED TIMETABLE OF PRINCIPAL EVENTS 5<br />

ACTION TO BE TAKEN 6<br />

PART I LETTER FROM THE CHAIRMAN OF THE EVOLUTION GROUP PLC 8<br />

PART II EXPLANATORY STATEMENT 13<br />

PART III THE SCHEME OF ARRANGEMENT 24<br />

PART IV CONDITIONS AND FURTHER TERMS 28<br />

PART V UNITED KINGDOM TAXATION 33<br />

PART VI ADDITIONAL INFORMATION 35<br />

PART VII INFORMATION INCORPORATED BY REFERENCE 63<br />

PART VIII DEFINITIONS 64<br />

PART IX NOTICE OF COURT MEETING 69<br />

PART X NOTICE OF GENERAL MEETING 71<br />

Page<br />

3


4<br />

NOTE ON FORWARD LOOKING STATEMENTS<br />

This document and the documents incorporated <strong>by</strong> reference in<strong>to</strong> it contains statements about <strong>Investec</strong> and <strong>Evolution</strong> that are or may<br />

be <strong>for</strong>ward looking statements. All statements other than statements of his<strong>to</strong>rical facts included in this document may be <strong>for</strong>ward looking<br />

statements. Without limitation, any statements preceded or followed <strong>by</strong> or that include the words “targets”, “plans” “believes”, “expects”,<br />

“aims”,” intends”, “will”, “may”, “anticipates”, “estimates”, “projects” or, words or terms of similar substance or the negative thereof, are<br />

<strong>for</strong>ward looking statements. Forward looking statements include statements relating <strong>to</strong> the following: (i) future capital expenditures,<br />

expenses, revenues, earnings, synergies, economic per<strong>for</strong>mance, indebtedness, financial condition, dividend policy, losses and future<br />

prospects; (ii) business and management strategies and the expansion and growth of <strong>Investec</strong>’s or <strong>Evolution</strong>’s operations and potential<br />

synergies resulting from the Offer; and (iii) the effects of government regulation on <strong>Investec</strong>’s or <strong>Evolution</strong>’s business.<br />

Such <strong>for</strong>ward looking statements involve risks and uncertainties that could significantly affect expected results and are based on certain<br />

key assumptions. Many fac<strong>to</strong>rs could cause actual results <strong>to</strong> differ materially from those projected or implied in any <strong>for</strong>ward looking<br />

statements. Due <strong>to</strong> such uncertainties and risks, readers are cautioned not <strong>to</strong> place undue reliance on such <strong>for</strong>ward looking statements,<br />

which speak only as of the date hereof. <strong>Investec</strong> and <strong>Evolution</strong> each disclaim any obligation <strong>to</strong> update any <strong>for</strong>ward looking or other<br />

statements contained herein, except as required <strong>by</strong> applicable law.<br />

All subsequent written and oral <strong>for</strong>ward looking statements attributable <strong>to</strong> <strong>Investec</strong> or <strong>Evolution</strong> or persons acting on their respective<br />

behalf are expressly qualified in their entirety <strong>by</strong> the cautionary statements above. <strong>The</strong> <strong>for</strong>ward looking statements included herein are<br />

made only as of the date of this document. <strong>Investec</strong> and <strong>Evolution</strong> do not intend, and does not undertake any obligation, <strong>to</strong> update these<br />

<strong>for</strong>ward looking statements.<br />

DISCLOSURE REQUIREMENTS OF THE CODE<br />

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an <strong>offer</strong>ee company or<br />

of any paper <strong>offer</strong>or (being any <strong>offer</strong>or other than an <strong>offer</strong>or in respect of which it has been announced that its <strong>offer</strong> is, or is likely <strong>to</strong> be,<br />

solely in cash) must make an Opening Position Disclosure following the commencement of the <strong>offer</strong> period and, if later, following the<br />

announcement in which any paper <strong>offer</strong>or is first identified. An Opening Position Disclosure must contain details of the person’s interests<br />

and short positions in, and rights <strong>to</strong> subscribe <strong>for</strong>, any relevant securities of each of (i) the <strong>offer</strong>ee company and (ii) any paper <strong>offer</strong>or(s).<br />

An Opening Position Disclosure <strong>by</strong> a person <strong>to</strong> whom Rule 8.3(a) applies must be made <strong>by</strong> no later than 3.30 pm (London time) on the<br />

10th business day following the commencement of the <strong>offer</strong> period and, if appropriate, <strong>by</strong> no later than 3.30 pm (London time) on the<br />

10th business day following the announcement in which any paper <strong>offer</strong>or is first identified. Relevant persons who deal in the relevant<br />

securities of the <strong>offer</strong>ee company or of a paper <strong>offer</strong>or prior <strong>to</strong> the deadline <strong>for</strong> making an Opening Position Disclosure must instead<br />

make a Dealing Disclosure.<br />

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the <strong>offer</strong>ee<br />

company or of any paper <strong>offer</strong>or must make a Dealing Disclosure if the person deals in any relevant securities of the <strong>offer</strong>ee company<br />

or of any paper <strong>offer</strong>or. A Dealing Disclosure must contain details of the dealing concerned and of the person’s interests and short<br />

positions in, and rights <strong>to</strong> subscribe <strong>for</strong>, any relevant securities of each of (i) the <strong>offer</strong>ee company and (ii) any paper <strong>offer</strong>or, save <strong>to</strong> the<br />

extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure <strong>by</strong> a person <strong>to</strong> whom Rule 8.3(b) applies<br />

must be made <strong>by</strong> no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.<br />

If two or more persons act <strong>to</strong>gether pursuant <strong>to</strong> an agreement or understanding, whether <strong>for</strong>mal or in<strong>for</strong>mal, <strong>to</strong> acquire or control an<br />

interest in relevant securities of an <strong>offer</strong>ee company or a paper <strong>offer</strong>or, they will be deemed <strong>to</strong> be a single person <strong>for</strong> the purpose of<br />

Rule 8.3.<br />

Opening Position Disclosures must also be made <strong>by</strong> the <strong>offer</strong>ee company and <strong>by</strong> any <strong>offer</strong>or and Dealing Disclosures must also be made<br />

<strong>by</strong> the <strong>offer</strong>ee company, <strong>by</strong> any <strong>offer</strong>or and <strong>by</strong> any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).<br />

Details of the <strong>offer</strong>ee and <strong>offer</strong>or companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures<br />

must be made can be found in the Disclosure Table on the Takeover Panel’s website at www.thetakeoverpanel.org.uk, including details<br />

of the number of relevant securities in issue, when the <strong>offer</strong> period commenced and when any <strong>offer</strong>or was first identified. If you are in<br />

any doubt as <strong>to</strong> whether you are required <strong>to</strong> make an Opening Position Disclosure or a Dealing Disclosure, you should contact the Panel’s<br />

Market Surveillance Unit on +44 (0)20 7638 0129.<br />

This document, <strong>to</strong>gether with all in<strong>for</strong>mation incorporated in<strong>to</strong> this document <strong>by</strong> reference <strong>to</strong> another source, subject <strong>to</strong> certain<br />

restrictions relating <strong>to</strong> persons resident in Restricted Jurisdictions, will be available on the websites of <strong>Evolution</strong> and <strong>Investec</strong> respectively<br />

www.evg<strong>plc</strong>.com and www.investec.com <strong>by</strong> no later than 12 noon on 4 Oc<strong>to</strong>ber 2011.


EXPECTED TIMETABLE OF PRINCIPAL EVENTS<br />

Event Expected time/date (1)<br />

Latest time <strong>for</strong> lodging Forms of Proxy <strong>for</strong>:<br />

Court Meeting (BLUE <strong>for</strong>m) 11.00 a.m. on 25 Oc<strong>to</strong>ber 2011<br />

General Meeting (WHITE <strong>for</strong>m) 11.05 a.m. on 25 Oc<strong>to</strong>ber 2011<br />

Voting Record Time 6.00 p.m. on 25 Oc<strong>to</strong>ber 2011<br />

<strong>Evolution</strong> Court Meeting (2) 11.00 a.m. on 27 Oc<strong>to</strong>ber 2011<br />

<strong>Evolution</strong> General Meeting (2)(3) 11.05 a.m. on 27 Oc<strong>to</strong>ber 2011<br />

<strong>The</strong> following dates are indicative only and subject <strong>to</strong> change (please see note (4) below).<br />

Last day of dealings in, and <strong>for</strong> registration of transfers 5 December 2011<br />

of, and disablement in CREST of, <strong>Evolution</strong> Shares (4)<br />

Suspension of listing of, and dealings in, <strong>Evolution</strong> Shares (4) 4.30 p.m. on 5 December 2011<br />

Scheme Record Time (4) 6.00 p.m. on 5 December 2011<br />

Court hearing <strong>to</strong> sanction the Scheme and approve the Capital Reduction (4) 6 December 2011<br />

Effective Date of the Scheme (4) 7 December 2011<br />

New <strong>Investec</strong> Shares listed, and crediting of New <strong>Investec</strong> Shares 8.00 a.m. on 7 December 2011<br />

<strong>to</strong> CREST accounts (and cancellation of listing of <strong>Evolution</strong> Shares) (4)<br />

Trading in New <strong>Investec</strong> Shares commences (4) <strong>by</strong> 8.00 a.m. on 7 December 2011<br />

Latest date of despatch of certificates <strong>for</strong> New <strong>Investec</strong> Shares (4) on or <strong>by</strong> 21 December 2011<br />

Long-s<strong>to</strong>p date being the date <strong>by</strong> which the Scheme must be implemented (5) 31 March 2012<br />

Notes:<br />

(1) All times shown in this document are London times unless otherwise stated. <strong>The</strong> dates and times given are indicative only and are based on<br />

<strong>Evolution</strong>’s current expectations and may be subject <strong>to</strong> change (including as a result of changes <strong>to</strong> Court times, the regula<strong>to</strong>ry<br />

timetable and/or the process <strong>for</strong> settlement of the Offer). If any of the times and/or dates above change the revised times and/or dates will be<br />

notified <strong>to</strong> Shareholders <strong>by</strong> announcement through the Regula<strong>to</strong>ry News Service of the London S<strong>to</strong>ck Exchange.<br />

(2) <strong>The</strong> Court Meeting and General Meeting will be held at the offices of Jones Day at 21 Tudor Street, London EC4Y 0DJ.<br />

(3) To commence at the time fixed or, if later, immediately following the conclusion or adjournment of the Court Meeting.<br />

(4) <strong>The</strong>se times and dates are indicative only and will depend, amongst other things, on the dates upon which: (i) the conditions are satisfied or (where<br />

permitted) waived; (ii) the Court sanctions the Scheme and confirms the associated Capital Reduction; and (iii) the Scheme Court Order sanctioning<br />

the Scheme and confirming the Capital Reduction along with the statement of capital are delivered <strong>to</strong> the Registrar of Companies. <strong>The</strong> Effective Date<br />

<strong>for</strong> the Scheme will not occur prior <strong>to</strong> 7 December 2011. Although the precise timing and quantum of <strong>Investec</strong>’s interim dividend in respect of the<br />

six months ended 30 September 2011 remains <strong>to</strong> be announced, based on previous dividend timetables, it is expected that the New <strong>Investec</strong><br />

Shares <strong>to</strong> be issued <strong>to</strong> <strong>Evolution</strong> Shareholders pursuant <strong>to</strong> the Scheme will be issued after the last cum-dividend trading date <strong>for</strong> such dividend, and<br />

accordingly, will not rank <strong>for</strong> any dividend declared <strong>by</strong> <strong>Investec</strong> in respect of such period.<br />

(5) This date may be extended <strong>by</strong> agreement between <strong>Evolution</strong> and <strong>Investec</strong>, with the prior consent of the Panel and (if required) the approval of the<br />

Court.<br />

5


6<br />

ACTION TO BE TAKEN<br />

For the reasons set out in this document, the <strong>Evolution</strong> Direc<strong>to</strong>rs unanimously consider that the Offer described in this document is in<br />

the best interests of Shareholders. Accordingly, in order <strong>to</strong> implement the Offer, the <strong>Evolution</strong> Direc<strong>to</strong>rs recommend that you vote in<br />

favour of the Resolutions <strong>to</strong> give effect <strong>to</strong> the Scheme, as the <strong>Evolution</strong> Direc<strong>to</strong>rs intend <strong>to</strong> do in respect of their own beneficial holdings<br />

of <strong>Evolution</strong> Shares, and that you take the action described below.<br />

Voting at the Court Meeting and the General Meeting<br />

<strong>The</strong> Scheme will require approval at the meeting of Shareholders convened <strong>by</strong> order of the Court <strong>to</strong> be held at the offices of Jones Day<br />

at 21 Tudor Street, London EC4Y 0DJ. <strong>The</strong> Court Meeting will start at 11.00 a.m. on 27 Oc<strong>to</strong>ber 2011. Implementation of the Scheme<br />

also requires approval of Shareholders at the General Meeting <strong>to</strong> be held at the same venue at 11.05 a.m. on 27 Oc<strong>to</strong>ber 2011 (or as<br />

soon thereafter as the Court Meeting has concluded or been adjourned). Notices of the Shareholder Meetings are set out at Parts IX and<br />

X of this document.<br />

Please check you have received the following with this document:<br />

• a BLUE Form of Proxy <strong>for</strong> use in respect of the Court Meeting on 27 Oc<strong>to</strong>ber 2011; and<br />

• a WHITE Form of Proxy <strong>for</strong> use in respect of the General Meeting on 27 Oc<strong>to</strong>ber 2011.<br />

It is important that, <strong>for</strong> the Court Meeting in particular, as many votes as possible are cast so that the Court may be satisfied<br />

that there is a fair representation of shareholder opinion. You are there<strong>for</strong>e strongly encouraged <strong>to</strong> sign and return your<br />

Forms of Proxy in accordance with the instructions thereon as soon as possible and, in any event, so as <strong>to</strong> be received <strong>by</strong><br />

<strong>Evolution</strong>’s Registrars, Capita, of PXS, <strong>The</strong> Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU, <strong>by</strong> the following times<br />

and dates:<br />

• BLUE Forms of Proxy <strong>for</strong> the Court Meeting <strong>by</strong> 11.00 a.m. on 25 Oc<strong>to</strong>ber 2011; and<br />

• WHITE Forms of Proxy <strong>for</strong> the General Meeting <strong>by</strong> 11.05 a.m. on 25 Oc<strong>to</strong>ber 2011.<br />

Alternatively, BLUE Forms of Proxy (but NOT WHITE Forms of Proxy) may be handed <strong>to</strong> representatives of Capita or the Chairman of the<br />

Court Meeting be<strong>for</strong>e the start of the Court Meeting on 27 Oc<strong>to</strong>ber 2011 and will still be valid.<br />

<strong>The</strong> completion and return of a Form of Proxy will not prevent you from attending and voting in person at the Court Meeting, the General<br />

Meeting or any adjournment thereof, if you so wish and are so entitled.<br />

Multiple proxy voting instructions<br />

As a registered Shareholder, you are entitled <strong>to</strong> appoint a proxy in respect of some or all of your <strong>Evolution</strong> Shares. You are also entitled<br />

<strong>to</strong> appoint more than one proxy. A space has been included on the Forms of Proxy <strong>to</strong> allow you <strong>to</strong> specify the number of <strong>Evolution</strong> Shares<br />

in respect of which that proxy is appointed.<br />

If you wish <strong>to</strong> appoint more than one proxy in respect of your shareholding, you should pho<strong>to</strong>copy the Form of Proxy or contact Capita<br />

on 0871 664 0300 from within the UK or on +44 20 8639 3399 if calling from outside the UK. Calls <strong>to</strong> the 0871 664 0300 number<br />

cost 10 pence per minute plus network extras. Lines are open 8.30 a.m. <strong>to</strong> 5.30 p.m. (London time) Monday <strong>to</strong> Friday (except UK public<br />

holidays). Calls <strong>to</strong> the helpline from outside the UK will be charged at the applicable international rate. Different charges may apply <strong>to</strong><br />

calls from mobile telephones and calls may be recorded and randomly moni<strong>to</strong>red <strong>for</strong> security and training purposes. <strong>The</strong> helpline cannot<br />

provide advice on the merits of the Offer nor give any financial, legal or tax advice.<br />

Electronic appointment of proxies<br />

Shareholders holding <strong>Evolution</strong> Shares through CREST<br />

Shareholders who hold <strong>Evolution</strong> Shares through CREST and who wish <strong>to</strong> appoint a proxy or proxies <strong>for</strong> the Shareholder Meetings or any<br />

adjournment(s) <strong>by</strong> using the CREST electronic proxy appointment service may do so <strong>by</strong> following the procedures described in the CREST<br />

Manual. CREST personal members or other CREST sponsored members, and those CREST members who have appointed (a) voting<br />

service provider(s), should refer <strong>to</strong> their CREST sponsor or voting service provider(s), who will be able <strong>to</strong> take the appropriate action on<br />

their behalf.<br />

In order <strong>for</strong> a proxy appointment or instruction made <strong>by</strong> means of CREST <strong>to</strong> be valid, the appropriate CREST message (a “CREST Proxy<br />

Instruction”) must be properly authenticated in accordance with Euroclear’s specifications and must contain the in<strong>for</strong>mation required<br />

<strong>for</strong> such instructions, as described in the CREST Manual. <strong>The</strong> message, regardless of whether it constitutes the appointment of a proxy<br />

or an amendment <strong>to</strong> the instructions given <strong>to</strong> a previously appointed proxy, must, in order <strong>to</strong> be valid, be transmitted so as <strong>to</strong> be received<br />

<strong>by</strong> the Registrars (ID RA10) at least 48 hours prior <strong>to</strong> the Court Meeting or General Meeting, as applicable. For this purpose, the time of<br />

receipt will be taken <strong>to</strong> be the time (as determined <strong>by</strong> the time stamp applied <strong>to</strong> the message <strong>by</strong> the CREST Applications Host) from<br />

which the Registrars are able <strong>to</strong> retrieve the message <strong>by</strong> enquiry <strong>to</strong> CREST in the manner prescribed <strong>by</strong> CREST.<br />

CREST members and, where applicable, their CREST sponsors or voting service provider(s), should note that Euroclear does not make<br />

available special procedures in CREST <strong>for</strong> any particular messages. Normal system timings and limitations will there<strong>for</strong>e apply in relation<br />

<strong>to</strong> the input of CREST Proxy Instructions. It is the responsibility of the CREST member concerned <strong>to</strong> take (or, if the CREST member is a<br />

CREST personal member or sponsored member or has appointed (a) voting service provider(s), <strong>to</strong> procure that his CREST sponsor or<br />

voting service provider(s) take(s)) such action as shall be necessary <strong>to</strong> ensure that a message is transmitted <strong>by</strong> means of the CREST<br />

system <strong>by</strong> any particular time. In this connection, CREST members and, where applicable, their CREST sponsor or voting service


provider(s) are referred, in particular, <strong>to</strong> those sections of the CREST Manual concerning practical limitations of the CREST system and<br />

timings.<br />

<strong>Evolution</strong> may treat as invalid a CREST Proxy Instruction in the circumstances set out in the Uncertificated Securities Regulations 2001.<br />

Appointing a proxy via the internet proxy service<br />

Shareholders entitled <strong>to</strong> attend and vote at the Shareholder Meetings may appoint a proxy electronically <strong>by</strong> logging on <strong>to</strong> the website of<br />

Capita at www.capitashareportal.com and entering the voting ID, task ID and shareholder reference number shown on their Forms of<br />

Proxy. Full details of the procedure <strong>to</strong> be followed <strong>to</strong> appoint a proxy electronically are given on the website. Further in<strong>for</strong>mation is also<br />

included in the instructions included on the Forms of Proxy.<br />

<strong>The</strong> appointment of a proxy or proxies electronically or through CREST shall not prevent a Shareholder from attending and voting at either<br />

Shareholder Meeting or any adjournment thereof.<br />

<strong>Evolution</strong> Share Schemes<br />

Participants in the <strong>Evolution</strong> Share Schemes should refer <strong>to</strong> section 11 of Part II (Explana<strong>to</strong>ry Statement) of this document <strong>for</strong> in<strong>for</strong>mation<br />

relating <strong>to</strong> the effect of the Offer on their rights under such share scheme.<br />

Assistance<br />

If you have any questions about this document, the Court Meeting, the General Meeting or the Offer, including in relation <strong>to</strong><br />

the completion and return of the Forms of Proxy, please call the Shareholder Helpline on 0871 664 0300 from within the UK<br />

or on +44 20 8639 3399 if calling from outside the UK. Calls <strong>to</strong> the 0871 664 0300 number cost 10 pence per minute plus<br />

network extras. Lines are open 8.30 a.m. <strong>to</strong> 5.30 p.m. (London time) Monday <strong>to</strong> Friday (except UK public holidays). Calls <strong>to</strong><br />

the helpline from outside the UK will be charged at the applicable international rate. Different charges may apply <strong>to</strong> calls<br />

from mobile telephones and calls may be recorded and randomly moni<strong>to</strong>red <strong>for</strong> security and training purposes. <strong>The</strong> helpline<br />

cannot provide advice on the merits of the Offer nor give any financial, legal or tax advice.<br />

7


Direc<strong>to</strong>rs:<br />

8<br />

PART I<br />

LETTER FROM THE CHAIRMAN OF THE EVOLUTION GROUP PLC<br />

Martin Gray (Non-Executive Chairman)<br />

Alex Snow (Chief Executive)<br />

Philip Howell (Executive Direc<strong>to</strong>r)<br />

Peter Gibbs (Senior Independent Non-Executive Direc<strong>to</strong>r)<br />

Chris<strong>to</strong>pher Chambers (Non-Executive Direc<strong>to</strong>r)<br />

Roger Perkin (Non-Executive Direc<strong>to</strong>r)<br />

Lord MacLaurin of Knebworth, DL (Non-Executive Direc<strong>to</strong>r)<br />

To all holders of <strong>Evolution</strong> Shares<br />

Dear <strong>Evolution</strong> Shareholder,<br />

<strong>Recommended</strong> Offer <strong>for</strong> <strong>Evolution</strong> <strong>by</strong> <strong>Investec</strong><br />

Registered Office:<br />

9th Floor<br />

100 Wood Street<br />

London EC2V 7AN<br />

Registered in<br />

England and Wales<br />

with company number 03359425<br />

3 Oc<strong>to</strong>ber 2011<br />

1 Introduction<br />

On 9 September 2011, the <strong>Evolution</strong> Direc<strong>to</strong>rs and the <strong>Investec</strong> Direc<strong>to</strong>rs announced that they had agreed the terms of a recommended<br />

all share <strong>offer</strong> under which <strong>Investec</strong> will acquire the entire issued ordinary share capital of <strong>Evolution</strong>.<br />

<strong>The</strong> purpose of this document is <strong>to</strong>:<br />

(i) explain the background <strong>to</strong> and reasons <strong>for</strong> the Offer;<br />

(ii) explain why the <strong>Evolution</strong> Direc<strong>to</strong>rs unanimously consider the Offer <strong>to</strong> be in the best interests of <strong>Evolution</strong> Shareholders as a whole;<br />

and<br />

(iii) unanimously recommend that you vote in favour of the Resolutions <strong>to</strong> be proposed at the Court Meeting and the General Meeting,<br />

as the <strong>Evolution</strong> Direc<strong>to</strong>rs who hold <strong>Evolution</strong> Shares have irrevocably agreed <strong>to</strong> do in respect of <strong>Evolution</strong> Shares held <strong>by</strong> them.<br />

2 Summary of the terms of the Offer<br />

It is proposed that the Offer will be implemented <strong>by</strong> way of a Court sanctioned scheme of arrangement under Part 26 of the Companies<br />

Act.<br />

Under the Offer, which will be subject <strong>to</strong> terms and conditions which are set out in Part IV (Conditions and Further Terms) hereof,<br />

<strong>Evolution</strong> Shareholders will, in aggregate, receive approximately 53.8 million fully paid newly issued <strong>Investec</strong> Shares. On the basis of the<br />

prevailing share price of <strong>Investec</strong>, being 433.5 pence, at the time the <strong>Evolution</strong> Direc<strong>to</strong>rs agreed in principle <strong>to</strong> give their recommendation,<br />

the Offer valued the entire issued share capital of <strong>Evolution</strong> at £233.2 million. Accordingly, <strong>Evolution</strong> Shareholders will receive:<br />

<strong>for</strong> each <strong>Evolution</strong> Share: 0.23124 New <strong>Investec</strong> Shares<br />

which, on the above basis, equates <strong>to</strong> a value of 100.24 pence per <strong>Evolution</strong> Share.<br />

<strong>The</strong> value of 100.24 pence <strong>for</strong> each <strong>Evolution</strong> Share represents a premium of:<br />

• approximately 44.7 per cent. <strong>to</strong> the average closing mid-market price per <strong>Evolution</strong> Share, of 69.2 pence, over the three month<br />

trading period <strong>to</strong> 2 August 2011 (being the last Business Day prior <strong>to</strong> the commencement of the Offer Period);<br />

• approximately 36.4 per cent. <strong>to</strong> the closing mid-market price per <strong>Evolution</strong> Share, of 73.5 pence, on 2 August 2011 (being the last<br />

Business Day prior <strong>to</strong> the commencement of the Offer Period); and<br />

• approximately 25.3 per cent. <strong>to</strong> the closing price per <strong>Evolution</strong> Share of 80.0 pence on 30 September 2011 (being the latest<br />

practicable date prior <strong>to</strong> the publication of this document).<br />

On the basis of the prevailing share price of <strong>Investec</strong> on 30 September 2011 (the latest practicable date prior <strong>to</strong> the publication of this<br />

document), being 349.6 pence, the Offer equates <strong>to</strong> a value of 80.84 pence per <strong>Evolution</strong> Share.<br />

<strong>The</strong> value of 80.84 pence <strong>for</strong> each <strong>Evolution</strong> Share represents a premium of:<br />

• approximately 16.8 per cent. <strong>to</strong> the average closing mid-market price per <strong>Evolution</strong> Share, of 69.2 pence, over the three month<br />

trading period <strong>to</strong> 2 August 2011 (being the last Business Day prior <strong>to</strong> the commencement of the Offer Period);


• approximately 10.0 per cent. <strong>to</strong> the closing mid-market price per <strong>Evolution</strong> Share, of 73.5 pence, on 2 August 2011 (being the last<br />

Business Day prior <strong>to</strong> the commencement of the Offer Period); and<br />

• approximately 1.1 per cent. <strong>to</strong> the closing price per <strong>Evolution</strong> Share of 80.0 pence on 30 September 2011 (being the latest<br />

practicable date prior <strong>to</strong> the publication of this document).<br />

No dividends shall be paid <strong>by</strong> <strong>Evolution</strong> between the date of the Announcement and the Effective Date save <strong>for</strong> an interim dividend of<br />

1 pence per <strong>Evolution</strong> Share announced on 29 July 2011 and payable <strong>to</strong> shareholders on the register on 12 August 2011.<br />

<strong>The</strong> New <strong>Investec</strong> Shares issued <strong>to</strong> <strong>Evolution</strong> Shareholders pursuant <strong>to</strong> the Scheme will rank on issue pari passu in all respects with the<br />

existing <strong>Investec</strong> Shares. <strong>The</strong> expected transaction timetable is set out on page 5 of this document. <strong>The</strong> parties have agreed that, in light<br />

of the likely timetable <strong>for</strong> seeking regula<strong>to</strong>ry and anti-trust clearances, the Scheme will not become effective prior <strong>to</strong> 7 December 2011.<br />

<strong>The</strong> current expectation is that the Effective Date will occur in December. Although the precise timing and quantum of <strong>Investec</strong>’s interim<br />

dividend in respect of the six months ended 30 September 2011 remains <strong>to</strong> be announced, based on previous dividend timetables, it is<br />

expected that the New <strong>Investec</strong> Shares <strong>to</strong> be issued <strong>to</strong> <strong>Evolution</strong> Shareholders pursuant <strong>to</strong> the Scheme will be issued after the last cumdividend<br />

trading date <strong>for</strong> such dividend and, accordingly, will not rank <strong>for</strong> any dividend declared <strong>by</strong> <strong>Investec</strong> in respect of such period.<br />

<strong>The</strong> New <strong>Investec</strong> Shares <strong>to</strong> be issued under the Scheme are expected <strong>to</strong> represent approximately 9.02 per cent. of the issued share<br />

capital of <strong>Investec</strong> and approximately 6.17 per cent. of the combined issued share capital of <strong>Investec</strong> and <strong>Investec</strong> Limited, in each case<br />

as enlarged <strong>by</strong> the acquisition of <strong>Evolution</strong>.<br />

<strong>The</strong> New <strong>Investec</strong> Shares will be issued on the Scheme becoming effective <strong>to</strong> <strong>Evolution</strong> Shareholders on the register at the Scheme<br />

Record Time.<br />

Fractions of New <strong>Investec</strong> Shares will not be allotted or issued pursuant <strong>to</strong> the Scheme and will be disregarded.<br />

<strong>The</strong> Scheme requires that <strong>Evolution</strong> Shareholders vote in favour of the Scheme at a Court Meeting <strong>to</strong> be held at 11.00 a.m. on 27 Oc<strong>to</strong>ber<br />

2011 and that <strong>Evolution</strong> Shareholders vote in favour of the General Meeting Resolution at the General Meeting <strong>to</strong> be held at 11.05 a.m.<br />

on 27 Oc<strong>to</strong>ber 2011 (or as soon thereafter as the Court Meeting has been concluded or adjourned). Following the Court Meeting and the<br />

General Meeting, the Scheme will become effective upon the delivery of the Scheme Court Order <strong>to</strong> the Registrar of Companies.<br />

Further details of the Court Meeting, the General Meeting and Scheme Court Order are set out in paragraph 12 of this letter and in<br />

paragraph 13 of Part II (Explana<strong>to</strong>ry Statement) of this document.<br />

3 Background <strong>to</strong> and reasons <strong>for</strong> the recommendation<br />

<strong>Evolution</strong> has delivered a decade of growth, both organic and through value creating acquisitions. Over the last 10 years, revenues have<br />

increased <strong>by</strong> over £102 million from £7.2 million <strong>for</strong> the year ended 2001 <strong>to</strong> £109.5 million <strong>for</strong> the year ended 2010 (a compound<br />

annual growth rate of 35.3 per cent.). Assets under management have grown <strong>by</strong> over £5.4 billion <strong>to</strong> £5.8 billion over the same period<br />

(a compound annual growth rate of 34.6 per cent.). <strong>The</strong>re has been an increased dividend payment each year.<br />

<strong>The</strong> <strong>Evolution</strong> Direc<strong>to</strong>rs believe that the Offer represents an opportunity <strong>for</strong> <strong>Evolution</strong> Shareholders <strong>to</strong> realise an immediate and attractive<br />

premium <strong>to</strong> the closing mid-market price per <strong>Evolution</strong> Share, of 73.5 pence on 2 August 2011 (being the last Business Day prior <strong>to</strong> the<br />

commencement of the Offer Period). <strong>The</strong> Offer allows shareholders <strong>to</strong> participate in the potential upside and opportunities from a<br />

combination with <strong>Investec</strong> as well as providing an interest in a more liquid FTSE 100 security. In addition, the <strong>Evolution</strong> Direc<strong>to</strong>rs believe<br />

that employees and clients will benefit from being part of a leading international specialist bank and asset manager. As such, the<br />

<strong>Evolution</strong> Direc<strong>to</strong>rs unanimously recommend that <strong>Evolution</strong> Shareholders vote in favour of the Resolutions required <strong>to</strong> give effect <strong>to</strong> the<br />

Scheme as set out in paragraph 15.<br />

4 Irrevocable Undertakings and Letters of Intent<br />

<strong>Investec</strong> has received irrevocable undertakings from each of the <strong>Evolution</strong> Direc<strong>to</strong>rs who hold <strong>Evolution</strong> Shares <strong>to</strong> vote or procure the<br />

vote in favour of the resolutions <strong>to</strong> be proposed at the Court Meeting and the General Meeting in respect of their own beneficial holdings<br />

of 6,027,184 <strong>Evolution</strong> Shares, representing approximately 2.59 per cent. of the existing issued share capital of <strong>Evolution</strong>. <strong>The</strong><br />

undertakings given <strong>by</strong> the <strong>Evolution</strong> Direc<strong>to</strong>rs cease <strong>to</strong> be binding if the Scheme is withdrawn or lapses, unless <strong>Investec</strong> exercises its<br />

right <strong>to</strong> announce a Takeover Offer <strong>for</strong> the entire issued share capital of <strong>Evolution</strong>, not already owned <strong>by</strong> it, in which case it shall cease<br />

<strong>to</strong> have effect on the withdrawal or lapsing of the Takeover Offer.<br />

<strong>Investec</strong> has also received an irrevocable undertaking from Landsdowne Partners <strong>to</strong> vote or procure the vote in favour of the resolutions<br />

<strong>to</strong> be proposed at the Court Meeting and the General Meeting in respect of their entire beneficial holding of 12,809,506 <strong>Evolution</strong><br />

Shares, representing approximately 5.51 per cent. of the existing issued share capital of <strong>Evolution</strong>. <strong>The</strong> undertaking given <strong>by</strong> Landsdowne<br />

Partners will lapse and be of no effect if, inter alia, a third party announces a firm intention <strong>to</strong> make an <strong>offer</strong> under Rule 2.5 of the Code<br />

<strong>for</strong> all of the issued share capital of <strong>Evolution</strong> which values an <strong>Evolution</strong> Share at more than 10 per cent. of the value of the Offer.<br />

<strong>Investec</strong> has obtained letters of intent from Blackrock Investment Managers (UK) Limited, Majedie Asset Management, Aber<strong>for</strong>th Partners<br />

and Schroder Investment Management Limited <strong>to</strong> vote in favour of the Scheme and the Resolutions <strong>to</strong> be proposed at the Court Meeting<br />

and the General Meeting in respect of their respective holdings of 20,935,457, 6,266,555, 15,797,644, and 9,698,872 <strong>Evolution</strong><br />

Shares as at 8 September 2011. Aber<strong>for</strong>th Partners announced that it had sold 464,300 and 896,567 of its <strong>Evolution</strong> Shares respectively<br />

on 15 September 2011 and 16 September 2011 and that in light of those disposals, its intention <strong>to</strong> vote in favour of the Resolutions <strong>to</strong><br />

give effect <strong>to</strong> the Scheme applied <strong>to</strong> the 14,436,777 <strong>Evolution</strong> Shares it continues <strong>to</strong> own. Letters of intent have there<strong>for</strong>e been obtained<br />

over <strong>Evolution</strong> Shares representing, in aggregate, approximately 22.06 per cent. of the existing issued share capital of <strong>Evolution</strong>.<br />

9


Further details of these irrevocable undertakings and the letters of intent are set out in paragraph 6 of Part VI (Additional In<strong>for</strong>mation)<br />

of this document.<br />

5 <strong>Investec</strong>’s strategic plans <strong>for</strong> <strong>Evolution</strong> <strong>Group</strong> and intentions regarding management and employees<br />

<strong>The</strong>re is a strong geographic fit between the <strong>Investec</strong> and <strong>Evolution</strong> <strong>Group</strong> investment businesses, in particular, in relation <strong>to</strong> Williams de<br />

Broë’s wealth and investment businesses. Williams de Broë’s UK footprint will add <strong>to</strong> <strong>Investec</strong>’s existing UK network through its offices<br />

in Birmingham and the South-West of England. <strong>The</strong> <strong>Evolution</strong> Direc<strong>to</strong>rs believe that this will be beneficial <strong>to</strong> clients of the Enlarged <strong>Group</strong>.<br />

<strong>Investec</strong> has stated that whilst it may over time seek <strong>to</strong> consolidate operations in cities where the Enlarged <strong>Group</strong> has two offices, there<br />

are no current plans <strong>to</strong> change the locations of <strong>Investec</strong> or <strong>Evolution</strong>’s places of business or <strong>to</strong> redeploy the fixed assets of <strong>Evolution</strong>. <strong>The</strong><br />

<strong>Evolution</strong> Direc<strong>to</strong>rs believe this will provide a degree of stability <strong>for</strong> <strong>Evolution</strong> <strong>Group</strong>’s existing business.<br />

<strong>Investec</strong> has stated that it has great respect <strong>for</strong> the business that has been built up within Williams de Broë, in particular the client<br />

relationships of its investment managers and has indicated that it is committed <strong>to</strong> retaining these managers and supporting them in<br />

growing the relationships with their clients. <strong>Investec</strong>’s existing wealth and investment operation has proven and scalable settlement and<br />

support capability. Accordingly, <strong>Investec</strong> has indicated that it intends, through its strategic and integration committees, <strong>to</strong> achieve<br />

operational synergies, including some headcount reductions in support functions, but does not expect this <strong>to</strong> impact the client service<br />

and operational effectiveness of the business. <strong>The</strong> <strong>Evolution</strong> Direc<strong>to</strong>rs believe that <strong>Investec</strong>’s plans <strong>for</strong> the Williams de Broë business are<br />

compelling and acknowledge that some headcount reductions may be appropriate in this context.<br />

<strong>Investec</strong>’s stated existing strategy is <strong>to</strong> be the leading mid-market investment bank in the UK. Through the acquisition of <strong>Evolution</strong><br />

Securities, <strong>Investec</strong> has indicated that it expects <strong>to</strong> augment <strong>Investec</strong>’s existing well-ranked UK investment banking capabilities and<br />

strong corporate and institutional client franchise. <strong>Evolution</strong>’s fixed income and debt capital markets <strong>offer</strong>ing is considered <strong>to</strong> be a good<br />

complement <strong>to</strong> <strong>Investec</strong>’s existing business in that area. <strong>Investec</strong> has stated that it intends <strong>to</strong> reduce aggregate investment banking<br />

headcount <strong>to</strong> avoid unnecessary overlap with its existing activities whilst maintaining an appropriately sized employee base. <strong>The</strong> <strong>Evolution</strong><br />

Direc<strong>to</strong>rs are of the view that in the current climate, a rationalisation of the investment banking business of <strong>Evolution</strong> Securities would<br />

have been required in any event.<br />

<strong>The</strong> existing chief executive of <strong>Evolution</strong>, Alex Snow, will become the executive Chairman of <strong>Investec</strong>’s UK investment banking division<br />

and will join the boards of <strong>Investec</strong> Bank and <strong>Investec</strong> Wealth. David Currie will continue as head of <strong>Investec</strong>’s UK investment banking<br />

division. Philip Howell will remain the chief executive of Williams de Broë and will join the board of <strong>Investec</strong> Wealth and become a member<br />

of the strategic and integration committees of the greater wealth and investment group. Jonathan Wragg, the chief executive of <strong>Investec</strong><br />

Wealth and an existing member of the strategic and integration committees will join the board of Williams de Broë. <strong>The</strong> <strong>Evolution</strong><br />

Direc<strong>to</strong>rs believe that the involvement of Alex Snow and Philip Howell in senior management positions within the Enlarged <strong>Group</strong> will be<br />

beneficial <strong>to</strong> the effective integration of the respective businesses.<br />

<strong>Investec</strong> has confirmed that, following completion of the Offer, the existing employment rights, including pension rights, of the<br />

management and employees of <strong>Evolution</strong> will be fully safeguarded.<br />

In accordance with the requirements of Rule 2.12 of the Code, <strong>Evolution</strong> has made available <strong>to</strong> employees a copy of the announcement<br />

of the Offer published on 9 September 2011 and has in<strong>for</strong>med employees of the right of employee representatives under Rule 25.9 of<br />

the Code <strong>to</strong> require that a separate opinion of the employee representatives on the effects of the Offer on employment be appended <strong>to</strong><br />

this document. As at the date of publication of this document, no such opinion has been provided. If and <strong>to</strong> the extent that <strong>Evolution</strong> is<br />

provided with such an opinion after the date of publication of this document, <strong>Evolution</strong> will publish that opinion in accordance with the<br />

requirements of Rule 25.9 of the Code.<br />

6 <strong>Evolution</strong> Share Schemes<br />

Participants in the <strong>Evolution</strong> Share Schemes will be contacted separately regarding the effect of the Offer on their rights under the<br />

<strong>Evolution</strong> Share Schemes.<br />

Details of the impact of the Scheme on participants in the <strong>Evolution</strong> Share Schemes is set out in paragraph 11 of Part II (Explana<strong>to</strong>ry<br />

Statement) of this document.<br />

Following completion of the Offer, <strong>Evolution</strong> Shares will cease <strong>to</strong> be listed and no further awards will be made under the <strong>Evolution</strong> Share<br />

Schemes. <strong>The</strong> management and senior employees of <strong>Evolution</strong> will be included in <strong>Investec</strong>’s incentivisation arrangements following<br />

completion of the Offer. No proposals have been made on the terms of any incentivisation arrangements <strong>for</strong> relevant employees or<br />

managers or the continuing direc<strong>to</strong>rs.<br />

7 Implementation Agreement and break fee arrangements<br />

<strong>Evolution</strong> and <strong>Investec</strong> have entered in<strong>to</strong> an Implementation Agreement which provides, among other things, <strong>for</strong> the implementation of<br />

the Offer and contains certain assurances and confirmations between the parties, including provisions <strong>to</strong> implement the Scheme on a<br />

timely basis and governing the conduct of the business of <strong>Evolution</strong>. Further in<strong>for</strong>mation regarding the Implementation Agreement is set<br />

out in paragraph 9 of Part VI (Additional In<strong>for</strong>mation) of this document.<br />

8 Conditionality<br />

<strong>The</strong> Offer will be implemented <strong>by</strong> means of a scheme of arrangement of <strong>Evolution</strong> under Part 26 of the Companies Act and will be<br />

conditional upon, amongst other things, the approval of the Scheme <strong>by</strong> Shareholders and the sanction of the Scheme and the<br />

confirmation of the associated Capital Reduction <strong>by</strong> the Court.<br />

10


<strong>The</strong> Offer is also conditional on certain anti-trust and regula<strong>to</strong>ry conditions being fulfilled. Please refer <strong>to</strong> paragraph 14 of Part II<br />

(Explana<strong>to</strong>ry Statement) and Part IV (Conditions and Further Terms) of this document <strong>for</strong> the further details of the Conditions <strong>to</strong> the Offer.<br />

9 Cancellation of listing of <strong>Evolution</strong> Shares and re-registration<br />

Your attention is drawn <strong>to</strong> paragraph 15 of the letter from Credit Suisse set out in Part II (Explana<strong>to</strong>ry Statement) of this document in<br />

relation <strong>to</strong> <strong>Investec</strong>’s intentions regarding the de-listing and cancellation of trading in <strong>Evolution</strong> Shares and re-registration of <strong>Evolution</strong> as<br />

a private company following the Effective Date.<br />

10 UK taxation<br />

Your attention is drawn <strong>to</strong> Part V (United Kingdom Taxation) of this document. If you are in any doubt as <strong>to</strong> your tax position, or you are<br />

subject <strong>to</strong> taxation in any jurisdiction other than the UK, you are strongly advised <strong>to</strong> consult an appropriate professional independent<br />

financial adviser.<br />

11 Overseas Shareholders<br />

Overseas Shareholders should refer <strong>to</strong> paragraph 17 of Part II (Explana<strong>to</strong>ry Statement) of this document.<br />

12 Shareholder Meetings<br />

<strong>The</strong> Scheme requires the approval of <strong>Evolution</strong> Shareholders <strong>by</strong> the passing of a resolution at the Court Meeting <strong>to</strong> be held on 27 Oc<strong>to</strong>ber<br />

2011. <strong>The</strong> resolution must be approved <strong>by</strong> a majority in number of the <strong>Evolution</strong> Shareholders present and voting, either in person or <strong>by</strong><br />

proxy, representing not less than 75 per cent. in value of the <strong>Evolution</strong> Shares in respect of which votes are cast <strong>by</strong> such <strong>Evolution</strong><br />

Shareholders.<br />

Implementation of the Scheme will also require the passing of the General Meeting Resolution (requiring the approval of <strong>Evolution</strong><br />

Shareholders representing at least 75 per cent. of the votes cast) at the General Meeting, which will be held immediately after the Court<br />

Meeting.<br />

Following the Shareholder Meetings, the Scheme and the related Capital Reduction must be sanctioned, authorised and confirmed <strong>by</strong><br />

the Court and will only become effective upon the delivery of the Scheme Court Order <strong>to</strong> the Registrar of Companies. Upon the Scheme<br />

becoming effective, it will be binding on all <strong>Evolution</strong> Shareholders irrespective of whether or not they attended or voted at the Court<br />

Meeting or the General Meeting (and, if they attended and voted, whether or not they voted in favour).<br />

Your attention is drawn <strong>to</strong> paragraph 13 Part II (Explana<strong>to</strong>ry Statement) of this document which contains further in<strong>for</strong>mation with respect<br />

<strong>to</strong> the Shareholder Meetings.<br />

It is important that, <strong>for</strong> the Court Meeting in particular, as many votes as possible are cast so that the Court may be satisfied<br />

that there is a fair and reasonable representation of Shareholder opinion. You are there<strong>for</strong>e strongly urged <strong>to</strong> complete, sign<br />

and return the BLUE Form of Proxy <strong>for</strong> the Court Meeting as soon as possible.<br />

13 Action <strong>to</strong> be taken<br />

Notices convening the Court Meeting and the General Meeting are set out in Parts IX and X, respectively, of this document. You will find<br />

accompanying this document a BLUE Form of Proxy <strong>for</strong> use at the Court Meeting and a WHITE Form of Proxy <strong>for</strong> use at the General<br />

Meeting.<br />

Whether or not you intend <strong>to</strong> be present at either Shareholder Meeting, you are requested <strong>to</strong> complete, sign and return both the<br />

accompanying Form of Proxy <strong>for</strong> the Court Meeting (BLUE) and the accompanying Form of Proxy <strong>for</strong> the General Meeting (WHITE) in<br />

accordance with the instructions printed on the respective <strong>for</strong>ms.<br />

If you hold your <strong>Evolution</strong> Shares in uncertificated <strong>for</strong>m, you may vote using the CREST Proxy Voting Service in accordance with the<br />

procedures set out in the CREST Manual (please also refer <strong>to</strong> the notes <strong>to</strong> the notices of the Court Meeting and the General Meeting set<br />

out in Parts IX and X respectively).<br />

You may appoint a proxy electronically <strong>by</strong> logging on <strong>to</strong> the website of Capita at www.capitashareportal.com and entering the voting ID,<br />

task ID and shareholder reference number shown on your Forms of Proxy. Full details of the procedure <strong>to</strong> be followed <strong>to</strong> appoint a proxy<br />

electronically are given on the website. Further in<strong>for</strong>mation is also included in the instructions included on the Forms of Proxy.<br />

Your attention is drawn <strong>to</strong> pages 6 <strong>to</strong> 7 of this document (Action <strong>to</strong> be taken) which explains in detail the action you should take in<br />

relation <strong>to</strong> the Offer and the Scheme.<br />

14 Further in<strong>for</strong>mation<br />

Your attention is drawn <strong>to</strong> the further in<strong>for</strong>mation contained in Part II (Explana<strong>to</strong>ry Statement), Part III (<strong>The</strong> Scheme of Arrangement),<br />

Part IV (Conditions and Further Terms), Part V (United Kingdom Taxation) and Part VI (Additional In<strong>for</strong>mation) of this document and <strong>to</strong><br />

the expected timetable of principal events set out on page 5 of this document. Please note that the timings set out in this document are<br />

indicative only and subject <strong>to</strong> change. You should also refer <strong>to</strong> the in<strong>for</strong>mation incorporated <strong>by</strong> reference referred <strong>to</strong> in Part VII.<br />

You are advised <strong>to</strong> read the whole of this document and not just rely on the summary in<strong>for</strong>mation contained in this letter.<br />

If you have any further questions about this document, the Court Meeting, the General Meeting, or the Offer, including in relation <strong>to</strong> the<br />

completion and return of the Forms of Proxy, please call the Shareholder Helpline on 0871 664 0300 from within the UK or on +44 20<br />

8639 3399 if you are calling from outside the UK. Calls <strong>to</strong> the 0871 664 0300 number cost 10 pence per minute plus network extras.<br />

Lines are open 8.30 a.m. <strong>to</strong> 5.30 p.m. (London time) Monday <strong>to</strong> Friday (except UK public holidays). Calls <strong>to</strong> the helpline from outside<br />

the UK will be charged at the applicable international rate. Different charges may apply <strong>to</strong> calls from mobile telephones and calls may<br />

11


e recorded and randomly moni<strong>to</strong>red <strong>for</strong> security and training purposes. <strong>The</strong> helpline cannot provide advice on the merits of the Offer<br />

nor give any financial, legal or tax advice.<br />

15 Recommendation<br />

<strong>The</strong> <strong>Evolution</strong> Direc<strong>to</strong>rs, who have been so advised <strong>by</strong> Credit Suisse (as the independent advisers <strong>for</strong> the purposes of Rule<br />

3 of the Code), consider the terms of the Offer <strong>to</strong> be fair and reasonable <strong>for</strong> <strong>Evolution</strong> Shareholders. In providing advice <strong>to</strong><br />

the <strong>Evolution</strong> Direc<strong>to</strong>rs, Credit Suisse has taken in<strong>to</strong> account the commercial assessments of the <strong>Evolution</strong> Direc<strong>to</strong>rs. <strong>The</strong><br />

<strong>Evolution</strong> Direc<strong>to</strong>rs consider the terms of the Offer <strong>to</strong> be in the best interests of <strong>Evolution</strong> Shareholders as a whole.<br />

Accordingly, the <strong>Evolution</strong> Direc<strong>to</strong>rs unanimously recommend that <strong>Evolution</strong> Shareholders vote in favour of the Scheme at<br />

the Court Meeting and in favour of the General Meeting Resolution, as they have irrevocably undertaken <strong>to</strong> do themselves<br />

in respect of their own beneficial holdings of 6,027,184 <strong>Evolution</strong> Shares (representing as at the latest practicable date prior<br />

<strong>to</strong> the publication of this document, in aggregate, approximately 2.59 per cent. of the existing issued share capital of<br />

<strong>Evolution</strong>).<br />

Yours faithfully<br />

Martin Gray<br />

Non-Executive Chairman<br />

<strong>The</strong> <strong>Evolution</strong> <strong>Group</strong> <strong>Plc</strong><br />

12


3 Oc<strong>to</strong>ber 2011<br />

To all holders of <strong>Evolution</strong> Shares<br />

Dear <strong>Evolution</strong> Shareholder,<br />

PART II<br />

EXPLANATORY STATEMENT<br />

(in compliance with section 897 of the Companies Act 2006)<br />

<strong>Recommended</strong> Offer <strong>for</strong> <strong>Evolution</strong> <strong>by</strong> <strong>Investec</strong><br />

Credit Suisse Securities (Europe) Limited<br />

One Cabot Square<br />

London E14 4QJ<br />

1 Introduction<br />

On 9 September 2011, the <strong>Evolution</strong> Direc<strong>to</strong>rs and the <strong>Investec</strong> Direc<strong>to</strong>rs announced that they had agreed the terms of a recommended<br />

all share <strong>offer</strong> under which <strong>Investec</strong> will acquire the entire issued ordinary share capital of <strong>Evolution</strong>, <strong>to</strong> be effected <strong>by</strong> means of a scheme<br />

of arrangement pursuant <strong>to</strong> the provisions of Part 26 of the Companies Act, including a reduction of capital.<br />

We have been authorised <strong>by</strong> the <strong>Evolution</strong> Direc<strong>to</strong>rs <strong>to</strong> write <strong>to</strong> you <strong>to</strong> explain the terms of the Offer and <strong>to</strong> provide you with other relevant<br />

in<strong>for</strong>mation.<br />

Your attention is drawn <strong>to</strong> the letter from the Chairman of <strong>Evolution</strong> set out in Part I of this document which <strong>for</strong>ms part of<br />

this explana<strong>to</strong>ry statement. That letter explains, amongst other things, why the <strong>Evolution</strong> Direc<strong>to</strong>rs, who have been so<br />

advised <strong>by</strong> Credit Suisse, consider the terms of the Offer <strong>to</strong> be fair and reasonable <strong>for</strong> <strong>Evolution</strong> Shareholders. In providing<br />

advice <strong>to</strong> the <strong>Evolution</strong> Direc<strong>to</strong>rs, Credit Suisse has taken in<strong>to</strong> account the commercial assessments of the <strong>Evolution</strong><br />

Direc<strong>to</strong>rs. <strong>The</strong> letter also explains why the <strong>Evolution</strong> Direc<strong>to</strong>rs consider the terms of the Offer <strong>to</strong> be in the best interests of<br />

<strong>Evolution</strong> Shareholders as a whole.<br />

Accordingly, the <strong>Evolution</strong> Direc<strong>to</strong>rs unanimously recommend that <strong>Evolution</strong> Shareholders vote in favour of the Scheme at<br />

the Court Meeting and in favour of the General Meeting Resolution, as they have irrevocably undertaken <strong>to</strong> do themselves<br />

in respect of their own beneficial holdings of 6,027,184 <strong>Evolution</strong> Shares (representing as at the latest practicable date prior<br />

<strong>to</strong> publication of this document, in aggregate, approximately 2.59 per cent. of the existing issued share capital of <strong>Evolution</strong>).<br />

If you wish <strong>to</strong> vote in favour of the Resolutions <strong>to</strong> implement the Scheme, please take the actions described at pages 6 <strong>to</strong> 7 (Action <strong>to</strong><br />

be Taken) of this document within the timeframes stipulated. <strong>The</strong> terms of the Scheme are set out in full in Part III (<strong>The</strong> Scheme of<br />

Arrangement) of this document. Your attention is also drawn <strong>to</strong> Part IV (Conditions and Further Terms) of this document.<br />

2 Summary of the terms of the Offer<br />

Under the Offer, which will be subject <strong>to</strong> terms and conditions which are set out in Part IV (Conditions and Further Terms) of this<br />

document, <strong>Evolution</strong> Shareholders will, in aggregate, receive approximately 53.8 million fully paid newly issued <strong>Investec</strong> Shares. On the<br />

basis of the prevailing share price of <strong>Investec</strong>, being 433.5 pence, at the time the <strong>Evolution</strong> Direc<strong>to</strong>rs agreed in principle <strong>to</strong> give their<br />

recommendation, the Offer valued the entire issued share capital of <strong>Evolution</strong> at £233.2 million. Accordingly, <strong>Evolution</strong> Shareholders will<br />

receive:<br />

<strong>for</strong> each <strong>Evolution</strong> Share: 0.23124 New <strong>Investec</strong> Shares<br />

which, on the above basis, equates <strong>to</strong> a value of 100.24 pence per <strong>Evolution</strong> Share.<br />

<strong>The</strong> value of 100.24 pence <strong>for</strong> each <strong>Evolution</strong> Share represents a premium of:<br />

• approximately 44.7 per cent. <strong>to</strong> the average closing mid-market price per <strong>Evolution</strong> Share, of 69.2 pence, over the three month<br />

trading period <strong>to</strong> 2 August 2011 (being the last Business Day prior <strong>to</strong> the commencement of the Offer Period);<br />

• approximately 36.4 per cent. <strong>to</strong> the closing mid-market price per <strong>Evolution</strong> Share, of 73.5 pence, on 2 August 2011 (being the last<br />

Business Day prior <strong>to</strong> the commencement of the Offer Period); and<br />

• approximately 25.3 per cent. <strong>to</strong> the closing price per <strong>Evolution</strong> Share of 80.0 pence on 30 September 2011 (being the latest<br />

practicable date prior <strong>to</strong> the publication of this document).<br />

On the basis of the prevailing share price of <strong>Investec</strong> on 30 September 2011 (the latest practicable date prior <strong>to</strong> the publication of this<br />

document), being 349.6 pence, the Offer equates <strong>to</strong> a value of 80.84 pence per <strong>Evolution</strong> Share.<br />

13


<strong>The</strong> value of 80.84 pence <strong>for</strong> each <strong>Evolution</strong> Share represents a premium of:<br />

• approximately 16.8 per cent. <strong>to</strong> the average closing mid-market price per <strong>Evolution</strong> Share, of 69.2 pence, over the three month<br />

trading period <strong>to</strong> 2 August 2011 (being the last Business Day prior <strong>to</strong> the commencement of the Offer Period);<br />

• approximately 10.0 per cent. <strong>to</strong> the closing mid-market price per <strong>Evolution</strong> Share, of 73.5 pence, on 2 August 2011 (being the last<br />

Business Day prior <strong>to</strong> the commencement of the Offer Period); and<br />

• approximately 1.1 per cent. <strong>to</strong> the closing price per <strong>Evolution</strong> Share of 80.0 pence on 30 September 2011 (being the latest<br />

practicable date prior <strong>to</strong> the publication of this document).<br />

No dividends shall be paid <strong>by</strong> <strong>Evolution</strong> between the date of the Announcement and the Effective Date save <strong>for</strong> an interim dividend of 1<br />

pence per <strong>Evolution</strong> Share announced on 29 July 2011 and payable <strong>to</strong> shareholders on the register on 12 August 2011.<br />

3 New <strong>Investec</strong> Shares<br />

<strong>The</strong> New <strong>Investec</strong> Shares will be listed on the Official List, will be admitted <strong>to</strong> trading on the London S<strong>to</strong>ck Exchange and will be issued<br />

free from all liens, charges, encumbrances and other third party rights and/or interests of any nature whatsoever. On the basis of current<br />

expectations as <strong>to</strong> the timing of regula<strong>to</strong>ry approvals and Court availability, it is expected that New <strong>Investec</strong> Shares will be issued,<br />

Admission will become effective and dealings <strong>for</strong> normal settlement in the New <strong>Investec</strong> Shares will commence in December 2011.<br />

<strong>The</strong> New <strong>Investec</strong> Shares will be issued credited as fully paid and will rank on issue pari passu in all respects with the existing <strong>Investec</strong><br />

Shares. <strong>The</strong> expected transaction timetable is set out on page 5 of this document. <strong>The</strong> parties have agreed that, in light of the likely<br />

timetable <strong>for</strong> seeking regula<strong>to</strong>ry and anti-trust clearances, the Scheme will not become effective prior <strong>to</strong> 7 December 2011. <strong>The</strong> current<br />

expectation is that the Effective Date will occur in December. Although the precise timing and quantum of <strong>Investec</strong>’s interim dividend in<br />

respect of the six months ended 30 September 2011 remains <strong>to</strong> be announced, based on previous dividend timetables, it is expected<br />

that the New <strong>Investec</strong> Shares <strong>to</strong> be issued <strong>to</strong> <strong>Evolution</strong> Shareholders pursuant <strong>to</strong> the Scheme will be issued after the last cum-dividend<br />

trading date <strong>for</strong> such dividend and, accordingly, will not rank <strong>for</strong> any dividend declared <strong>by</strong> <strong>Investec</strong> in respect of such period.<br />

<strong>The</strong> New <strong>Investec</strong> Shares <strong>to</strong> be issued on the Scheme becoming effective <strong>to</strong> <strong>Evolution</strong> Shareholders on the register at the Scheme<br />

Record Time, will be issued in registered <strong>for</strong>m and will be capable of being held in certificated or uncertificated <strong>for</strong>m. Pending the issue<br />

of definitive certificates <strong>for</strong> the New <strong>Investec</strong> Shares, transfers of New <strong>Investec</strong> Shares in certificated <strong>for</strong>m will be certified against the<br />

register. No temporary documents of title in respect of the New <strong>Investec</strong> Shares will be issued.<br />

4 Financial effects of the Offer<br />

As a result of and following completion of the acquisition, <strong>Investec</strong> expects <strong>to</strong> consolidate <strong>Evolution</strong>’s assets and liabilities. As at 30 June<br />

2011, being the end of <strong>Evolution</strong>’s half year, and under <strong>Evolution</strong>’s his<strong>to</strong>rical accounting policies, <strong>Evolution</strong> had a book tangible net asset<br />

value of £108.8 million. A fair value assessment of <strong>Evolution</strong>’s assets, liabilities and business will be required <strong>to</strong> be carried out under<br />

<strong>Investec</strong>’s accounting policies following completion of the Offer <strong>to</strong> determine the on-going tangible and intangible carrying values at<br />

which the <strong>Evolution</strong> business will be carried on <strong>Investec</strong>’s Balance Sheet.<br />

<strong>The</strong> acquisition is expected <strong>to</strong> be marginally earnings per share dilutive (be<strong>for</strong>e any IFRS fair value, other adjustments and one-off<br />

integration costs) in the first year of ownership following completion of the Offer of the <strong>Investec</strong> <strong>Group</strong>. This statement should not be<br />

construed as a profit <strong>for</strong>ecast or be interpreted <strong>to</strong> mean that the future earnings per share, profits, margins or cash flows of <strong>Investec</strong> will<br />

necessarily be greater or less than the his<strong>to</strong>ric published earnings per share, profits, margins or cash flows of <strong>Investec</strong>.<br />

Under the Offer, <strong>Evolution</strong> Shareholders will receive 0.23124 New <strong>Investec</strong> Shares <strong>for</strong> every <strong>Evolution</strong> Share held. <strong>The</strong> following table<br />

sets out, <strong>for</strong> illustrative purposes only and on the bases and assumptions set out in the notes below, the financial effects of the Offer on<br />

the capital value and income <strong>for</strong> a holder of one <strong>Evolution</strong> Share, if the Scheme becomes effective:<br />

(a) Increase in Capital Value<br />

Note Pence<br />

Market value of 0.23124 New <strong>Investec</strong> Share 1 80.84<br />

Market value of one <strong>Evolution</strong> Share 2 80.00<br />

Increase in capital value 3 0.84<br />

This represents an increase of 1.1%<br />

(b) Increase in Income<br />

Note Pence<br />

Dividend income from 0.23124 New <strong>Investec</strong> Shares 4 3.90<br />

Dividend income from one <strong>Evolution</strong> Share 5 2.80<br />

Increase in income 3 1.20<br />

This represents an increase in income of 42.9%<br />

14


Notes:<br />

(1) <strong>The</strong> market value of New <strong>Investec</strong> Shares is based on the closing mid-market quotation of 349.6 pence per <strong>Investec</strong> Share as at the close of<br />

business on 30 September 2011, being the latest practicable date prior <strong>to</strong> publication of this document.<br />

(2) <strong>The</strong> market value of one <strong>Evolution</strong> Share is based on the closing mid-market quotation of 80 pence per <strong>Evolution</strong> Share as at the close of business<br />

on 30 September 2011, being the latest practicable date prior <strong>to</strong> the publication of this document.<br />

(3) In assessing the financial effects of receiving New <strong>Investec</strong> Shares, no account has been taken of any potential taxation liability of an <strong>Evolution</strong><br />

Shareholder or of any timing differences in the payment of dividends.<br />

(4) <strong>The</strong> dividend income from one <strong>Investec</strong> Share is the aggregate of the 8.0 pence interim dividend <strong>for</strong> the six months ended 30 September 2010<br />

(announced on 8 November 2010 and paid on 21 December 2010) and the 9.0 pence final dividend <strong>for</strong> the year ended 31 March 2011, grossed<br />

up <strong>by</strong> the exchange ratio of 0.23124 <strong>Investec</strong> shares per <strong>Evolution</strong> Share. See paragraph 2 of the Part I (Letter from the Chairman of <strong>The</strong> <strong>Evolution</strong><br />

<strong>Group</strong> <strong>Plc</strong>) in relation <strong>to</strong> likely timing of the transaction and <strong>Investec</strong>’s interim dividend in respect of the six months ended 30 September 2011.<br />

(5) <strong>The</strong> dividend income from one <strong>Evolution</strong> Share is the aggregate of the 1.0 pence interim dividend <strong>for</strong> the six months ended 30 June 2011<br />

(announced on 29 July 2011 and payable on 12 August 2011) and the 1.75 pence final dividend <strong>for</strong> the year ended 31 December 2010.<br />

5 Background <strong>to</strong> and reasons <strong>for</strong> the Offer<br />

As a specialist bank and asset manager, the <strong>Investec</strong> <strong>Group</strong> has focused on developing a balanced and diversified portfolio of businesses<br />

serving the needs of select market niches where it can compete effectively. <strong>The</strong> <strong>Investec</strong> <strong>Group</strong>’s private client investment management<br />

and asset management activities have developed strongly over the past few years and are core components of its business model.<br />

<strong>The</strong> <strong>Investec</strong> <strong>Group</strong> seeks <strong>to</strong> maintain an appropriate balance between revenue earned from operational risk businesses and revenue<br />

earned from financial risk businesses. This ensures that the <strong>Investec</strong> <strong>Group</strong> is not over-reliant on any one part of its business <strong>to</strong> sustain<br />

its activities and that it has a large recurring revenue base that the direc<strong>to</strong>rs of <strong>Investec</strong> believe enable it <strong>to</strong> better navigate through<br />

varying cycles and <strong>to</strong> support its long-term growth objectives. <strong>The</strong> Offer is supportive of these long-term growth objectives.<br />

<strong>The</strong> <strong>Investec</strong> <strong>Group</strong>’s current strategic objectives include increasing the proportion of its non-lending revenue base. Against this<br />

background, the <strong>Investec</strong> <strong>Group</strong> intends <strong>to</strong> continue <strong>to</strong> strengthen and develop its private client investment management and asset<br />

management plat<strong>for</strong>ms.<br />

<strong>Evolution</strong>’s principal operating activities comprise a private client investment management division and an investment banking division.<br />

As at 30 June 2011, <strong>Evolution</strong> had net tangible assets of £108.8 million, which included cash and cash equivalents of £73.7 million,<br />

and assets under management of £6.0 billion. Subsequent <strong>to</strong> that date, <strong>Evolution</strong> announced it had reached agreement <strong>to</strong> acquire BNP<br />

Paribas Private Investment Management which, as at 30 June 2011, had assets under management of approximately £1.8 billion.<br />

<strong>Investec</strong> has grown its private client investment management and wealth management operations over many years, most recently with<br />

the acquisition in 2010 of the 53 per cent. stake in Rensburg Sheppards not already owned <strong>by</strong> it having held 47 per cent. and had a<br />

close working relationship with the business over the previous 5 years. <strong>The</strong> business is now branded as <strong>Investec</strong> Wealth & Investment<br />

with assets under management at 31 March 2011 of £14.9 billion in the UK as well as having an international reach and <strong>for</strong>ming one<br />

of the core pillars of the global <strong>Investec</strong> <strong>Group</strong>. <strong>The</strong> acquisition of <strong>Evolution</strong> is designed <strong>to</strong> create a major UK player in the private client<br />

investment management industry that would benefit from increased resources and expertise and enjoy further economies of scale. <strong>The</strong>re<br />

is a strong geographic fit between the two businesses, with <strong>Evolution</strong>’s UK footprint adding <strong>to</strong> <strong>Investec</strong>’s existing UK network through its<br />

offices in Birmingham and the South-West of England. <strong>Investec</strong> believes that it is a well-known and respected business, and that this<br />

will be reassuring <strong>to</strong> Williams de Broë’s clients and its employees following completion of the transaction and subsequent integration.<br />

<strong>Investec</strong> has grown its UK investment banking operations considerably since the acquisition of Guinness Mahon Holdings PLC in 1998.<br />

<strong>The</strong> business <strong>offer</strong>s a full service mid-market investment banking capability comprising both corporate finance and securities, acting <strong>for</strong><br />

corporate and institutional clients. It has 90 retained UK listed corporate clients of which 24 are in the FTSE 250, publishes research on<br />

309 UK listed groups, makes markets in c.200 s<strong>to</strong>cks and in June 2011 was ranked No.1 Small and Mid-Cap and No.2 in the UK<br />

brokerage Extel awards. <strong>The</strong> division increasingly benefits from the capabilities of <strong>Investec</strong> UK’s capital markets division. <strong>The</strong> acquisition<br />

of <strong>Evolution</strong>’s equities, corporate finance, fixed income and debt advisory activities is designed <strong>to</strong> augment the existing operations <strong>to</strong><br />

provide a stronger combined investment banking operation.<br />

<strong>Investec</strong> believes that the Offer represents a compelling strategic fit and that the combination of <strong>Investec</strong>’s existing private client<br />

investment management business with that of Williams de Broë will create a stronger plat<strong>for</strong>m, allowing it <strong>to</strong> significantly enhance its<br />

market position. Furthermore, there is great potential <strong>to</strong> generate longer term value <strong>for</strong> the combined business and its employees.<br />

<strong>Investec</strong> also believes a combination of <strong>Evolution</strong> Securities with <strong>Investec</strong> Investment Bank will contribute <strong>to</strong> its existing strategy <strong>to</strong> be<br />

the leading mid-market investment bank in the UK.<br />

6 Background <strong>to</strong> and reasons <strong>for</strong> the recommendation<br />

Your attention is drawn <strong>to</strong> paragraph 3 of the letter from the Chairman of <strong>Evolution</strong> in Part I of this document which sets out the<br />

background <strong>to</strong> and reasons <strong>for</strong> the recommendation of the Offer <strong>by</strong> the <strong>Evolution</strong> Direc<strong>to</strong>rs.<br />

7 In<strong>for</strong>mation on the <strong>Investec</strong> <strong>Group</strong><br />

<strong>The</strong> <strong>Investec</strong> <strong>Group</strong> is an international specialist bank and asset manager that provides a diverse range of financial products and services<br />

<strong>to</strong> a select client base. It was founded as a leasing company in Johannesburg in 1974, acquired a banking licence in 1980 and was listed<br />

on the JSE Limited South Africa in 1986.<br />

In July 2002, the <strong>Investec</strong> <strong>Group</strong> implemented a dual listed companies structure, which synthetically merged <strong>Investec</strong>, listed on the<br />

Official List and traded on the London S<strong>to</strong>ck Exchange, with <strong>Investec</strong> Limited, which is listed on the JSE. <strong>Investec</strong> also has a secondary<br />

listing on the JSE. <strong>Investec</strong> is a constituent of the FTSE 100 index and <strong>to</strong>gether with <strong>Investec</strong> Limited has a pro <strong>for</strong>ma market capitalisation<br />

15


of approximately £3.0 billion as at 29 September 2011.<br />

<strong>The</strong> <strong>Investec</strong> <strong>Group</strong> has expanded through a combination of substantial organic growth and a series of strategic acquisitions. It now has<br />

an efficient integrated international business plat<strong>for</strong>m <strong>offer</strong>ing all of its core activities in the UK and South Africa, with select activities<br />

in Australia and elsewhere.<br />

<strong>The</strong> <strong>Investec</strong> <strong>Group</strong> is organised as a network comprising six business divisions: asset management, wealth & investment, property<br />

activities, private banking, investment banking and capital markets. Its head office provides certain group-wide integrating functions and<br />

is also responsible <strong>for</strong> its central funding and the trade finance business.<br />

For the year ended 31 March 2011, the <strong>Investec</strong> <strong>Group</strong> reported operating profit (net profit be<strong>for</strong>e tax, goodwill, acquired intangibles and<br />

non-operating items but after earnings attributable <strong>to</strong> non-controlling interests) of £434.4 million, assets of £50.9 billion, <strong>to</strong>tal capital<br />

resources of £5.2 billion and <strong>to</strong>tal third party assets under management of £88.9 billion.<br />

<strong>Investec</strong> currently has a long term issuer rating of Ba1 (Moody’s) with a negative outlook. This has remained unchanged throughout the<br />

Offer Period.<br />

<strong>The</strong> following text has been extracted from the <strong>Investec</strong> <strong>Group</strong>’s pre-close trading update released on 15 September 2011:<br />

Against a backdrop of poor economic fundamentals and weak debt and equity markets, operating conditions have been more difficult<br />

than originally anticipated. <strong>The</strong> Asset Management and Wealth Management businesses have continued <strong>to</strong> per<strong>for</strong>m well as a result of<br />

increased average funds under management and net inflows. <strong>The</strong> Specialist Banking businesses have benefited from growth in net<br />

interest income and fee income but earnings from principal activities have been under pressure. <strong>The</strong> <strong>Investec</strong> <strong>Group</strong>’s geographical and<br />

operational diversity has, however, supported a sound operational per<strong>for</strong>mance.<br />

Salient financial features include:<br />

• Since 31 March 2011:<br />

16<br />

• Core loans and advances are marginally down <strong>to</strong> £18.6 billion, however, in neutral currency they have increased <strong>by</strong> 2 per cent.;<br />

• Cus<strong>to</strong>mer deposits increased <strong>by</strong> 3 per cent. <strong>to</strong> £25.1 billion;<br />

• Third party assets under management decreased <strong>by</strong> 4 per cent. <strong>to</strong> £85.6 billion, as a result of weak markets, notwithstanding<br />

net inflows of c.£2.6 billion.<br />

• Core advances (excluding own originated securitised assets) as a percentage of the cus<strong>to</strong>mer deposits were 70.0 per cent.<br />

(31 March 2011: 72.4 per cent.).<br />

• <strong>The</strong> <strong>Investec</strong> <strong>Group</strong> has a sound balance sheet with low gearing, substantial cash and near cash and solid capital ratios.<br />

Operating conditions are difficult as the global geopolitical landscape remains uncertain. <strong>The</strong> <strong>Investec</strong> <strong>Group</strong>’s operational per<strong>for</strong>mance<br />

remains stable underpinned <strong>by</strong> a solid recurring income base.<br />

Financial In<strong>for</strong>mation on <strong>Investec</strong> is incorporated <strong>by</strong> reference in Part VII of this document.<br />

8 In<strong>for</strong>mation on <strong>Evolution</strong><br />

<strong>Evolution</strong> is the holding company of <strong>Evolution</strong> Securities, Williams de Broë and Darwin Strategic. Founded in April 2001, <strong>Evolution</strong> is<br />

listed on the Official List and traded on the London S<strong>to</strong>ck Exchange.<br />

Williams de Broë is one of the UK’s leading and fastest growing private client investment managers, with a heritage dating back <strong>to</strong> 1869<br />

and offices in Bath, Birmingham, Bournemouth, Edinburgh, Exeter, Guild<strong>for</strong>d and London.<br />

<strong>The</strong> business employs over 150 investment professionals in seven UK locations, including over 70 investment managers providing a<br />

comprehensive range of investment services <strong>to</strong> all of its clients and their professional advisers.<br />

<strong>Evolution</strong> has expanded its private client business over the last five years both through organic growth and with the successful integration<br />

in 2009 of the new teams in Edinburgh and the Singer & Friedlander Investment Management Limited acquisition in London, repositioning<br />

the business in its sec<strong>to</strong>r.<br />

Williams de Broë’s per<strong>for</strong>mance and research capability have most recently been recognised <strong>by</strong>:<br />

• <strong>The</strong> Daily Telegraph Wealth Management awards, winning Research Analyst of the Year 2010, and<br />

• <strong>The</strong> Financial Times Wealth Management Review 2011 where two of its portfolio strategies were ranked first and second <strong>for</strong><br />

per<strong>for</strong>mance over the past 3 years.<br />

As at 30 June 2011, Williams de Broë had assets under management of approximately £6.0 billion. Subsequent <strong>to</strong> that date, <strong>Evolution</strong><br />

announced that Williams de Broë had reached agreement <strong>to</strong> acquire BNP Paribas Private Investment Management. As at 30 June 2011<br />

BNP Paribas Private Investment Management had assets under management of approximately £1.8 billion.<br />

<strong>Evolution</strong> Securities is a leading investment bank focused on serving an international institutional corporate client base, specialising in<br />

the UK and European equity and debt markets. Services include equity and fixed income research, institutional sales and trading, equity<br />

market making, debt capital markets and equity corporate finance and corporate broking.


<strong>Evolution</strong> Securities’ corporate broking and advisory team has 80 corporate clients. <strong>The</strong> business has executed 30 equity issues since<br />

January 2010 raising over £2.6 billion and has significant strength and track record in the natural resources sec<strong>to</strong>rs.<br />

<strong>Evolution</strong> Securities publishes research on more than 250 UK and Pan-European listed companies, and makes markets in over 400<br />

s<strong>to</strong>cks. <strong>Evolution</strong> Securities was ranked first in both FTSE 100 and FTSE 250 s<strong>to</strong>ck recommendation categories <strong>by</strong> StarMine Analyst<br />

Awards.<br />

<strong>Evolution</strong> Securities was voted Top European Fixed Income Agency Broker of 2011 <strong>by</strong> Credit Magazine <strong>for</strong> the 3rd consecutive year. In<br />

2010 the fixed income business traded over EUR16 billion worth of bonds in more than 2,100 different securities.<br />

<strong>Evolution</strong> Securities has also been a market leader in the debt capital markets business during 2011, resulting in the successful<br />

issuances of retail bonds <strong>for</strong> Tesco, Provident Financial and Places <strong>for</strong> People raising in excess of £300 million.<br />

For the 6 months ended 30 June 2011, the <strong>Evolution</strong> <strong>Group</strong> reported an after tax profit of £2.8 million and gross assets of £372.1 million.<br />

For the 12 month period ended 31 December 2010, the <strong>Evolution</strong> <strong>Group</strong> reported a loss after tax of £2.0 million.<br />

Since <strong>Evolution</strong>’s half year announcement on the 29 July 2011, market conditions have been extremely volatile. Equity markets in<br />

particular have remained extremely unpredictable, and have impacted revenues in a number of its businesses during August and early<br />

September 2011. Notwithstanding this, Williams de Broë continues <strong>to</strong> trade profitably, although <strong>to</strong>tal assets under management have<br />

fallen since June 2011 as a result of the sharp global decline in equity markets. Additionally, on 8 August 2011, the <strong>Evolution</strong> Direc<strong>to</strong>rs<br />

announced the acquisition of BNP Paribas Private Investment Management, which as at 30 June 2011, had assets under management<br />

of approximately £1.8 billion. This transaction, which is subject <strong>to</strong> FSA consent <strong>to</strong> the change of control, is expected <strong>to</strong> complete prior<br />

<strong>to</strong> the end of the current financial year. In <strong>Evolution</strong>’s securities business, <strong>Evolution</strong> Securities’, revenues in the short term have been<br />

impacted <strong>by</strong> the severe market shifts and ongoing weakness in market confidence. Despite the difficulties in <strong>for</strong>ecasting revenues in this<br />

area, the securities business has been active in securing a number of new corporate mandates expected <strong>to</strong> complete in the second half<br />

of 2011.<br />

<strong>The</strong> <strong>Evolution</strong> Direc<strong>to</strong>rs are not aware of any current ratings or outlooks publicly accorded <strong>to</strong> <strong>Evolution</strong> <strong>by</strong> ratings agencies.<br />

Financial in<strong>for</strong>mation on <strong>Evolution</strong> is incorporated <strong>by</strong> reference in Part VII of this document.<br />

9 Irrevocable undertakings and letters of intent<br />

<strong>Investec</strong> has received irrevocable undertakings from each of the <strong>Evolution</strong> Direc<strong>to</strong>rs who hold <strong>Evolution</strong> Shares <strong>to</strong> vote or procure the<br />

vote in favour of the resolutions <strong>to</strong> be proposed at the Court Meeting and the General Meeting in respect of their own beneficial holdings<br />

of 6,027,184 <strong>Evolution</strong> Shares, representing approximately 2.59 per cent. of the existing issued share capital of <strong>Evolution</strong>. <strong>The</strong><br />

undertakings given <strong>by</strong> the <strong>Evolution</strong> Direc<strong>to</strong>rs cease <strong>to</strong> be binding if the Scheme is withdrawn or lapses, unless <strong>Investec</strong> exercises its<br />

right <strong>to</strong> announce a Takeover Offer <strong>for</strong> the entire issued share capital of <strong>Evolution</strong>, not already owned <strong>by</strong> it, in which case it shall cease<br />

<strong>to</strong> have effect on the withdrawal or lapsing of the Takeover Offer.<br />

<strong>Investec</strong> has also received an irrevocable undertaking from Landsdowne Partners <strong>to</strong> vote or procure the vote in favour of the Resolutions<br />

<strong>to</strong> be proposed at the Court Meeting and the General Meeting in respect of their entire beneficial holdings of 12,809,506 <strong>Evolution</strong><br />

Shares, representing approximately 5.51 per cent. of the existing issued share capital of <strong>Evolution</strong>. <strong>The</strong> undertaking given <strong>by</strong> Landsdowne<br />

Partners will lapse and be of no effect if, inter alia, a third party announces a firm intention <strong>to</strong> make an <strong>offer</strong> under Rule 2.5 of the Code<br />

<strong>for</strong> all of the issued share capital of <strong>Evolution</strong> which values an <strong>Evolution</strong> Share at more than 10 per cent. of the value of the Offer.<br />

<strong>Investec</strong> has obtained letters of intent from Blackrock Investment Managers (UK) Limited, Majedie Asset Management, Aber<strong>for</strong>th<br />

Partners and Schroder Investment Management Limited <strong>to</strong> vote in favour of the Scheme and the Resolutions <strong>to</strong> be proposed at the<br />

Court Meeting and the General Meeting in respect of their respective holdings of 20,935,457, 6,266,555, 15,797,644 and 9,698,872<br />

<strong>Evolution</strong> Shares as at 8 September 2011. Aber<strong>for</strong>th Partners announced that it had sold 464,300 and 896,567 of its <strong>Evolution</strong> Shares<br />

respectively on 15 September 2011 and 16 September 2011 and that in light of those disposals, its intention <strong>to</strong> vote in favour of the<br />

Resolutions <strong>to</strong> give effect <strong>to</strong> the Scheme applied <strong>to</strong> the 14,436,777 <strong>Evolution</strong> Shares it continues <strong>to</strong> own. Letters of intent have there<strong>for</strong>e<br />

been obtained over <strong>Evolution</strong> Shares representing, in aggregate, approximately 22.06 per cent. of the existing issued share capital of<br />

<strong>Evolution</strong>.<br />

Further details of these irrevocable undertakings and the letters of intent are set out in paragraph 6 of Part VI (Additional In<strong>for</strong>mation)<br />

of this document.<br />

10 Intentions <strong>for</strong> <strong>Evolution</strong> <strong>Group</strong> management and employees<br />

In<strong>for</strong>mation regarding the intentions <strong>for</strong> the management and employees of <strong>Evolution</strong> and the views of the <strong>Evolution</strong> Direc<strong>to</strong>rs on this are<br />

set out in paragraph 5 of Part I (Letter from the Chairman of <strong>The</strong> <strong>Evolution</strong> <strong>Group</strong> <strong>Plc</strong>) of this document.<br />

11 <strong>Evolution</strong> Share Schemes<br />

Awards and options under the <strong>Evolution</strong> Share Schemes will vest and become exercisable in accordance with their terms as a result of<br />

the Offer and will be satisfied <strong>by</strong> transfers of <strong>Evolution</strong> Shares or New <strong>Investec</strong> Shares <strong>by</strong> the trustee of the Trust. In particular:<br />

• options which are not yet exercisable may be exercised conditionally on Court sanction and will lapse on Court sanction if not<br />

exercised;<br />

• all of the <strong>Evolution</strong> Shares subject <strong>to</strong> any call rights granted be<strong>for</strong>e 29 June 2011 and the call right granted <strong>to</strong> Mr. Snow on<br />

14 September referred <strong>to</strong> in paragraph 7.1(e) of Part VI (Additional In<strong>for</strong>mation) of this document will be au<strong>to</strong>matically exchanged<br />

<strong>for</strong> New <strong>Investec</strong> Shares on the terms of the Offer following the Effective Date. A proportion of awards over <strong>Evolution</strong> Shares held<br />

17


18<br />

<strong>by</strong> participants in the ESIP and call rights granted after 29 June 2011 (other than the call right granted <strong>to</strong> Mr. Snow referred <strong>to</strong><br />

above) will also be au<strong>to</strong>matically exchanged <strong>for</strong> New <strong>Investec</strong> Shares on the terms of the Offer following the Effective Date on a time<br />

apportioned basis, depending on the proportion of the per<strong>for</strong>mance period elapsed from the date of grant <strong>to</strong> the Effective Date;<br />

• interests in <strong>Evolution</strong> Shares held <strong>by</strong> participants under the JSOP may vest, subject <strong>to</strong> satisfaction of applicable per<strong>for</strong>mance<br />

conditions, but the majority will lapse and will be acquired <strong>by</strong> the trustee of the Trust <strong>for</strong> £1 in aggregate;<br />

• no entitlements <strong>to</strong> <strong>Evolution</strong> Shares will arise under the ESL GSOP or the WdeB GSOP; and<br />

• employees in the SIP will participate through the trustee of the SIP in respect of their <strong>Evolution</strong> Shares held in the SIP and <strong>Evolution</strong><br />

Shares will be exchanged <strong>for</strong> New <strong>Investec</strong> Shares on the terms of the Offer. <strong>The</strong> New <strong>Investec</strong> Shares will remain in the SIP on the<br />

same terms as the <strong>Evolution</strong> Shares but the plan will be closed and no further awards will be made following the Effective Date.<br />

Participants in the <strong>Evolution</strong> Share Schemes will be written <strong>to</strong> separately regarding the effect of the Offer on their rights under the<br />

<strong>Evolution</strong> Share Schemes.<br />

12 <strong>The</strong> <strong>Evolution</strong> Direc<strong>to</strong>rs and the effect of the Scheme on their interests<br />

<strong>The</strong> <strong>Evolution</strong> Shares held <strong>by</strong> the <strong>Evolution</strong> Direc<strong>to</strong>rs will be subject <strong>to</strong> the Scheme. In<strong>for</strong>mation on the <strong>Evolution</strong> Shares held <strong>by</strong> the<br />

<strong>Evolution</strong> Direc<strong>to</strong>rs is provided in paragraph 5 of Part VI (Additional In<strong>for</strong>mation) of this document.<br />

Particulars of the service contracts and letters of appointment of the <strong>Evolution</strong> Direc<strong>to</strong>rs are set out in paragraph 7 of Part VI (Additional<br />

In<strong>for</strong>mation) of this document.<br />

<strong>The</strong> effect of the Scheme on options and awards held <strong>by</strong> <strong>Evolution</strong> Direc<strong>to</strong>rs in common with those held <strong>by</strong> other participants in the<br />

<strong>Evolution</strong> Share Schemes, is described in paragraph 11 above of this Part II.<br />

Save as set out above, the effect of the Scheme on the interests of the <strong>Evolution</strong> Direc<strong>to</strong>rs does not differ from its effect on the like<br />

interest of any other Shareholder.<br />

13 Description of the Scheme and the Shareholder Meetings<br />

(a) <strong>The</strong> Scheme<br />

<strong>The</strong> Offer will be implemented <strong>by</strong> means of a Court-sanctioned scheme of arrangement between <strong>Evolution</strong> and its shareholders under<br />

Part 26 of the Companies Act. <strong>The</strong> provisions of the Scheme are set out in full in Part III (<strong>The</strong> Scheme of Arrangement) of this document.<br />

<strong>The</strong> purpose of the Scheme is <strong>to</strong> provide <strong>for</strong> <strong>Investec</strong> <strong>to</strong> become the holder of the entire issued ordinary share capital of <strong>Evolution</strong>. This<br />

is <strong>to</strong> be achieved <strong>by</strong> the cancellation of the <strong>Evolution</strong> Shares held <strong>by</strong> <strong>Evolution</strong> Shareholders and the application of the reserve arising<br />

from such cancellation in paying up in full such number of New <strong>Evolution</strong> Shares as is equal <strong>to</strong> the number of <strong>Evolution</strong> Shares cancelled,<br />

and issuing the same <strong>to</strong> <strong>Investec</strong> and/or its nominee(s). <strong>Investec</strong> will then issue New <strong>Investec</strong> Shares <strong>to</strong> <strong>Evolution</strong> Shareholders who hold<br />

<strong>Evolution</strong> Shares at the Scheme Record Time. Fractions of New <strong>Investec</strong> Shares will not be allotted or issued pursuant <strong>to</strong> the Scheme<br />

and will be disregarded.<br />

It is intended that <strong>Investec</strong> will acquire or have allotted <strong>to</strong> it one deferred <strong>Evolution</strong> Share prior <strong>to</strong> the Scheme Record Time and this<br />

deferred share will not be subject <strong>to</strong> the Scheme.<br />

To become effective, the Scheme requires, amongst other things, the approval <strong>by</strong> a majority in number of <strong>Evolution</strong> Shareholders<br />

representing at least 75 per cent. in value of the <strong>Evolution</strong> Shares held <strong>by</strong> such <strong>Evolution</strong> Shareholders voting, either in person or <strong>by</strong><br />

proxy, at the Court Meeting, <strong>to</strong>gether with the sanction of the Court and the passing <strong>by</strong> the <strong>Evolution</strong> Shareholders of the General<br />

Meeting Resolution necessary <strong>to</strong> implement the Scheme at the General Meeting.<br />

In addition, both the Scheme and the Capital Reduction must be approved <strong>by</strong> the Court. Upon implementation of the Scheme, the<br />

<strong>Evolution</strong> Shares will be cancelled and <strong>Evolution</strong> Shareholders will be issued New <strong>Investec</strong> Shares in proportion <strong>to</strong> their holdings as set<br />

out above.<br />

<strong>The</strong> Scheme also requires the satisfaction or waiver of the other Conditions set out in Part IV (Conditions and Further Terms) of this<br />

document. <strong>The</strong>se Conditions include, amongst others, the obtaining of certain anti-trust and regula<strong>to</strong>ry clearances. Upon the Scheme<br />

becoming effective, it will be binding on all Shareholders, irrespective of whether or not they attend or vote at the Court Meeting or the<br />

General Meeting (and, if they attended and voted, whether or not they voted in favour).<br />

(b) <strong>The</strong> Shareholder Meetings<br />

Be<strong>for</strong>e the Court’s approval can be sought <strong>to</strong> sanction the Scheme, the Scheme will require approval of <strong>Evolution</strong> Shareholders at the<br />

Court Meeting (being the approval of a majority in number of <strong>Evolution</strong> Shareholders who are present and vote either in person or <strong>by</strong><br />

proxy at the Court Meeting and who represent 75 per cent. or more in value of all <strong>Evolution</strong> Shares held <strong>by</strong> such <strong>Evolution</strong> Shareholders)<br />

and the passing of the General Meeting Resolution <strong>by</strong> Shareholders at the General Meeting.<br />

Notices of the Court Meeting and the General Meeting are set out in Parts IX (Notice of Court Meeting) and X (Notice of General Meeting)<br />

of this document respectively.<br />

All <strong>Evolution</strong> Shareholders whose names appear on the register of members of <strong>Evolution</strong> at 6.00 p.m. on 25 Oc<strong>to</strong>ber 2011 or, if such<br />

Shareholder Meetings are adjourned, on the register of members at 6.00 p.m. on the date two Business Days be<strong>for</strong>e the date set <strong>for</strong><br />

the adjourned Shareholder Meetings, shall be entitled <strong>to</strong> attend and vote at the relevant meeting in respect of the number of <strong>Evolution</strong><br />

Shares registered in their name at the relevant time.


<strong>The</strong> Court Meeting and General Meeting will be held at the offices of Jones Day at 21 Tudor Street, London EC4Y 0DJ.<br />

<strong>The</strong> Court Meeting<br />

<strong>The</strong> Court Meeting, which has been convened <strong>for</strong> 11.00 a.m. on 27 Oc<strong>to</strong>ber 2011, is being held at the direction of the Court <strong>to</strong> seek<br />

the approval of <strong>Evolution</strong> Shareholders <strong>for</strong> the Scheme. At the Court Meeting, voting will be <strong>by</strong> way of poll and each <strong>Evolution</strong> Shareholder<br />

present in person or <strong>by</strong> proxy will be entitled <strong>to</strong> one vote <strong>for</strong> each <strong>Evolution</strong> Share held. In order <strong>for</strong> the resolution <strong>to</strong> be passed, it must<br />

be approved <strong>by</strong> a majority in number of those <strong>Evolution</strong> Shareholders, present and voting, either in person or <strong>by</strong> proxy, representing 75<br />

per cent. or more in value of all <strong>Evolution</strong> Shares held <strong>by</strong> such <strong>Evolution</strong> Shareholders.<br />

It is important that, <strong>for</strong> the Court Meeting in particular, as many votes as possible are cast so that the Court may be satisfied<br />

that there is a fair and reasonable representation of Shareholder opinion.<br />

<strong>The</strong> General Meeting<br />

<strong>The</strong> General Meeting has been convened <strong>for</strong> 11.05 a.m. on 27 Oc<strong>to</strong>ber 2011, or as soon thereafter as the Court Meeting has concluded<br />

or been adjourned, <strong>to</strong> consider and, if thought fit, pass the General Meeting Resolution (which requires votes in favour representing at<br />

least 75 per cent. of the votes cast) <strong>to</strong> approve:<br />

(i) the cancellation of the <strong>Evolution</strong> Shares in accordance with the Scheme, representing a reduction of <strong>Evolution</strong>’s share capital equal<br />

<strong>to</strong> the aggregate nominal value of such shares;<br />

(ii) the subsequent issue of New <strong>Evolution</strong> Shares <strong>to</strong> <strong>Investec</strong> and/or its nominee(s) in accordance with the Scheme;<br />

(iii) the giving of authority <strong>to</strong> the <strong>Evolution</strong> Direc<strong>to</strong>rs pursuant <strong>to</strong> section 551 of the Companies Act <strong>to</strong> allot securities in <strong>Evolution</strong>;<br />

(iv) certain amendments <strong>to</strong> the <strong>Evolution</strong> Articles (as described below); and<br />

(v) the giving of authority <strong>to</strong> the <strong>Evolution</strong> Direc<strong>to</strong>rs <strong>to</strong> allot a Deferred Share <strong>for</strong> cash.<br />

<strong>The</strong> Deferred Share referred <strong>to</strong> in step (v) will be allotted and issued <strong>to</strong> <strong>Investec</strong> <strong>for</strong> a subscription price of one pence payable in cash.<br />

By acquiring the Deferred Share prior <strong>to</strong> the Effective Date, there will be no requirement under section 593 of the Companies Act <strong>for</strong> an<br />

independent valuation of the <strong>Evolution</strong> Shares allotted <strong>to</strong> <strong>Investec</strong> under the Scheme.<br />

Amendments <strong>to</strong> the <strong>Evolution</strong> Articles<br />

It is proposed that the <strong>Evolution</strong> Articles be amended <strong>to</strong> provide that, subject <strong>to</strong> the implementation of the Scheme, any <strong>Evolution</strong> Shares<br />

issued on or after the Effective Date (other than <strong>to</strong> <strong>Investec</strong> and/or its nominees) will immediately be transferred <strong>to</strong> <strong>Investec</strong> (or as it may<br />

direct) in consideration <strong>for</strong> and conditional upon <strong>Investec</strong> issuing 0.23124 New <strong>Investec</strong> Shares <strong>for</strong> each <strong>Evolution</strong> Share transferred (as<br />

adjusted <strong>by</strong> the <strong>Evolution</strong> Direc<strong>to</strong>rs in the event of any reorganisation of, or alteration <strong>to</strong>, the share capital of <strong>Evolution</strong> or <strong>Investec</strong> in such<br />

manner, if any, as <strong>Evolution</strong>’s audi<strong>to</strong>rs may determine <strong>to</strong> be appropriate).<br />

It is also proposed that the <strong>Evolution</strong> Articles be amended <strong>to</strong> ensure that any <strong>Evolution</strong> Shares which are issued after the General<br />

Meeting but be<strong>for</strong>e the Scheme Record Time will be subject <strong>to</strong> and bound <strong>by</strong> the Scheme.<br />

<strong>The</strong> proposed amendments <strong>to</strong> the <strong>Evolution</strong> Articles referred <strong>to</strong> above are set out in the Notice of General Meeting in Part X of this<br />

document.<br />

Entitlement <strong>to</strong> vote at the Shareholder Meetings<br />

Each holder of <strong>Evolution</strong> Shares who is entered in <strong>Evolution</strong>’s register of members at the Voting Record Time (expected <strong>to</strong> be 6.00 p.m.<br />

on 25 Oc<strong>to</strong>ber 2011) will be entitled <strong>to</strong> attend and vote at the Court Meeting and the General Meeting. If either Shareholder Meeting is<br />

adjourned, only those Shareholders on the register of members at 6.00 p.m. on the day which is two Business Days be<strong>for</strong>e the adjourned<br />

meeting will be entitled <strong>to</strong> attend and vote.<br />

Each Shareholder is entitled <strong>to</strong> appoint a proxy or proxies <strong>to</strong> attend and, on a poll, <strong>to</strong> vote instead of him or her. A proxy need not be a<br />

Shareholder of the Company. A BLUE Form of Proxy <strong>for</strong> the Court Meeting and a WHITE Form of Proxy <strong>for</strong> the General Meeting, are<br />

enclosed. To be valid those Forms of Proxy must be duly completed and signed and must be received <strong>by</strong> Capita, PXS, <strong>The</strong> Registry,<br />

34 Beckenham Road, Beckenham, Kent BR3 4TU <strong>by</strong> 11.00 a.m. (<strong>for</strong> the Court Meeting) and 11.05 a.m. (<strong>for</strong> the General Meeting), both<br />

times on 25 Oc<strong>to</strong>ber 2011. However, in the case of the Court Meeting, the BLUE Form of Proxy can also be handed <strong>to</strong> representatives<br />

of Capita or the Chairman of the meeting be<strong>for</strong>e the start of the meeting.<br />

If you propose <strong>to</strong> attend the Shareholder Meetings, please detach and bring with you the attendance slip <strong>to</strong> assist your<br />

admission.<br />

Shareholders who return completed Forms of Proxy may still attend the Shareholder Meetings instead of their proxies and vote in person<br />

if they wish. In the event of a poll on which a Shareholder votes in person, his/her proxy votes lodged with the Company will be excluded.<br />

Registered Shareholders are entitled <strong>to</strong> appoint a proxy in respect of some or all of their <strong>Evolution</strong> Shares. Registered Shareholders are<br />

also entitled <strong>to</strong> appoint more than one proxy. A space has been included in the Forms of Proxy <strong>to</strong> allow Shareholders <strong>to</strong> specify the<br />

number of <strong>Evolution</strong> Shares in respect of which that proxy is appointed. Shareholders who return a Form of Proxy duly executed but leave<br />

this space blank will be deemed <strong>to</strong> have appointed a proxy in respect of all of their <strong>Evolution</strong> Shares.<br />

Registered Shareholders who wish <strong>to</strong> appoint more than one proxy in respect of their shareholding should contact Capita <strong>for</strong> further<br />

Forms of Proxy or pho<strong>to</strong>copy the Forms of Proxy as required. Such Shareholders should also read the section entitled “Multiple Proxy<br />

Voting Instructions” on page 6 (Action <strong>to</strong> be Taken) of this document.<br />

19


If you hold your <strong>Evolution</strong> Shares in uncertificated <strong>for</strong>m (i.e. in CREST) you may vote using the CREST Proxy Voting Service in accordance<br />

with the procedures set out in the CREST manual (please also refer <strong>to</strong> the accompanying notes <strong>to</strong> the Notice of the General Meeting set<br />

out at the end of this document). Proxies submitted via CREST (under CREST participant ID RA10) must be received <strong>by</strong> Capita not later<br />

than 11.00 a.m. on 25 Oc<strong>to</strong>ber 2011 in the case of the Court Meeting and <strong>by</strong> 11.05 a.m. on 25 Oc<strong>to</strong>ber 2011 in the case of the General<br />

Meeting or, in the case of any adjournment, not later than 48 hours be<strong>for</strong>e the time fixed <strong>for</strong> the holding of the adjourned meeting.<br />

Shareholders entitled <strong>to</strong> attend and vote at the Shareholder Meetings may appoint a proxy electronically <strong>by</strong> logging on <strong>to</strong> the website of<br />

Capita at www.capitashareportal.com and entering the voting ID, task ID and shareholder reference number shown on their Forms of<br />

Proxy. Full details of the procedure <strong>to</strong> be followed <strong>to</strong> appoint a proxy electronically are given on the website. Further in<strong>for</strong>mation is also<br />

included in the instructions included on the Forms of Proxy.<br />

<strong>The</strong> completion and return of a Form of Proxy or the appointment of a proxy or proxies electronically or through CREST shall not prevent<br />

a Shareholder from attending and voting in person at either Shareholder Meeting or any adjournment thereof, if a Shareholder so wishes<br />

and is so certified.<br />

Further in<strong>for</strong>mation on the action <strong>to</strong> be taken is set out on pages 6 and 7 (Action <strong>to</strong> be Taken) of this document.<br />

(c) Sanction of the Scheme <strong>by</strong> the Court<br />

<strong>The</strong> Scheme also requires the sanction of the Court and the Capital Reduction must be confirmed <strong>by</strong> the Court. <strong>The</strong> Court hearing <strong>to</strong><br />

sanction the Scheme and confirm the Capital Reduction is expected <strong>to</strong> be held in December 2011. <strong>Investec</strong> has agreed <strong>to</strong> undertake <strong>to</strong><br />

the Court <strong>to</strong> execute and do and procure <strong>to</strong> be executed and done all such documents, acts and things as may be necessary or desirable<br />

<strong>to</strong> be executed or done <strong>by</strong> it <strong>for</strong> the purpose of giving effect <strong>to</strong> this Scheme.<br />

<strong>The</strong> Scheme will be implemented in accordance with its terms on delivery of a copy of the Scheme Court Order <strong>to</strong> the Registrar of<br />

Companies.<br />

If the Scheme is implemented, it will be binding on all Shareholders irrespective of whether or not they attend or vote in favour of the<br />

Scheme at the Court Meeting or in favour of the General Meeting Resolution at the General Meeting. If the Scheme is not implemented<br />

<strong>by</strong> 31 March 2012 (or such later date (if any) as <strong>Investec</strong> and <strong>Evolution</strong> may, with the consent of the Panel, agree and (if required) the<br />

Court may allow), the Scheme will not be implemented and the Offer will not proceed.<br />

14 Conditions <strong>to</strong> the Offer<br />

<strong>The</strong> Conditions <strong>to</strong> the Offer are set out in full in Part IV (Conditions and Further Terms) of this document. In summary, the Offer is<br />

conditional upon:<br />

(i) the Scheme becoming unconditional and being implemented <strong>by</strong> 31 March 2012 or such later date as the parties may agree with<br />

the consent of the Court and/or the Panel;<br />

(ii) the approval of the Scheme <strong>by</strong> a majority in number of those <strong>Evolution</strong> Shareholders who are present and vote either in person or<br />

<strong>by</strong> proxy at the Court Meeting and who represent 75 per cent. or more in value of the <strong>Evolution</strong> Shares held <strong>by</strong> them;<br />

(iii) the passing of the resolution necessary <strong>to</strong> approve and implement the Scheme, as set out in the notice of General Meeting at Part<br />

X (Notice of General Meeting) of this document;<br />

(iv) the sanction of the Scheme and confirmation of the Capital Reduction <strong>by</strong> the Court (in either case, with or without modification, on<br />

terms reasonably acceptable <strong>to</strong> <strong>Evolution</strong> and <strong>Investec</strong>);<br />

(v) the delivery of a copy of the Scheme Court Order <strong>to</strong> the Registrar of Companies;<br />

(vi) the UKLA having acknowledged <strong>to</strong> <strong>Investec</strong> or its agent (and such acknowledgement not having been withdrawn) that the application<br />

<strong>for</strong> the admission of the New <strong>Investec</strong> Shares <strong>to</strong> the Official List with a premium listing has been approved and (after satisfaction of<br />

any conditions <strong>to</strong> which such approval is expressed <strong>to</strong> be subject (“listing conditions”)) will become effective as soon as a dealing<br />

notice has been issued <strong>by</strong> the FSA and any listing conditions having been satisfied and the London S<strong>to</strong>ck Exchange having<br />

acknowledged <strong>to</strong> <strong>Investec</strong> or its agent (and such acknowledgement not having been withdrawn) that the New <strong>Investec</strong> Shares will<br />

be admitted <strong>to</strong> trading;<br />

(vii) the satisfaction or waiver of certain antitrust and regula<strong>to</strong>ry conditions, including, but not limited <strong>to</strong>, clearances from the OFT and<br />

Irish Competition Authority and approval from the FSA, Central Bank of Ireland and Hong Kong Securities and Futures Commission<br />

in respect of the Offer; and<br />

(viii) the other Conditions set out in Part IV (Conditions and Further Terms) of this document which are not otherwise summarised in<br />

paragraphs (i) <strong>to</strong> (vii) above being satisfied or waived.<br />

<strong>The</strong> Conditions relating <strong>to</strong> the approval of the Scheme <strong>by</strong> the <strong>Evolution</strong> Shareholders, the passing of the resolutions necessary <strong>to</strong><br />

implement the Scheme at the General Meeting, the sanction of the Scheme and confirmation of the Capital Reduction <strong>by</strong> the Court, and<br />

the Condition described in (vi) above regarding the Admission of the New <strong>Investec</strong> Shares, are not capable of being waived in whole or<br />

in part.<br />

15 Cancellation of listing of <strong>Evolution</strong> Shares and re-registration<br />

Prior <strong>to</strong> the Scheme becoming effective, applications will be made <strong>by</strong> <strong>Evolution</strong> <strong>to</strong> the UK Listing Authority <strong>to</strong> cancel the listing of the<br />

<strong>Evolution</strong> Shares on the Official List and <strong>to</strong> the London S<strong>to</strong>ck Exchange <strong>to</strong> cancel the admission <strong>to</strong> trading of the <strong>Evolution</strong> Shares on the<br />

20


London S<strong>to</strong>ck Exchange’s market <strong>for</strong> listed securities, on or shortly after the Effective Date.<br />

On the basis of the indicative timetable set out on page 5 of this document, the last day of dealings in, and registrations of transfers of,<br />

<strong>Evolution</strong> Shares is expected <strong>to</strong> be in December 2011, following which the <strong>Evolution</strong> Shares will be temporarily suspended from the<br />

Official List and trading on the London S<strong>to</strong>ck Exchange’s main market <strong>for</strong> listed securities. No transfers <strong>for</strong> <strong>Evolution</strong> Shares will be<br />

registered after that date.<br />

On the Effective Date, <strong>Evolution</strong> will become a wholly owned subsidiary of <strong>Investec</strong> and share certificates in respect of <strong>Evolution</strong> Shares<br />

will cease <strong>to</strong> be valid and should be destroyed. In addition, on the Effective Date, entitlements <strong>to</strong> <strong>Evolution</strong> Shares held within the CREST<br />

system will be cancelled.<br />

It is also proposed that following the Effective Date, <strong>Evolution</strong> will be re-registered as a private limited company.<br />

16 Settlement<br />

Subject <strong>to</strong> implementation of the Scheme (and except as provided in paragraph (iv) below in relation <strong>to</strong> certain Excluded Overseas<br />

Shareholders), settlement of the consideration <strong>to</strong> which any holder of <strong>Evolution</strong> Shares is entitled under the Scheme will be effected in<br />

the manner set out below.<br />

(a) Consideration where <strong>Evolution</strong> Shares are held in uncertificated <strong>for</strong>m (that is, in CREST)<br />

Where, on the Effective Date, an <strong>Evolution</strong> Shareholder holds <strong>Evolution</strong> Shares in uncertificated <strong>for</strong>m, the New <strong>Investec</strong> Shares <strong>to</strong> which<br />

the <strong>Evolution</strong> Shareholder is entitled will be issued in uncertificated <strong>for</strong>m through CREST. <strong>Investec</strong> will procure that Euroclear is instructed<br />

<strong>to</strong> credit the relevant <strong>Evolution</strong> Shareholder’s appropriate s<strong>to</strong>ck account in CREST with the applicable number of New <strong>Investec</strong> Shares at<br />

the commencement of dealings in the New <strong>Investec</strong> Shares.<br />

As from the Scheme Record Time, each holding of <strong>Evolution</strong> Shares credited <strong>to</strong> any s<strong>to</strong>ck account in CREST will be disabled and all<br />

<strong>Evolution</strong> Shares will be removed from CREST in due course.<br />

Notwithstanding the above, <strong>Investec</strong> reserves the right <strong>to</strong> settle all or part of such consideration in the manner set out in sub-paragraph<br />

(c) below if, <strong>for</strong> reasons outside its reasonable control, it is not able <strong>to</strong> effect settlement in accordance with this sub-paragraph (a).<br />

(b) Consideration where <strong>Evolution</strong> Shares are held in certificated <strong>for</strong>m<br />

Where, on the Effective Date, an <strong>Evolution</strong> Shareholder holds <strong>Evolution</strong> Shares in certificated <strong>for</strong>m, the New <strong>Investec</strong> Shares <strong>to</strong> which<br />

the <strong>Evolution</strong> Shareholder is entitled will be issued in certificated <strong>for</strong>m.<br />

Definitive certificates <strong>for</strong> the New <strong>Investec</strong> Shares will be despatched <strong>by</strong> first class post (or <strong>by</strong> such other method as may be approved<br />

<strong>by</strong> the Panel) within 14 days after the Effective Date.<br />

On the Effective Date, each certificate representing a holding of <strong>Evolution</strong> Shares will cease <strong>to</strong> be valid. Following settlement of the<br />

consideration <strong>to</strong> which an <strong>Evolution</strong> Shareholder is entitled under the Scheme, such <strong>Evolution</strong> Shareholder will be bound on the request<br />

of <strong>Evolution</strong> either: (i) <strong>to</strong> destroy such <strong>Evolution</strong> Share certificates; or (ii) <strong>to</strong> return such <strong>Evolution</strong> Share certificates <strong>to</strong> <strong>Evolution</strong>, or <strong>to</strong><br />

any person appointed <strong>by</strong> <strong>Evolution</strong> <strong>for</strong> cancellation.<br />

(c) General<br />

Fractions of New <strong>Investec</strong> Shares will not be allotted or issued pursuant <strong>to</strong> the Scheme and will be disregarded.<br />

All documents sent <strong>to</strong> <strong>Evolution</strong> Shareholders in accordance with this paragraph will be sent at the risk of the person entitled there<strong>to</strong>.<br />

In relation <strong>to</strong> New <strong>Investec</strong> Shares <strong>to</strong> be issued in certificated <strong>for</strong>m, temporary documents of title will not be issued pending the despatch<br />

<strong>by</strong> post of definitive certificates <strong>for</strong> such New <strong>Investec</strong> Shares as referred <strong>to</strong> in sub-paragraph (b) above. Pending the issue of definitive<br />

certificates <strong>for</strong> such New <strong>Investec</strong> Shares, <strong>for</strong>mer <strong>Evolution</strong> Shareholders wishing <strong>to</strong> register transfers of such New <strong>Investec</strong> Shares may<br />

certify their share transfer <strong>for</strong>ms against the register of members of <strong>Investec</strong> <strong>by</strong> contacting <strong>Investec</strong>’s Registrars, Computershare Inves<strong>to</strong>r<br />

Services <strong>plc</strong>, on +44 870 707 1077. On the registration of any such transfers, the transferee will receive a share certificate in respect<br />

of the New <strong>Investec</strong> Shares which are the subject of the relevant transfer.<br />

Save with the consent of the Panel, settlement of the consideration <strong>to</strong> which any <strong>Evolution</strong> Shareholder is entitled under the Scheme<br />

will be implemented in full in accordance with the terms set out in this Part II without regard <strong>to</strong> any lien, right of set off, counterclaim or<br />

analogous right <strong>to</strong> which <strong>Investec</strong> may otherwise be, or claim <strong>to</strong> be, entitled against any <strong>Evolution</strong> Shareholder.<br />

(d) Excluded Overseas Shareholders<br />

Due <strong>to</strong> restrictions on Excluded Overseas Shareholders holding New <strong>Investec</strong> Shares, <strong>Investec</strong> may, in its sole discretion, determine that<br />

either: (a) any New <strong>Investec</strong> Shares issued <strong>to</strong> an Excluded Overseas Shareholder be sold, in which event the relevant New <strong>Investec</strong><br />

Shares shall be issued <strong>to</strong> such holder and <strong>Investec</strong> shall appoint a person <strong>to</strong> procure that such shares be sold on behalf of such holder,<br />

or (b) that such <strong>Investec</strong> Shares shall not be issued <strong>to</strong> such holder but shall instead be issued <strong>to</strong> a nominee <strong>for</strong> such holder who shall<br />

sell the <strong>Investec</strong> Shares so issued.<br />

21


17 Overseas Shareholders<br />

(a) General<br />

Overseas Shareholders may be affected <strong>by</strong> the laws of other jurisdictions in relation <strong>to</strong> the Offer, the Scheme or Admission. Overseas<br />

Shareholders should in<strong>for</strong>m themselves about and observe all applicable legal requirements.<br />

It is the responsibility of any person in<strong>to</strong> whose possession this document comes <strong>to</strong> satisfy themselves as <strong>to</strong> the full observance of the<br />

laws of the relevant jurisdiction in connection with the allotment and issue of New <strong>Investec</strong> Shares pursuant <strong>to</strong> the Offer, including the<br />

obtaining of any governmental, exchange control or other consents which may be required and/or compliance with other necessary<br />

<strong>for</strong>malities which are required <strong>to</strong> be observed and the payment of any issue, transfer or other taxes or levies due in such jurisdiction.<br />

If the issue of New <strong>Investec</strong> Shares <strong>to</strong> any Overseas Shareholder, or <strong>to</strong> any person who is reasonably believed <strong>to</strong> be an Overseas<br />

Shareholder, would or may infringe the laws of such jurisdiction or would or may require any governmental or other consent or any<br />

registration, filing or other <strong>for</strong>mality which cannot be complied with, or compliance with which would be unduly onerous, <strong>Investec</strong> may in<br />

its sole discretion determine that the Overseas Shareholder should be treated as an Excluded Overseas Shareholder in which case<br />

settlement of the consideration <strong>to</strong> which such Excluded Overseas Shareholder is entitled will be effected as described in paragraph 16(d)<br />

of this Part II.<br />

This document has been prepared <strong>for</strong> the purposes of complying with English law and the City Code and the rules of the FSA and the<br />

in<strong>for</strong>mation disclosed may not be the same as that which would have been disclosed if this document had been prepared in accordance<br />

with the laws of jurisdictions outside the United Kingdom. Overseas Shareholders should consult their own legal and tax advisers with<br />

respect <strong>to</strong> the legal and tax consequences of the Offer in their particular circumstances<br />

THIS DOCUMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITY, NOR SHALL<br />

THERE BE ANY SALE, ISSUANCE OR TRANSFER OF THE SECURITIES REFERRED TO IN THIS DOCUMENT IN ANY JURISDICTION IN<br />

CONTRAVENTION OF APPLICABLE LAW.<br />

(b) United States Shareholders<br />

<strong>The</strong> New <strong>Investec</strong> Shares <strong>to</strong> be issued <strong>to</strong> <strong>Evolution</strong> Shareholders pursuant <strong>to</strong> the Scheme will be issued in reliance on the exemption<br />

from the registration requirements of Section 3(a)(10) of the US Securities Act and, as a consequence, will not be registered thereunder<br />

or under the securities laws of any state or other jurisdiction of the United States.<br />

Securities <strong>to</strong> be issued <strong>to</strong> <strong>Evolution</strong> Shareholders pursuant <strong>to</strong> the Scheme generally should not be treated as ‘‘restricted securities’’<br />

within the meaning of Rule 144(a)(3) under the US Securities Act and persons who receive securities in the Scheme (other than<br />

‘‘affiliates’’ as described in the paragraph below) may resell them without restriction under the US Securities Act.<br />

Under the US securities laws, an <strong>Evolution</strong> Shareholder who is deemed <strong>to</strong> be an affiliate of <strong>Investec</strong> or <strong>Evolution</strong> be<strong>for</strong>e completion of<br />

the Scheme may not resell New <strong>Investec</strong> Shares received pursuant <strong>to</strong> the Scheme in the United States without registration under the<br />

US Securities Act, except pursuant <strong>to</strong> an applicable exemption from the registration requirements of the US Securities Act or in a<br />

transaction not subject <strong>to</strong> such requirements. Whether a person is an affiliate of a company <strong>for</strong> such purposes depends upon the<br />

circumstances, but affiliates of a company can include certain officers and direc<strong>to</strong>rs and significant shareholders. Persons who believe<br />

they may be affiliates of <strong>Investec</strong> or <strong>Evolution</strong> should consult their own legal advisers prior <strong>to</strong> any sale of securities received in the<br />

Scheme.<br />

For the purposes of qualifying <strong>for</strong> the exemption from the registration requirements of the US Securities Act af<strong>for</strong>ded <strong>by</strong> Section 3(a)(10)<br />

thereof, <strong>Evolution</strong> will advise the Court that its sanctioning of the Scheme will be relied upon <strong>by</strong> <strong>Investec</strong> as an approval of the Scheme<br />

following a hearing on its fairness <strong>to</strong> <strong>Evolution</strong> Shareholders, at which hearing all <strong>Evolution</strong> Shareholders are entitled <strong>to</strong> attend in person<br />

or through counsel <strong>to</strong> support or oppose the sanctioning of the Scheme and with respect <strong>to</strong> which notification has been given <strong>to</strong> all<br />

<strong>Evolution</strong> Shareholders.<br />

18 Taxation<br />

Shareholders should read Part V (United Kingdom Taxation) of this document which contains a general description of the United Kingdom<br />

tax consequences of the Offer. If they are in any doubt as <strong>to</strong> their tax position, they should contact their professional adviser immediately.<br />

<strong>Evolution</strong> Shareholders who are or may be subject <strong>to</strong> tax outside the UK (including under US tax laws) should consult an appropriate<br />

independent professional adviser as <strong>to</strong> the tax consequences of the Scheme.<br />

19 Modifications <strong>to</strong> the Scheme<br />

<strong>The</strong> Scheme contains a provision <strong>for</strong> <strong>Evolution</strong> and <strong>Investec</strong> <strong>to</strong> consent on behalf of all persons concerned <strong>to</strong> any modification of, or<br />

addition <strong>to</strong>, the Scheme or <strong>to</strong> any condition approved or imposed <strong>by</strong> the Court. <strong>The</strong> Court would be unlikely <strong>to</strong> approve any modification<br />

of, or additions <strong>to</strong>, or impose a condition <strong>to</strong> the Scheme which might be material <strong>to</strong> the interests of <strong>Evolution</strong> Shareholders unless<br />

<strong>Evolution</strong> Shareholders were in<strong>for</strong>med of such modification, addition or condition. It would be a matter <strong>for</strong> the Court <strong>to</strong> decide, in its<br />

discretion, whether or not a further meeting of <strong>Evolution</strong> Shareholders should be held in these circumstances.<br />

20 Right <strong>to</strong> implement the Offer <strong>by</strong> way of a Takeover Offer<br />

<strong>Investec</strong> has reserved the right <strong>to</strong> elect <strong>to</strong> implement the acquisition of the <strong>Evolution</strong> Shares <strong>by</strong> way of a Takeover Offer as an alternative<br />

<strong>to</strong> the Scheme. Any such Takeover Offer will be subject <strong>to</strong> an acceptance condition of <strong>Investec</strong> having acquired (whether pursuant <strong>to</strong> the<br />

Offer or otherwise) such percentage (being more than fifty per cent.) of the <strong>Evolution</strong> Shares as <strong>Investec</strong> may decide, having consulted<br />

with <strong>Evolution</strong> and the Panel, and will otherwise be implemented on the same terms (subject <strong>to</strong> appropriate amendments), so far as<br />

applicable, as those which would apply <strong>to</strong> the Scheme and in compliance with applicable laws and regulations.<br />

22


21 Further in<strong>for</strong>mation<br />

Your attention is drawn <strong>to</strong> the Chairman’s Letter in Part I of this document and the full text of the Scheme document as set out in Part<br />

III (the Scheme of Arrangement) of this document. Your attention is also drawn <strong>to</strong> the following sections, which <strong>for</strong>m part of this<br />

document.<br />

Part IV Conditions and Further Terms<br />

Part V United Kingdom Taxation<br />

Part VI Additional In<strong>for</strong>mation<br />

Part VII In<strong>for</strong>mation Incorporated <strong>by</strong> Reference<br />

Part VIII Definitions<br />

Part IX Notice of Court Meeting<br />

Part X Notice of General Meeting<br />

22 Action <strong>to</strong> be taken<br />

It is important that, <strong>for</strong> the Court Meeting in particular, as many votes as possible are cast so that the Court may be satisfied that there<br />

is a fair representation of shareholder opinion. Please refer <strong>to</strong> pages 6 and 7 (Action <strong>to</strong> be Taken) of this document <strong>for</strong> details of the<br />

steps that you will need (and are encouraged) <strong>to</strong> take in connection with this document and the Offer.<br />

George Maddison<br />

For and on behalf of<br />

Credit Suisse Securities (Europe) Limited<br />

23


24<br />

PART III<br />

THE SCHEME OF ARRANGEMENT<br />

IN THE HIGH COURT OF JUSTICE No. 8266 of 2011<br />

CHANCERY DIVISION<br />

COMPANIES COURT<br />

IN THE MATTER OF THE EVOLUTION GROUP PLC<br />

– and –<br />

IN THE MATTER OF THE COMPANIES ACT 2006<br />

SCHEME OF ARRANGEMENT<br />

(under Part 26 of the Companies Act 2006)<br />

BETWEEN<br />

THE EVOLUTION GROUP PLC<br />

AND<br />

THE HOLDERS OF ITS SCHEME SHARES<br />

(as hereinafter defined)<br />

PRELIMINARY<br />

(A) In this Scheme, unless inconsistent with the subject or context, the following expressions bear the following meanings:<br />

“Act” the Companies Act 2006 (as amended)<br />

“business day” a day on which London S<strong>to</strong>ck Exchange <strong>plc</strong> is open <strong>for</strong> the transaction of business<br />

“certificated” or “in<br />

certificated <strong>for</strong>m”<br />

not in uncertificated <strong>for</strong>m (that is, not in CREST)<br />

“Company” <strong>The</strong> <strong>Evolution</strong> <strong>Group</strong> <strong>Plc</strong>, incorporated in England and Wales with registered number 3359425<br />

“Court” the High Court of Justice in England and Wales<br />

“Court Meeting” the meeting of Scheme Shareholders convened <strong>by</strong> order of the Court pursuant <strong>to</strong> section 896<br />

of the Act <strong>to</strong> consider and, if thought fit, approve this Scheme, including any adjournment<br />

thereof<br />

“CREST” the system <strong>for</strong> the paperless settlement of trades in securities and the holding of uncertificated<br />

securities operated <strong>by</strong> Euroclear in accordance with the Uncertificated Securities Regulations<br />

2001<br />

“Effective Date” the date on which this Scheme becomes effective in accordance with Clause 6<br />

“Euroclear” Euroclear UK & Ireland Limited, incorporated in England and Wales with registered number<br />

2878738<br />

“<strong>Evolution</strong> Articles” means the articles of association of <strong>Evolution</strong> that came in<strong>to</strong> <strong>for</strong>ce on 1 Oc<strong>to</strong>ber 2008<br />

“<strong>Evolution</strong> Shares” ordinary shares of 1 pence each in the capital of the Company<br />

“holder” includes a person entitled <strong>by</strong> transmission<br />

“<strong>Investec</strong>” <strong>Investec</strong> <strong>plc</strong>, registered in England and Wales with registered number 03633621<br />

“<strong>Investec</strong> <strong>Group</strong>” <strong>Investec</strong>, <strong>Investec</strong> Limited and their respective subsidiaries<br />

“<strong>Investec</strong> Shares” ordinary shares of £0.0002 each in the capital of <strong>Investec</strong><br />

“members” members of the Company on the register of members at any relevant date<br />

“New <strong>Evolution</strong> Shares” the new <strong>Evolution</strong> Shares <strong>to</strong> be allotted and issued pursuant <strong>to</strong> Clause 1.2


“Registrar of Companies” the Registrar of Companies in England and Wales<br />

“Scheme” this scheme of arrangement in its present <strong>for</strong>m or with or subject <strong>to</strong> any modification, addition<br />

or condition approved or imposed <strong>by</strong> the Court and agreed <strong>to</strong> <strong>by</strong> the Company and <strong>Investec</strong><br />

“Scheme Record Time” 6.00 p.m. on the business day immediately prior <strong>to</strong> the Effective Date<br />

“Scheme Shareholders” registered holders of Scheme Shares<br />

“Scheme Shares” (i) the <strong>Evolution</strong> Shares in issue at the date of this Scheme;<br />

“uncertificated” or “in<br />

uncertificated <strong>for</strong>m”<br />

(ii) any <strong>Evolution</strong> Shares issued after the date of this Scheme and be<strong>for</strong>e the Voting Record<br />

Time; and<br />

(iii) any <strong>Evolution</strong> Shares issued at or after the Voting Record Time and be<strong>for</strong>e the Scheme<br />

Record Time in respect of which the original or any subsequent holders thereof are, or shall<br />

have agreed in writing <strong>to</strong> be, bound <strong>by</strong> this Scheme<br />

recorded on the relevant register as being held in uncertificated <strong>for</strong>m in CREST and title <strong>to</strong> which<br />

may be transferred <strong>by</strong> means of CREST<br />

“Voting Record Time” 6.00 p.m. on the day which is two business days be<strong>for</strong>e the date of the Court Meeting or, if the<br />

Court Meeting is adjourned, 6.00 p.m. on the day which is two business days be<strong>for</strong>e the date<br />

of such adjourned meeting<br />

“£”, “pence” and “p” the lawful currency of the United Kingdom<br />

and references <strong>to</strong> Clauses are <strong>to</strong> Clauses of this Scheme, and references <strong>to</strong> time are <strong>to</strong> London time.<br />

(B) <strong>The</strong> share capital of the Company as at the close of business on 30 September 2011 was £232,680.307 divided in<strong>to</strong> 232,680,307<br />

<strong>Evolution</strong> Shares of 1 pence each, all of which were credited as fully paid. It is proposed that a deferred share of 1 pence be issued<br />

<strong>to</strong> <strong>Investec</strong> <strong>for</strong> cash be<strong>for</strong>e the Scheme Record Time.<br />

(C) At the date of this Scheme, 145,000 <strong>Evolution</strong> Shares are registered in the name of <strong>Investec</strong> Wealth & Investment Limited, a<br />

subsidiary of <strong>Investec</strong>, who holds these shares on behalf of discretionary clients.<br />

(D) <strong>Investec</strong> has agreed <strong>to</strong> appear <strong>by</strong> Counsel at the hearing <strong>to</strong> sanction this Scheme and <strong>to</strong> submit <strong>to</strong> be bound <strong>by</strong> and <strong>to</strong> undertake<br />

<strong>to</strong> the Court <strong>to</strong> be bound <strong>by</strong> this Scheme and <strong>to</strong> execute and do or procure <strong>to</strong> be executed and done all such documents, acts and<br />

things as may be necessary or desirable <strong>to</strong> be executed or done <strong>by</strong> it <strong>for</strong> the purpose of giving effect <strong>to</strong> this Scheme.<br />

(E) <strong>Investec</strong> has agreed <strong>to</strong> procure that any member of the <strong>Investec</strong> <strong>Group</strong> holding <strong>Evolution</strong> Shares will appear <strong>by</strong> Counsel on the<br />

hearing <strong>to</strong> sanction this Scheme and shall undertake in respect of such <strong>Evolution</strong> Shares <strong>to</strong> be bound <strong>by</strong> this Scheme.<br />

THE SCHEME<br />

1 Cancellation of Scheme Shares<br />

1.1 <strong>The</strong> capital of the Company shall be reduced <strong>by</strong> cancelling and extinguishing all of the Scheme Shares.<br />

1.2 Subject <strong>to</strong> and <strong>for</strong>thwith upon the said reduction of capital referred <strong>to</strong> in Clause 1.1 taking effect:<br />

1.2.1 the share capital of the Company shall be increased <strong>to</strong> its <strong>for</strong>mer amount <strong>by</strong> the creation of such number of New <strong>Evolution</strong><br />

Shares as shall be equal <strong>to</strong> the number of Scheme Shares cancelled pursuant <strong>to</strong> Clause 1.1; and<br />

1.2.2 the reserve arising in the books of account of the Company as a result of the said reduction of capital shall be capitalised<br />

and applied in paying up in full at par the New <strong>Evolution</strong> Shares created pursuant <strong>to</strong> Clause 1.2.1 which shall be allotted<br />

and issued credited as fully paid <strong>to</strong> <strong>Investec</strong> and/or its nominee(s).<br />

2 Consideration <strong>for</strong> the cancellation of the Scheme Shares<br />

2.1 In consideration <strong>for</strong> the cancellation of the Scheme Shares and the allotment and issue of the New <strong>Evolution</strong> Shares as provided in<br />

Clause 1, <strong>Investec</strong> shall (subject <strong>to</strong> the remaining provisions of this Scheme) allot and issue <strong>to</strong> the holders of Scheme Shares (as<br />

appearing in the register of members of the Company at the Scheme Record Time):<br />

For every Scheme Share 0.23124 <strong>Investec</strong> Shares<br />

2.2 <strong>The</strong> aggregate number of <strong>Investec</strong> Shares <strong>to</strong> which a holder of Scheme Shares shall be entitled under Clause 2.1 shall be rounded<br />

down <strong>to</strong> the nearest whole number. No fractions of <strong>Investec</strong> Shares shall be allotted <strong>to</strong> any holder of Scheme Shares, and all<br />

fractions <strong>to</strong> which, but <strong>for</strong> this Clause 2.2, holders of Scheme Shares would have become entitled shall be disregarded.<br />

2.3 <strong>The</strong> <strong>Investec</strong> Shares <strong>to</strong> be issued pursuant <strong>to</strong> Clause 2.1 shall be issued, credited as fully paid, and shall rank equally in all respects<br />

with all other fully paid <strong>Investec</strong> Shares and shall be entitled <strong>to</strong> all dividends and other distributions declared, paid or made <strong>by</strong><br />

<strong>Investec</strong> <strong>by</strong> reference <strong>to</strong> a record date on or after the Effective Date.<br />

25


3 Overseas Shareholders<br />

3.1 <strong>The</strong> provisions of Clause 2 shall be subject <strong>to</strong> any prohibition or condition imposed <strong>by</strong> law. Without prejudice <strong>to</strong> the generality of the<br />

<strong>for</strong>egoing, if, in respect of any holder of Scheme Shares with a registered address in a jurisdiction outside the United Kingdom, or<br />

whom <strong>Investec</strong> reasonably believes <strong>to</strong> be a citizen, resident or national of a jurisdiction outside the United Kingdom <strong>Investec</strong> is<br />

advised that the allotment and/or issue of <strong>Investec</strong> Shares pursuant <strong>to</strong> Clause 2 would or may infringe the laws of such jurisdiction<br />

or would or may require <strong>Investec</strong> <strong>to</strong> comply with any governmental or other consent or any registration, filing or other <strong>for</strong>mality with<br />

which <strong>Investec</strong> is unable <strong>to</strong> comply or compliance with which <strong>Investec</strong> regards as unduly onerous, <strong>Investec</strong> may, in its sole discretion,<br />

either:<br />

26<br />

3.1.1 determine that such <strong>Investec</strong> Shares shall be sold, in which event the <strong>Investec</strong> Shares shall be issued <strong>to</strong> such holder and<br />

<strong>Investec</strong> shall appoint a person <strong>to</strong> act pursuant <strong>to</strong> this Clause 3.1.1 and such person shall be authorised on behalf of such<br />

holder <strong>to</strong> procure that any shares in respect of which <strong>Investec</strong> has made such determination shall, as soon as practicable<br />

following the Effective Date, be sold; or<br />

3.1.2 determine that such <strong>Investec</strong> Shares shall not be issued <strong>to</strong> such holder but shall instead be issued <strong>to</strong> a nominee <strong>for</strong> such<br />

holder appointed <strong>by</strong> <strong>Investec</strong> on terms that the nominee shall, as soon as practicable following the Effective Date, sell the<br />

<strong>Investec</strong> Shares so issued.<br />

3.2 Any sale under Clause 3.1 shall be carried out at the best price which can reasonably be obtained at the time of sale and the net<br />

proceeds of such sale (after the deduction of all expenses and commissions incurred in connection with such sale, including any<br />

value added tax payable on the proceeds of sale) shall be paid <strong>to</strong> such holder <strong>by</strong> sending a cheque or creating an assured payment<br />

obligation in accordance with the provisions of Clause 4.1.<br />

3.3 To give effect <strong>to</strong> any sale under Clause 3.1, the person appointed <strong>by</strong> <strong>Investec</strong> in accordance with Clause 3.1.1 shall be authorised<br />

as at<strong>to</strong>rney on behalf of the holder concerned, and the nominee appointed <strong>by</strong> <strong>Investec</strong> in accordance with Clause 3.1.2 shall be<br />

authorised, <strong>to</strong> execute and deliver as transferor a <strong>for</strong>m of transfer or other instrument or instruction of transfer and <strong>to</strong> give such<br />

instructions and <strong>to</strong> do all other things which he may consider necessary or expedient in connection with such sale. In the absence<br />

of bad faith or wilful default, none of the Company, <strong>Investec</strong> or the person or nominee so appointed shall have any liability <strong>for</strong> any<br />

loss or damage arising as a result of the timing or terms of such sale.<br />

4 Settlement of consideration<br />

4.1 As soon as practicable after the Effective Date and in any event no later than 14 days after the Effective Date, <strong>Investec</strong> shall:<br />

4.1.1 allot and issue the <strong>Investec</strong> Shares which it is required <strong>to</strong> allot and issue <strong>to</strong> holders of Scheme Shares pursuant <strong>to</strong> this<br />

Scheme and:<br />

(a) in the case of Scheme Shares which at the Scheme Record Time are in certificated <strong>for</strong>m, procure the despatch of<br />

certificates <strong>for</strong> such <strong>Investec</strong> Shares <strong>to</strong> the persons entitled there<strong>to</strong> in accordance with Clause 4.2; and<br />

(b) in the case of Scheme Shares which at the Scheme Record Time are in uncertificated <strong>for</strong>m, procure that Euroclear is<br />

instructed <strong>to</strong> credit the appropriate s<strong>to</strong>ck account in CREST of the relevant holder with such holder’s entitlement <strong>to</strong><br />

such <strong>Investec</strong> Shares, provided that <strong>Investec</strong> reserves the right <strong>to</strong> settle all or part of such consideration in the<br />

manner set out in Clause 4.1.1(a) if, <strong>for</strong> reasons outside its reasonable control, it is not able <strong>to</strong> effect settlement in<br />

accordance with this Clause 4.1.1(b);<br />

4.1.2 in the case of Scheme Shares sold pursuant <strong>to</strong> Clause 3.1 which at the Scheme Record Time are in certificated <strong>for</strong>m,<br />

procure the despatch <strong>to</strong> the persons entitled there<strong>to</strong> in accordance with Clause 4.2 of cheques <strong>for</strong> the sums payable <strong>to</strong><br />

them respectively in accordance with Clause 3; and<br />

4.1.3 in the case of Scheme Shares sold pursuant <strong>to</strong> Clause 3.1 which at the Scheme Record Time are in uncertificated <strong>for</strong>m,<br />

procure that Euroclear is instructed <strong>to</strong> create an assured payment obligation in favour of the payment bank of the persons<br />

entitled there<strong>to</strong> in accordance with the CREST assured payment arrangements <strong>for</strong> the sums payable <strong>to</strong> them respectively<br />

in accordance with Clause 3, provided that <strong>Investec</strong> reserves the right <strong>to</strong> make payment of the said sums <strong>by</strong> cheque as<br />

set out in Clause 4.1.2 if, <strong>for</strong> reasons outside its reasonable control, it is not able <strong>to</strong> effect settlement in accordance with<br />

this Clause 4.1.3.<br />

4.2 All deliveries of share certificates or cheques pursuant <strong>to</strong> this Scheme shall be effected <strong>by</strong> sending the same <strong>by</strong> first class post in<br />

prepaid envelopes addressed <strong>to</strong> the persons entitled there<strong>to</strong> at their respective addresses as appearing in the register of members<br />

of the Company or, in the case of joint holders, at the address of that one of the joint holders whose name stands first in the said<br />

register in respect of such joint holding, at the Scheme Record Time, and none of <strong>Investec</strong>, the Company or any person or nominee<br />

appointed <strong>by</strong> <strong>Investec</strong> shall be responsible <strong>for</strong> any loss or delay in the transmission or delivery of any share certificates or cheques<br />

sent in accordance with this Clause 4.2, which shall be sent at the risk of the persons entitled there<strong>to</strong>.<br />

4.3 All cheques shall be made payable <strong>to</strong> the persons respectively entitled <strong>to</strong> the moneys represented there<strong>by</strong> (except that, in the case<br />

of joint holders, <strong>Investec</strong> reserves the right <strong>to</strong> make such cheques payable <strong>to</strong> that one of the joint holders whose name stands first<br />

in the register of members of the Company at the Scheme Record Time in respect of such joint holding) and the encashment of any<br />

such cheque or the creation of any such assured payment obligation as is referred <strong>to</strong> in Clauses 4.1.3 shall be a complete discharge<br />

<strong>to</strong> <strong>Investec</strong> <strong>for</strong> the moneys represented there<strong>by</strong>.<br />

4.4 <strong>The</strong> provisions of this Clause 4 shall be subject <strong>to</strong> any prohibition or condition imposed <strong>by</strong> law.


5 Share certificates and cancellation of entitlements<br />

With effect from and including the Effective Date:<br />

5.1 all certificates representing Scheme Shares shall cease <strong>to</strong> have effect as documents of title <strong>to</strong> the Scheme Shares comprised<br />

therein and every holder of Scheme Shares shall be bound at the request of the Company <strong>to</strong> deliver up the same <strong>to</strong> the Company<br />

or <strong>to</strong> destroy the same; and<br />

5.2 Euroclear shall be instructed <strong>to</strong> cancel the entitlements <strong>to</strong> Scheme Shares of holders of Scheme Shares in uncertificated <strong>for</strong>m and<br />

appropriate entries shall be made in the register of members of the Company with effect from the Effective Date <strong>to</strong> reflect their<br />

cancellation.<br />

6 Effective Time<br />

6.1 This Scheme shall become effective in accordance with its terms as soon as a copy of the order of the Court sanctioning this<br />

Scheme under section 899 of the Act and confirming under section 648 of the Act the reduction of capital provided <strong>for</strong> <strong>by</strong> this<br />

Scheme shall have been delivered <strong>to</strong> the Registrar of Companies <strong>for</strong> registration.<br />

6.2 Unless this Scheme shall have become effective on or be<strong>for</strong>e 31 March 2012 or such later date, if any, as <strong>Investec</strong> and the<br />

Company may agree and the Court may allow, this Scheme shall never become effective.<br />

7 Modification<br />

<strong>Investec</strong> and the Company may jointly consent on behalf of all concerned <strong>to</strong> any modification of, or addition <strong>to</strong>, this Scheme or <strong>to</strong> any<br />

condition, which the Court may approve or impose.<br />

Dated 3 Oc<strong>to</strong>ber 2011<br />

27


28<br />

PART IV<br />

CONDITIONS AND FURTHER TERMS<br />

Part A: Conditions of the Offer<br />

1 <strong>The</strong> Offer is conditional upon the Scheme becoming unconditional and becoming effective subject <strong>to</strong> the City Code, <strong>by</strong> no later than<br />

31 March 2012 or such later date (if any) as <strong>Investec</strong> and <strong>Evolution</strong> may, with the consent of the Panel, agree and (if required) the<br />

Court may allow.<br />

2 <strong>The</strong> Scheme is conditional upon:<br />

(a) approval of the Scheme <strong>by</strong> a majority in number of the Scheme Shareholders entitled <strong>to</strong> vote and present and voting, either in<br />

person or <strong>by</strong> proxy, at the Court Meeting or at any adjournment of such meeting, representing no less than 75 per cent. in value<br />

of the Scheme Shares so voted;<br />

(b) all resolutions in connection with, or necessary <strong>to</strong> approve and implement, the Scheme as set out in the notice of the General<br />

Meeting being duly passed <strong>by</strong> the requisite majority at the General Meeting or at any adjournment of that meeting;<br />

(c) the sanction of the Scheme and the confirmation of the Capital Reduction in either case, without modification or with<br />

modification (on terms reasonably acceptable <strong>to</strong> <strong>Investec</strong> and <strong>Evolution</strong>) <strong>by</strong> the Court and the delivery <strong>for</strong> registration of copies<br />

of the Scheme Court Order and the statement of capital attached there<strong>to</strong> <strong>to</strong> the Registrar of Companies.<br />

3 In addition, <strong>Evolution</strong> and <strong>Investec</strong> have agreed that, subject <strong>to</strong> Part B below, the Scheme is also conditional upon the following<br />

Conditions and, accordingly, the necessary actions <strong>to</strong> make the Scheme effective will not be taken unless the following Conditions<br />

(as amended if appropriate) have been satisfied (where capable of satisfaction) or where permitted, waived, prior <strong>to</strong> the Scheme<br />

being sanctioned <strong>by</strong> the Court in accordance with Condition 2(c) above:<br />

(a) insofar as the Scheme creates a relevant merger situation within the meaning of section 23 of the Enterprise Act 2002, the<br />

Office of Fair Trading indicating in terms reasonably satisfac<strong>to</strong>ry <strong>to</strong> <strong>Investec</strong> that it has decided not <strong>to</strong> refer the Scheme or any<br />

part of it <strong>to</strong> the Competition Commission (“UK Competition Commission”); and<br />

(b) <strong>to</strong> the extent the Scheme falls <strong>to</strong> be notified under section 18(1) of the Competition Act 2002 (as amended) (the “Irish<br />

Competition Act”), the Irish Competition Authority either in<strong>for</strong>ming the parties of its determination under section 21(2)(a) of<br />

the Irish Competition Act that the Scheme may be put in<strong>to</strong> effect or the period specified in section 19(1)(c) of the Irish<br />

Competition Act elapsing without the Irish Competition Authority having in<strong>for</strong>med the parties of the determination (if any);<br />

(c) the FSA having <strong>for</strong>mally (and unconditionally or on such terms satisfac<strong>to</strong>ry <strong>to</strong> <strong>Investec</strong> (acting reasonably)) approved <strong>Investec</strong><br />

and any relevant affiliate of <strong>Investec</strong> which would be deemed <strong>to</strong> be acquiring control (as such term is defined in FSMA) as a<br />

controller of all and any relevant entities within the <strong>Evolution</strong> <strong>Group</strong> which are authorised in the UK <strong>by</strong> the FSA under FSMA<br />

(pursuant <strong>to</strong> the provisions of Part XII of FSMA);<br />

(d) the Securities and Futures Commission of Hong Kong having <strong>for</strong>mally (and unconditionally or on terms satisfac<strong>to</strong>ry <strong>to</strong> <strong>Investec</strong><br />

(acting reasonably)) approved, under section 132 of the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong<br />

(the “SFO”)), as a substantial shareholder (as such term is defined in the SFO), <strong>Investec</strong>, and any relevant affiliate of <strong>Investec</strong><br />

which would be deemed <strong>to</strong> be a substantial shareholder in respect of all and any entities within the <strong>Evolution</strong> <strong>Group</strong> which are<br />

licensed corporations (as such term is defined in the SFO);<br />

(e) Central Bank of Ireland having <strong>for</strong>mally (and unconditionally or on terms satisfac<strong>to</strong>ry <strong>to</strong> <strong>Investec</strong> (acting reasonably)) approved<br />

<strong>Investec</strong> and any relevant affiliate of <strong>Investec</strong> which would be deemed <strong>to</strong> be acquiring a direct or indirect qualifying holding (as<br />

such term is defined in European Communities (Assessment of Acquisitions in the Financial Sec<strong>to</strong>r) Regulations 2009) in<br />

respect of all and any of the entities within the <strong>Evolution</strong> <strong>Group</strong> which are UCITS management companies under Regulation 21<br />

of Statu<strong>to</strong>ry Instrument Number 353 of 2011;<br />

(f) (i) the UKLA having acknowledged <strong>to</strong> <strong>Investec</strong> or its agent (and such acknowledgement not having been withdrawn) that the<br />

application <strong>for</strong> the admission of the New <strong>Investec</strong> Shares <strong>to</strong> the Official List with a premium listing has been approved and (after<br />

satisfaction of any conditions <strong>to</strong> which such approval is expressed <strong>to</strong> be subject (“listing conditions”)) will become effective as<br />

soon as a dealing notice has been issued <strong>by</strong> the FSA and any listing conditions having been satisfied and (ii) the London S<strong>to</strong>ck<br />

Exchange having acknowledged <strong>to</strong> <strong>Investec</strong> or its agent (and such acknowledgement not having been withdrawn) that the New<br />

<strong>Investec</strong> Shares will be admitted <strong>to</strong> trading;<br />

(g) all necessary material notifications and filings having been made in connection with the Offer and all statu<strong>to</strong>ry and regula<strong>to</strong>ry<br />

obligations in connection with the Offer in any relevant jurisdiction having been complied with and all Authorisations deemed<br />

reasonably necessary or appropriate <strong>by</strong> <strong>Investec</strong> in any relevant jurisdiction <strong>for</strong>, or in respect of, the Offer and, the acquisition<br />

or the proposed acquisition of the <strong>Evolution</strong> Shares <strong>by</strong> <strong>Investec</strong> or any member of the Wider <strong>Investec</strong> <strong>Group</strong> having been<br />

obtained in terms reasonably satisfac<strong>to</strong>ry <strong>to</strong> <strong>Investec</strong> from all appropriate Third Parties, all or any applicable waiting and other<br />

time periods having expired, lapsed or been terminated (as appropriate) and all such Authorisations (<strong>to</strong>gether with all material<br />

Authorisations deemed reasonably necessary or appropriate <strong>to</strong> carry on the business of any member of the Wider <strong>Evolution</strong><br />

<strong>Group</strong>) remaining in full <strong>for</strong>ce and effect at the time at which the Scheme becomes effective and there being no notice of any<br />

intention <strong>to</strong> revoke, suspend, restrict, amend or not <strong>to</strong> renew any such Authorisations;


(h) no Third Party having given notice of a decision <strong>to</strong> take, institute, implement or threaten any action, proceeding, suit,<br />

investigation, enquiry or reference, or having required any action <strong>to</strong> be taken, or otherwise having done anything, or having<br />

enacted, made or proposed any statute, regulation or order, or taken any other step that would or might reasonably be expected<br />

<strong>to</strong>:<br />

(i) require, prevent or delay the divestiture, or alter the terms envisaged <strong>for</strong> any proposed divestiture <strong>by</strong> any member of the<br />

Wider <strong>Investec</strong> <strong>Group</strong> or any member of the Wider <strong>Evolution</strong> <strong>Group</strong> of all or any material part of their respective businesses,<br />

assets or properties or impose any limitation on the ability of any member of the Wider <strong>Investec</strong> <strong>Group</strong> or the Wider<br />

<strong>Evolution</strong> <strong>Group</strong> <strong>to</strong> conduct its business (or any part of it) or <strong>to</strong> own any of its assets or property or any part of them which,<br />

in any such case, is material in the context of the Wider <strong>Evolution</strong> <strong>Group</strong> taken as a whole;<br />

(ii) save pursuant <strong>to</strong> the Scheme or sections 974 <strong>to</strong> 991 of the Companies Act, require any member of the Wider <strong>Investec</strong><br />

<strong>Group</strong> or of the Wider <strong>Evolution</strong> <strong>Group</strong> <strong>to</strong> make an <strong>offer</strong> <strong>to</strong> acquire, any shares or other securities (or the equivalent) of any<br />

member of the Wider <strong>Evolution</strong> <strong>Group</strong> owned <strong>by</strong> any third party;<br />

(iii) impose any limitation on, or result in a material delay in, the ability of <strong>Investec</strong> directly or indirectly <strong>to</strong> acquire or <strong>to</strong> hold or<br />

<strong>to</strong> exercise effectively directly or indirectly all or any rights of ownership in respect of shares or loans or securities convertible<br />

in<strong>to</strong> shares or any other securities (or the equivalent) in <strong>Evolution</strong> or the ability of <strong>Investec</strong> <strong>to</strong> hold or exercise effectively<br />

any rights of ownership of shares, loans or other securities in, or <strong>to</strong> exercise management control over any member of the<br />

Wider <strong>Evolution</strong> <strong>Group</strong> or require a divestiture <strong>by</strong> <strong>Investec</strong> or any member of the Wider <strong>Investec</strong> <strong>Group</strong> of any rights or<br />

ownership in respect of shares or other securities in <strong>Evolution</strong> which, in any case, is material in the context of the Wider<br />

<strong>Evolution</strong> <strong>Group</strong> as a whole;<br />

(iv) otherwise adversely affect the business, assets, liabilities, financial or trading position, profits or prospects of any member<br />

of the Wider <strong>Evolution</strong> <strong>Group</strong>, in each case <strong>to</strong> an extent which is material in the context of the Wider <strong>Evolution</strong> <strong>Group</strong> taken<br />

as a whole;<br />

(v) result in any member of the Wider <strong>Evolution</strong> <strong>Group</strong> ceasing <strong>to</strong> be able <strong>to</strong> carry on business under any name under which<br />

it presently does so (the consequence of which would be material in the context of the Wider <strong>Evolution</strong> <strong>Group</strong> taken as a<br />

whole); or<br />

(vi) make the Offer, its implementation or the acquisition or proposed acquisition <strong>by</strong> <strong>Investec</strong> or any member of the Wider<br />

<strong>Investec</strong> <strong>Group</strong> of any shares or other securities in, or control or management of, <strong>Evolution</strong> void, unen<strong>for</strong>ceable or illegal,<br />

or restrict, prohibit or delay <strong>to</strong> a material extent or otherwise materially interfere with the implementation of, or impose<br />

material additional conditions or obligations with respect <strong>to</strong>, the Offer, or otherwise materially challenge or require material<br />

amendment of, the Offer or the acquisition or proposed acquisition of any <strong>Evolution</strong> Shares or the acquisition of control of<br />

<strong>Evolution</strong> or any member of the Wider <strong>Evolution</strong> <strong>Group</strong> <strong>by</strong> <strong>Investec</strong>,<br />

and all applicable waiting and other time periods during which any such Third Party could decide <strong>to</strong> take, institute, implement<br />

or threaten any such action, proceedings, suit, investigation, enquiry or reference or take any other step under the laws of any<br />

jurisdiction having expired, lapsed or been terminated;<br />

(i) save as Disclosed, there being no provision of any arrangement, agreement, lease, licence, permit or other instrument <strong>to</strong> which<br />

any member of the Wider <strong>Evolution</strong> <strong>Group</strong> is a party or <strong>by</strong> or <strong>to</strong> which any such member or any of its assets is or may be bound<br />

or be subject, which as a consequence of the Offer or the acquisition or the proposed acquisition <strong>by</strong> <strong>Investec</strong> or any member<br />

of the Wider <strong>Investec</strong> <strong>Group</strong> of any shares or other securities (or the equivalent) in <strong>Evolution</strong> or because of a change in the<br />

control or management of any member of the Wider <strong>Evolution</strong> <strong>Group</strong> or otherwise, would result, in any case <strong>to</strong> an extent which<br />

is material in the context of the Wider <strong>Evolution</strong> <strong>Group</strong> taken as a whole, in:<br />

(i) any monies borrowed <strong>by</strong>, or any other indebtedness, actual or contingent, of, any member of the Wider <strong>Evolution</strong> <strong>Group</strong><br />

being or becoming repayable, or being capable of being declared repayable immediately or prior <strong>to</strong> their or its stated<br />

maturity, or the ability of any such member <strong>to</strong> borrow monies or incur any indebtedness being withdrawn or inhibited;<br />

(ii) the creation or en<strong>for</strong>cement of any mortgage, charge or other security interest, over the whole or any part of the business,<br />

property or assets of any member of the Wider <strong>Evolution</strong> <strong>Group</strong> or any such mortgage, charge or other security interest<br />

(whenever arising or having arisen) becoming en<strong>for</strong>ceable;<br />

(iii) any such arrangement, agreement, lease, licence, permit or other instrument being terminated or adversely modified or<br />

affected or any onerous obligation or liability arising or any adverse action being taken thereunder;<br />

(iv) any assets or interests of any member of the Wider <strong>Evolution</strong> <strong>Group</strong> being or falling <strong>to</strong> be disposed of or charged or any<br />

right arising under which any such asset or interest could be required <strong>to</strong> be disposed of or charged;<br />

(v) the rights, liabilities, obligations or interests of any member of the Wider <strong>Evolution</strong> <strong>Group</strong> in, or the business of any such<br />

member with, any person, firm or body (or any arrangement or arrangements relating <strong>to</strong> any such interest or business)<br />

being terminated, adversely modified or affected;<br />

(vi) any such member of the Wider <strong>Evolution</strong> <strong>Group</strong> ceasing <strong>to</strong> be able <strong>to</strong> carry on business under any name under which it<br />

presently does so;<br />

29


30<br />

(vii) the value or financial or trading position or profits of <strong>Evolution</strong> or any member of the Wider <strong>Evolution</strong> <strong>Group</strong> being prejudiced<br />

or adversely affected; or<br />

(viii) the creation of any liability (actual or contingent) <strong>by</strong> any member of the Wider <strong>Evolution</strong> <strong>Group</strong>;<br />

(j) save as Disclosed, no member of the Wider <strong>Evolution</strong> <strong>Group</strong> having since 31 December 2010:<br />

(i) issued or agreed <strong>to</strong> issue or authorised or proposed or announced its intention <strong>to</strong> authorise or propose the issue of<br />

additional shares of any class, or securities convertible in<strong>to</strong>, or exchangeable <strong>for</strong>, or rights, warrants or options <strong>to</strong> subscribe<br />

<strong>for</strong> or acquire, any such shares or convertible securities (save as between <strong>Evolution</strong> and wholly-owned subsidiaries of<br />

<strong>Evolution</strong> and save <strong>for</strong> the issue of <strong>Evolution</strong> Shares pursuant <strong>to</strong> or in connection with the exercise or vesting of options or<br />

awards granted under, or the grant of options or awards under, the <strong>Evolution</strong> Share Schemes);<br />

(ii) recommended, declared, paid or made or proposed <strong>to</strong> recommend, declare, pay or make any bonus issue, dividend or<br />

other distribution whether payable in cash or otherwise other than dividends (or other distributions whether payable in cash<br />

or otherwise) lawfully paid or made <strong>by</strong> any wholly-owned subsidiary of <strong>Evolution</strong> <strong>to</strong> <strong>Evolution</strong> or any of its wholly-owned<br />

subsidiaries;<br />

(iii) other than pursuant <strong>to</strong> the implementation of the Offer (and save <strong>for</strong> transactions between <strong>Evolution</strong> and its wholly-owned<br />

subsidiaries and transactions in the ordinary course of business) implemented, effected, authorised, proposed or<br />

announced its intention <strong>to</strong> implement, effect, authorise or propose any merger, demerger, reconstruction, amalgamation,<br />

scheme, commitment or acquisition or disposal of assets or shares (or the equivalent thereof) in any undertaking or<br />

undertakings that is material in context of the Wider <strong>Evolution</strong> <strong>Group</strong> taken as a whole or any change in its share or loan<br />

capital (save <strong>for</strong> the issue of <strong>Evolution</strong> Shares on the exercise or vesting of options or awards granted be<strong>for</strong>e the date of<br />

this announcement under the <strong>Evolution</strong> Share Schemes);<br />

(iv) (save <strong>for</strong> transactions between <strong>Evolution</strong> and its wholly-owned subsidiaries and save <strong>for</strong> transactions in the ordinary course<br />

of business) disposed of, or transferred, mortgaged or created any security interest over any asset or any right, title or<br />

interest in any asset that is material in the context of the Wider <strong>Evolution</strong> <strong>Group</strong> taken as a whole or authorised, proposed<br />

or announced any intention <strong>to</strong> do so;<br />

(v) (save <strong>for</strong> transactions between <strong>Evolution</strong> and its wholly-owned subsidiaries) issued, authorised or proposed or announced<br />

an intention <strong>to</strong> authorise or propose, the issue of any debentures or (save <strong>for</strong> transactions between <strong>Evolution</strong> and its<br />

wholly-owned subsidiaries or transactions under existing credit arrangements or in the ordinary course of business) incur<br />

any indebtedness or contingent liability;<br />

(vi) entered in<strong>to</strong> or varied or authorised, proposed or announced an intention <strong>to</strong> enter in<strong>to</strong> or vary any contract, arrangement,<br />

agreement, transaction or commitment (whether in respect of capital expenditure or otherwise) otherwise than in the<br />

ordinary course of business which is of a long term, unusual or onerous nature or magnitude or which involves or is<br />

reasonably likely <strong>to</strong> involve an obligation of such a nature or magnitude which is, in any such case, or which is or is likely<br />

<strong>to</strong> be restrictive on the business of any member of the Wider <strong>Evolution</strong> <strong>Group</strong>, which is, in any such case, material in the<br />

context of the Wider <strong>Evolution</strong> <strong>Group</strong>;<br />

(vii) entered in<strong>to</strong> or varied <strong>to</strong> a material extent or authorised, proposed or announced its intention <strong>to</strong> enter in<strong>to</strong> or vary <strong>to</strong> a<br />

material extent the terms of, or make any <strong>offer</strong> (which remains open <strong>for</strong> acceptance) <strong>to</strong> enter in<strong>to</strong> or vary <strong>to</strong> a material<br />

extent the terms of, any service agreement with any direc<strong>to</strong>r or, save <strong>for</strong> salary increases, bonuses or variations of terms<br />

in the ordinary course, senior executive of <strong>Evolution</strong>;<br />

(viii) proposed, agreed <strong>to</strong> provide or modified the terms of any share option scheme, incentive scheme or other benefit relating<br />

<strong>to</strong> the employment or termination of employment of any person employed <strong>by</strong> the Wider <strong>Evolution</strong> <strong>Group</strong>, which is, in any<br />

such case, material in the context of the Wider <strong>Evolution</strong> <strong>Group</strong>;<br />

(ix) purchased, redeemed or repaid or announced a proposal <strong>to</strong> purchase, redeem or repay any of its own shares or other<br />

securities (or the equivalent) or reduced or made any other change <strong>to</strong> or proposed the reduction or other change <strong>to</strong> any<br />

part of its share capital, save <strong>for</strong> the allotment of shares in connection with the <strong>Evolution</strong> Share Schemes pursuant <strong>to</strong><br />

rights granted be<strong>for</strong>e the date of this announcement or as between <strong>Evolution</strong> and wholly-owned subsidiaries of <strong>Evolution</strong>;<br />

(x) waived, compromised or settled any claim otherwise than in the ordinary course of business which is material in the<br />

context of the Wider <strong>Evolution</strong> <strong>Group</strong> as a whole;<br />

(xi) terminated or varied the terms of any agreement or arrangement between any member of the Wider <strong>Evolution</strong> <strong>Group</strong> and<br />

any other person in a manner which would or might reasonably be expected <strong>to</strong> have a material adverse effect on the<br />

financial position of the Wider <strong>Evolution</strong> <strong>Group</strong> taken as a whole;<br />

(xii) (save as disclosed on publicly available registers or as envisaged in accordance with the terms of the Scheme) made any<br />

alteration <strong>to</strong> its articles of association;<br />

(xiii) made or agreed or consented <strong>to</strong> any significant change <strong>to</strong> the terms of the trust deeds constituting the pension schemes<br />

established <strong>for</strong> its direc<strong>to</strong>rs and/or employees and/or their dependants or <strong>to</strong> the benefits which accrue, or <strong>to</strong> the pensions<br />

which are payable, thereunder, or <strong>to</strong> the basis on which qualification <strong>for</strong> or accrual or entitlement <strong>to</strong> such benefits or<br />

pensions are calculated or determined or <strong>to</strong> the basis upon which the liabilities (including pensions) of such pension


schemes are funded or made, or agreed or consented <strong>to</strong> any change <strong>to</strong> the trustees involving the appointment of a trust<br />

corporation which is, in any such case, material in the context of the Wider <strong>Evolution</strong> <strong>Group</strong> taken as a whole;<br />

(xiv) been unable, or admitted in writing that it is unable, <strong>to</strong> pay its debts or having s<strong>to</strong>pped or suspended (or threatened <strong>to</strong> s<strong>to</strong>p<br />

or suspend) payment of its debts generally or ceased or threatened <strong>to</strong> cease carrying on all or a substantial part of any<br />

business which is material in the context of the Wider <strong>Evolution</strong> <strong>Group</strong> as a whole;<br />

(xv) (other than in respect of a company which is dormant and was solvent at the relevant time) taken or proposed any<br />

corporate action or had any action or proceedings or other steps instituted against it <strong>for</strong> its winding-up (voluntary or<br />

otherwise), dissolution or reorganisation or <strong>for</strong> the appointment of a receiver, administra<strong>to</strong>r, administrative receiver, trustee<br />

or similar officer of all or any material part of its assets or revenues or any analogous proceedings in any jurisdiction or<br />

appointed any analogous person in any jurisdiction; or<br />

(xvi) entered in<strong>to</strong> any agreement, arrangement or commitment or passed any resolution or made any proposal or announcement<br />

with respect <strong>to</strong>, or <strong>to</strong> effect, any of the transactions, matters or events referred <strong>to</strong> in this Condition (j);<br />

(k) save as Disclosed, since 31 December 2010 there having been:<br />

(i) no adverse change or deterioration in the business, assets, financial or trading position or profits or prospects of any<br />

member of the Wider <strong>Evolution</strong> <strong>Group</strong> which is material in the context of the Wider <strong>Evolution</strong> <strong>Group</strong> taken as a whole;<br />

(ii) no litigation, arbitration proceedings, prosecution or other legal proceedings having been announced or instituted <strong>by</strong> or<br />

against or remaining outstanding against or in respect of any member of the Wider <strong>Evolution</strong> <strong>Group</strong> and no enquiry or<br />

investigation <strong>by</strong> or complaint or reference <strong>to</strong> any Third Party against or in respect of any member of the Wider <strong>Evolution</strong><br />

<strong>Group</strong> having been threatened, announced or instituted or remaining outstanding, against or in respect of any member of<br />

the Wider <strong>Evolution</strong> <strong>Group</strong> and which in any such case might reasonably be expected <strong>to</strong> be material in the context of the<br />

Wider <strong>Evolution</strong> <strong>Group</strong> taken as a whole;<br />

(iii) no contingent or other liability having arisen or become apparent <strong>to</strong> any member of the <strong>Investec</strong> <strong>Group</strong> which might<br />

reasonably be expected <strong>to</strong> adversely affect any member of the Wider <strong>Evolution</strong> <strong>Group</strong> which is material in the context of<br />

the Wider <strong>Evolution</strong> <strong>Group</strong> taken as a whole; and<br />

(iv) no steps having been taken which are likely <strong>to</strong> result in the withdrawal, cancellation, termination or modification of any<br />

licence held <strong>by</strong> any member of the Wider <strong>Evolution</strong> <strong>Group</strong> which is necessary <strong>for</strong> the proper carrying on of its business<br />

which is material in the context of the Wider <strong>Evolution</strong> <strong>Group</strong> taken as a whole;<br />

(l) save as Disclosed, <strong>Investec</strong> not having discovered:<br />

(i) that the financial, business or other in<strong>for</strong>mation concerning the Wider <strong>Evolution</strong> <strong>Group</strong> publicly announced or fairly disclosed<br />

at any time <strong>by</strong> or on behalf of any member of the Wider <strong>Evolution</strong> <strong>Group</strong> is misleading, contains a misrepresentation of fact<br />

or omits <strong>to</strong> state a fact necessary <strong>to</strong> make the in<strong>for</strong>mation contained therein not misleading and which is in any case,<br />

material in the context of the Wider <strong>Evolution</strong> <strong>Group</strong> as a whole;<br />

(ii) that any member of the Wider <strong>Evolution</strong> <strong>Group</strong> is, otherwise than in the ordinary course of business, subject <strong>to</strong> any liability,<br />

contingent or otherwise, which is material in the context of the Wider <strong>Evolution</strong> <strong>Group</strong> taken as a whole; or<br />

(iii) any in<strong>for</strong>mation which adversely affects the import of any in<strong>for</strong>mation disclosed at any time <strong>by</strong> or on behalf of the <strong>Evolution</strong><br />

<strong>Group</strong> and which is material in the context of the Wider <strong>Evolution</strong> <strong>Group</strong> taken as a whole.<br />

Part B: Certain Further Terms of the Offer<br />

1 Subject <strong>to</strong> the requirements of the Panel, or if required, the Court, <strong>Investec</strong> reserves the right <strong>to</strong> waive (in whole or in part, all or any<br />

of the above Conditions in paragraph 3 (other than 3(f)). <strong>The</strong> Scheme will not become effective unless the Conditions have been fulfilled<br />

or (if capable of waiver) waived or where appropriate, have been determined <strong>by</strong> <strong>Investec</strong> <strong>to</strong> be or remain satisfied <strong>by</strong> no later than the<br />

date referred <strong>to</strong> in Condition 1 (or such later date as <strong>Investec</strong>, <strong>Evolution</strong>, the Panel and, if required, the Court, may allow).<br />

2 <strong>Investec</strong> shall be under no obligation <strong>to</strong> waive (if capable of waiver), <strong>to</strong> determine <strong>to</strong> be or remain satisfied or <strong>to</strong> treat as fulfilled any<br />

of the Conditions in paragraphs 3(a) <strong>to</strong> (l) (inclusive) <strong>by</strong> a date earlier than the latest date <strong>for</strong> the fulfilment of that Condition notwithstanding<br />

that the other conditions of the Offer may at such earlier date have been waived or fulfilled and that there are at such earlier date no<br />

circumstances indicating that any of such Conditions may not be capable of fulfilment.<br />

3 If <strong>Investec</strong> is required <strong>by</strong> the Panel <strong>to</strong> make an <strong>offer</strong> <strong>for</strong> <strong>Evolution</strong> Shares under the provisions of Rule 9 of the Code, <strong>Investec</strong> may<br />

make such alterations <strong>to</strong> any of the above Conditions, including Condition 1 above, and <strong>to</strong> the terms of the Offer as are necessary <strong>to</strong><br />

comply with the provisions of that Rule.<br />

4 <strong>Investec</strong> reserves the right, with the consent of the Panel, <strong>to</strong> elect <strong>to</strong> implement the acquisition of the <strong>Evolution</strong> Shares <strong>by</strong> way of a<br />

Takeover Offer (as defined in Part 28 of the Companies Act) as an alternative <strong>to</strong> the Scheme. Any such Takeover Offer will be implemented<br />

on substantially the same terms, so far as applicable, as those which would apply <strong>to</strong> the Scheme, subject <strong>to</strong> appropriate amendments<br />

<strong>to</strong> reflect the change in method of effecting the acquisition including (without limitation and subject <strong>to</strong> the consent of the Panel) an<br />

acceptance condition set at such percentage as <strong>Investec</strong> may decide, and in compliance with applicable laws and regulations.<br />

5 <strong>The</strong> Scheme will lapse if it is referred <strong>to</strong> the UK Competition Commission be<strong>for</strong>e the later of the time of the Court Meeting and the<br />

31


time of the General Meeting. In such event, <strong>Evolution</strong> will not be bound <strong>by</strong> the terms of the Scheme.<br />

6 <strong>The</strong> availability of the Offer <strong>to</strong> <strong>Evolution</strong> Shareholders who are not resident in the United Kingdom may be affected <strong>by</strong> the laws of<br />

the relevant jurisdictions in which they are resident. Persons who are not resident in the United Kingdom should in<strong>for</strong>m themselves of,<br />

and observe, any applicable requirements.<br />

7 Under Rule 13.4 of the Code, <strong>Investec</strong> may only invoke a Condition <strong>to</strong> the Offer so as <strong>to</strong> cause the Scheme not <strong>to</strong> proceed, <strong>to</strong> lapse<br />

or <strong>to</strong> be withdrawn where the circumstances which give rise <strong>to</strong> the right <strong>to</strong> invoke the Condition are of material significance <strong>to</strong> <strong>Investec</strong><br />

in the context of the Offer. <strong>The</strong> Conditions contained in paragraphs 1, 2, 3(a) and 3(f) above are not subject <strong>to</strong> Rule 13.4 of the Code.<br />

8 <strong>The</strong> Offer and Scheme will be governed <strong>by</strong> English law and will be subject <strong>to</strong> the exclusive jurisdiction of the English courts.<br />

32


PART V<br />

UNITED KINGDOM TAXATION<br />

<strong>The</strong> following paragraphs, which are intended as a general guide only, are based on current UK tax legislation and practice<br />

of Her Majesty’s Revenue & Cus<strong>to</strong>ms (“HMRC”). <strong>The</strong>y summarise certain limited aspects of the UK tax treatment of the<br />

Scheme, do not constitute tax advice and relate only <strong>to</strong> the position of Scheme Shareholders who are resident or ordinarily<br />

resident in the UK <strong>for</strong> taxation purposes and who hold their Scheme Shares beneficially as an investment (other than under<br />

a personal equity plan or an individual savings account) and who have not (and are not deemed <strong>to</strong> have) acquired their<br />

Scheme Shares <strong>by</strong> virtue of an office or employment. In addition, certain categories of Scheme Shareholders, such as<br />

brokers, dealers or traders in shares or securities, insurance companies and collective investment schemes may be subject<br />

<strong>to</strong> special rules and this summary does not apply <strong>to</strong> such Scheme Shareholders. If you are in any doubt as <strong>to</strong> your taxation<br />

position, or you are subject <strong>to</strong> taxation in a jurisdiction other than the UK, you should consult an appropriate independent<br />

professional financial adviser immediately.<br />

Special tax provisions may apply <strong>to</strong> Scheme Shareholders who have acquired or who acquire their Scheme Shares through<br />

the exercise of options or the vesting of awards under the <strong>Evolution</strong> Share Schemes, including provisions imposing a charge<br />

<strong>to</strong> income tax. This summary does not apply <strong>to</strong> such shareholders and such shareholders are advised <strong>to</strong> seek independent<br />

professional advice.<br />

1 UK taxation on chargeable gains<br />

1.1 Offer of New <strong>Investec</strong> Shares<br />

To the extent that a Scheme Shareholder receives New <strong>Investec</strong> Shares in exchange <strong>for</strong> Scheme Shares and does not hold (either alone<br />

or <strong>to</strong>gether with persons connected <strong>to</strong> him) more than five per cent. of, or of any class of, shares in or debentures of <strong>Evolution</strong>, he will<br />

not be treated as having made a disposal of his Scheme Shares. Instead, the New <strong>Investec</strong> Shares will be treated as the same asset as<br />

those Scheme Shares in respect of which he received the New <strong>Investec</strong> Shares, acquired at the same time and <strong>for</strong> the same consideration<br />

as those shares.<br />

Any Scheme Shareholder who holds (either alone or <strong>to</strong>gether with persons connected with him) more than five per cent of, or of any class<br />

of, shares in or debentures of <strong>Evolution</strong> is advised that an application <strong>for</strong> clearance has been made <strong>to</strong> HMRC under Section 138 of the<br />

Taxation of Chargeable Gains Act 1992 in respect of the Offer. If such clearance is given, any such shareholder should be treated in the<br />

manner described in the preceding paragraph. <strong>The</strong> Offer is not conditional on such clearance being obtained.<br />

1.2 Disposal of New <strong>Investec</strong> Shares<br />

A subsequent disposal of the New <strong>Investec</strong> Shares may, depending on individual circumstances of the person making the disposal<br />

(including the availability of exemptions and allowable losses), give rise <strong>to</strong> a liability <strong>to</strong> UK taxation of chargeable gains. Any chargeable<br />

gain or allowable loss on a disposal of the New <strong>Investec</strong> Shares should be calculated taking in<strong>to</strong> account a proportion of the allowable<br />

cost <strong>to</strong> the holder of acquiring his Scheme Shares.<br />

Additionally <strong>for</strong> corporate Scheme Shareholders, when calculating a chargeable gain but not an allowable loss, indexation allowance on<br />

that amount of the original allowable cost should be added. This indexation allowance will be calculated <strong>by</strong> reference <strong>to</strong> the date of<br />

disposal of the New <strong>Investec</strong> Shares.<br />

2 Tax on Income<br />

2.1 Dividends on New <strong>Investec</strong> Shares<br />

<strong>Investec</strong> will not be required <strong>to</strong> withhold tax at source when paying a dividend.<br />

A UK resident individual holder of New <strong>Investec</strong> Shares who receives a dividend from <strong>Investec</strong> will be entitled <strong>to</strong> a tax credit which may<br />

be set off against the shareholder’s <strong>to</strong>tal income tax liability on the dividend. <strong>The</strong> tax credit will be equal <strong>to</strong> l0 per cent. of the aggregate<br />

of the dividend and the tax credit (the “gross dividend”), which is also equal <strong>to</strong> one-ninth of the cash dividend received. Such an<br />

individual shareholder who is liable <strong>to</strong> income tax at the basic rate will be subject <strong>to</strong> tax on the dividend at the rate of l0 per cent. of the<br />

gross dividend, so that the tax credit will satisfy in full such shareholder’s liability <strong>to</strong> income tax on the dividend. In the case of such an<br />

individual shareholder who is liable <strong>to</strong> income tax at the higher rate, the tax credit will be set against but not fully match the shareholder’s<br />

tax liability on the gross dividend and such shareholder will have <strong>to</strong> account <strong>for</strong> additional income tax equal <strong>to</strong> 22.5 per cent. of the gross<br />

dividend (which is also equal <strong>to</strong> 25 per cent. of the cash dividend received) <strong>to</strong> the extent that the gross dividend when treated as the <strong>to</strong>p<br />

slice of the shareholder’s income falls above the threshold <strong>for</strong> higher rate income tax. In the case of such an individual shareholder who<br />

is subject <strong>to</strong> income tax at the additional rate, the tax credit will also be set against but not fully match the shareholder’s liability on the<br />

gross dividend and such shareholder will have <strong>to</strong> account <strong>for</strong> additional income tax equal <strong>to</strong> 32.5 per cent. of the gross dividend (which<br />

is also equal <strong>to</strong> approximately 36 per cent. of the cash dividend received) <strong>to</strong> the extent that the gross dividend when treated as the <strong>to</strong>p<br />

slice of the shareholder’s income falls above the threshold <strong>for</strong> additional rate income tax.<br />

A UK resident individual holder of New <strong>Investec</strong> Shares who is not liable <strong>to</strong> income tax in respect of the gross dividend and other UK<br />

resident taxpayers who are not liable <strong>to</strong> UK tax on dividends, including pension funds and charities, will not be entitled <strong>to</strong> claim repayment<br />

of the tax credit attaching <strong>to</strong> dividends paid <strong>by</strong> <strong>Investec</strong>.<br />

Holders of New <strong>Investec</strong> Shares who are within the charge <strong>to</strong> corporation tax will be subject <strong>to</strong> corporation tax on dividends paid <strong>by</strong><br />

<strong>Investec</strong>, unless (subject <strong>to</strong> special rules <strong>for</strong> such shareholders that are small companies) the dividends fall within an exempt class and<br />

certain other conditions are met. It is expected that the dividends paid <strong>by</strong> <strong>Investec</strong> would generally be exempt <strong>for</strong> such shareholders.<br />

33


Such shareholders will not be able <strong>to</strong> claim repayment of tax credits attaching <strong>to</strong> dividends.<br />

Non-UK resident holders of New <strong>Investec</strong> Shares will not generally be able <strong>to</strong> claim repayment from HMRC of any part of the tax credit<br />

attaching <strong>to</strong> dividends paid <strong>by</strong> <strong>Investec</strong>. Holders of New <strong>Investec</strong> Shares resident outside the UK may also be subject <strong>to</strong> <strong>for</strong>eign taxation<br />

on dividend income under local law. Shareholders who are not resident <strong>for</strong> tax purposes in the UK should obtain their own tax advice<br />

concerning tax liabilities on dividends received from <strong>Investec</strong>.<br />

2.2 Miscellaneous<br />

In addition <strong>to</strong> the clearance under Section 138 of the Taxation of Chargeable Gains Act 1992 referred <strong>to</strong> in paragraph 1.1 above, an<br />

application <strong>for</strong> clearance has been made <strong>to</strong> HMRC, pursuant <strong>to</strong> section 748 of the Corporation Tax Act 2010 and section 701 of the<br />

Income Tax Act 2007, that the anti-avoidance provisions of section 733 of the Corporation Tax Act 2010 and section 684 of the Income<br />

Tax Act 2007 respectively, relating <strong>to</strong> certain transactions in securities, will not apply <strong>to</strong> the transactions contemplated <strong>by</strong> the Scheme.<br />

<strong>The</strong> Offer is not conditional on such clearance being obtained.<br />

3 Stamp Duty and Stamp Duty Reserve Tax (‘‘SDRT’’)<br />

3.1 Acceptance of the Offer<br />

No UK stamp duty or SDRT will generally be payable <strong>by</strong> Scheme Shareholders as a result of the implementation of the Scheme.<br />

3.2 New <strong>Investec</strong> Shares<br />

Except in relation <strong>to</strong> depositary and clearance services (<strong>to</strong> which special rules apply), no UK stamp duty or SDRT will arise on the issue<br />

of New <strong>Investec</strong> Shares in registered <strong>for</strong>m <strong>by</strong> <strong>Investec</strong>.<br />

Transfers on sale of New <strong>Investec</strong> Shares will generally be subject <strong>to</strong> UK stamp duty at the rate of 0.5 per cent. of the consideration given<br />

<strong>for</strong> the transfer (rounded up <strong>to</strong> the next £5). <strong>The</strong> purchaser normally pays the stamp duty.<br />

An agreement <strong>to</strong> transfer New <strong>Investec</strong> Shares will normally give rise <strong>to</strong> a charge <strong>to</strong> SDRT at the rate of 0.5 per cent. of the amount or<br />

value of the consideration payable <strong>for</strong> the transfer. If a duly stamped transfer in respect of the agreement is produced within six years of<br />

the date on which the agreement is made (or, if the agreement is conditional, the date on which the agreement becomes unconditional),<br />

any SDRT paid is repayable, generally with interest, and if the SDRT has not been paid the SDRT charge is cancelled. SDRT is, in general,<br />

payable <strong>by</strong> the purchaser.<br />

Paperless transfers of New <strong>Investec</strong> Shares within the CREST system are generally liable <strong>to</strong> SDRT, rather than stamp duty, at the rate of<br />

0.5 per cent. of the amount or value of the consideration payable. CREST is obliged <strong>to</strong> collect SDRT on relevant transactions settled<br />

within the CREST system. Deposits of shares in<strong>to</strong> CREST will not generally be subject <strong>to</strong> SDRT, unless the transfer in<strong>to</strong> CREST is itself <strong>for</strong><br />

consideration.<br />

Where New <strong>Investec</strong> Shares are issued or transferred (a) <strong>to</strong>, or <strong>to</strong> a nominee (or, in the case of a transfer, an agent) <strong>for</strong>, a person whose<br />

business is or includes the provision of clearance services or (b) <strong>to</strong>, or <strong>to</strong> a nominee or agent <strong>for</strong>, a person whose business is or includes<br />

issuing depositary receipts, stamp duty or SDRT will, under current UK tax legislation, be payable at the higher rate of 1.5 per cent. of<br />

the amount or value of the consideration given or, in certain circumstances, the value of the shares. However, the European Courts of<br />

Justice has found in C-569107 HSBC Holdings <strong>Plc</strong> and Vidacos Nominees Limited v <strong>The</strong> Commissioners of Her Majesty’s Revenue &<br />

Cus<strong>to</strong>ms that the 1.5 per cent. SDRT charge is contrary <strong>to</strong> European Union Law where shares are issued <strong>to</strong> a clearance service, and<br />

HMRC has subsequently indicated that it will not seek <strong>to</strong> apply 1.5 per cent. stamp duty or SDRT when new shares are first issued <strong>to</strong> an<br />

EU clearance service or EU depositary receipts system. Following the HSBC Holdings case, HMRC announced that it will determine<br />

whether and how <strong>to</strong> amend the SDRT rules <strong>to</strong> ensure movements of shares in<strong>to</strong> and within clearance services bear their fair share of<br />

tax, whilst ensuring the rules are compatible with EU law. <strong>The</strong> law in this area may there<strong>for</strong>e be particularly susceptible <strong>to</strong> change. Any<br />

liability <strong>for</strong> stamp duty or SDRT which does arise will strictly be accountable <strong>by</strong> the clearance service or depositary receipt opera<strong>to</strong>r or<br />

their nominee, as the case may be, but may, in practice, be payable <strong>by</strong> the participants in the clearance service or depositary receipt<br />

scheme.<br />

<strong>The</strong> above statements in this section are intended as a general guide <strong>to</strong> the current stamp duty and SDRT position. Certain categories<br />

of person are not liable <strong>to</strong> stamp duty or SDRT and others may be liable at a higher rate or may, although not primarily liable <strong>for</strong> tax, be<br />

required <strong>to</strong> notify and account <strong>for</strong> SDRT under the Stamp Duty Reserve Tax Regulations 1986.<br />

34


PART VI<br />

ADDITIONAL INFORMATION<br />

1 Responsibility Statements<br />

1.1 <strong>The</strong> <strong>Evolution</strong> Direc<strong>to</strong>rs, whose names are set out in paragraph 2.1 of this Part VI, each accept responsibility <strong>for</strong> the in<strong>for</strong>mation<br />

contained in this document other than in<strong>for</strong>mation <strong>for</strong> which responsibility is taken <strong>by</strong> others pursuant <strong>to</strong> paragraph 1.2 of this Part VI.<br />

To the best of the knowledge and belief of the <strong>Evolution</strong> Direc<strong>to</strong>rs (who have taken all reasonable care <strong>to</strong> ensure that such is the case),<br />

the in<strong>for</strong>mation contained in this document <strong>for</strong> which they are responsible is in accordance with the facts and does not omit anything<br />

likely <strong>to</strong> affect the import of such in<strong>for</strong>mation.<br />

1.2 <strong>The</strong> <strong>Investec</strong> Direc<strong>to</strong>rs, whose names are set out in paragraph 2.2 of this Part VI, each accept responsibility <strong>for</strong> the in<strong>for</strong>mation<br />

contained in this document relating <strong>to</strong> the <strong>Investec</strong> <strong>Group</strong> and the <strong>Investec</strong> Direc<strong>to</strong>rs and their immediate families, related trusts and<br />

companies. To the best of the knowledge and belief of the <strong>Investec</strong> Direc<strong>to</strong>rs (who have taken all reasonable care <strong>to</strong> ensure that such is<br />

the case), the in<strong>for</strong>mation contained in this document <strong>for</strong> which they are responsible is in accordance with the facts and does not omit<br />

anything likely <strong>to</strong> affect the import of such in<strong>for</strong>mation.<br />

2 Direc<strong>to</strong>rs<br />

2.1 <strong>The</strong> <strong>Evolution</strong> Direc<strong>to</strong>rs and their principal functions are as follows:<br />

Name Current Position<br />

Martin Gray Non-Executive Chairman<br />

Alex Snow Chief Executive<br />

Philip Howell Executive Direc<strong>to</strong>r<br />

Peter Gibbs Senior Independent Non-Executive Direc<strong>to</strong>r<br />

Chris<strong>to</strong>pher Chambers Non-Executive Direc<strong>to</strong>r<br />

Roger Perkin Non-Executive Direc<strong>to</strong>r<br />

Lord MacLaurin Non-Executive Direc<strong>to</strong>r<br />

2.2 <strong>The</strong> <strong>Investec</strong> Direc<strong>to</strong>rs and their principal functions are as follows:<br />

Name Current Position<br />

Hugh S Herman Non-Executive Chairman<br />

Stephen Koseff Chief Executive Officer<br />

Bernard Kan<strong>to</strong>r Managing Direc<strong>to</strong>r<br />

Glynn Burger <strong>Group</strong> Risk and Finance Direc<strong>to</strong>r<br />

Hendrik du Toit <strong>Investec</strong> Asset Management Chief Executive Officer<br />

Sam E Abrahams Non-Executive Direc<strong>to</strong>r<br />

George F O Al<strong>for</strong>d Non-Executive Direc<strong>to</strong>r<br />

Cheryl A Carolus Non-Executive Direc<strong>to</strong>r<br />

Peregrine KO Crosthwaite Non-Executive Direc<strong>to</strong>r<br />

Olivia C Dickson Non-Executive Direc<strong>to</strong>r<br />

Bradley Fried Non-Executive Direc<strong>to</strong>r<br />

Haruko Fukuda OBE Non-Executive Direc<strong>to</strong>r<br />

Ian R Kan<strong>to</strong>r Non-Executive Direc<strong>to</strong>r<br />

M Peter Malungani Non-Executive Direc<strong>to</strong>r<br />

Sir David Prosser Non-Executive Direc<strong>to</strong>r (Senior Independent Direc<strong>to</strong>r)<br />

Peter R S Thomas Non-Executive Direc<strong>to</strong>r<br />

Fani Titi Non-Executive Direc<strong>to</strong>r<br />

35


3 Persons acting in concert<br />

3.1 In addition <strong>to</strong> the <strong>Investec</strong> Direc<strong>to</strong>rs, the persons who, <strong>for</strong> the purposes of the City Code, are acting in concert with <strong>Investec</strong> in<br />

respect of the Offer are:<br />

36<br />

Name Type Registered Office Relationship with <strong>Investec</strong><br />

Merrill Lynch International<br />

(BAML)<br />

Private unlimited company<br />

registered in England and<br />

Wales<br />

Hargreave Hale Limited Private company registered<br />

in England and Wales<br />

<strong>Investec</strong> Wealth &<br />

Investment Limited<br />

<strong>Investec</strong> Asset Management<br />

Limited<br />

Private company registered<br />

in England and Wales<br />

Private company registered<br />

in England and Wales<br />

2 King Edward Street, London<br />

EC1A 1HQ<br />

Neptune Court, Hallam Way,<br />

Blackpool, FY4 5LZ<br />

2 Gresham Street, London,<br />

EC2V 7QP<br />

2 Gresham Street, London,<br />

EC2V 7QP<br />

connected adviser<br />

<strong>Investec</strong> controls 33.18 per<br />

cent. of Hargreave Hale Limited<br />

subsidiary<br />

subsidiary<br />

3.2 <strong>The</strong> persons who, <strong>for</strong> the purposes of the City Code, are acting in concert with <strong>Evolution</strong> in respect of the Offer are:<br />

Name Type Registered Office Relationship with <strong>Investec</strong><br />

Credit Suisse Private company registered in<br />

England and Wales<br />

Williams de Broë Private Company registered in<br />

England and Wales<br />

Capita Trustees Limited Private Company registered in<br />

Jersey<br />

Capita IRG Trustees Limited Private Company registered in<br />

England and Wales<br />

One Cabot Square, London<br />

E14 4QJ<br />

100 Wood Street, London<br />

EC2V 7AN<br />

12 Castle Street, St Helier,<br />

Jersey JE2 3RT<br />

<strong>The</strong> Registry, 34 Beckenham<br />

Road, Beckenham, Kent BR3<br />

4TU<br />

connected adviser<br />

subsidiary<br />

trustee of the <strong>Evolution</strong><br />

Employee’s Share Trust<br />

trustee of the SIP<br />

4 Market quotations<br />

<strong>The</strong> following table shows the closing-middle market prices, as derived from the daily Official List, <strong>for</strong> <strong>Evolution</strong> Shares and <strong>Investec</strong><br />

Shares on:<br />

4.1 the first Business Day in each of the six months immediately prior <strong>to</strong> the date of publication of this document on 3 Oc<strong>to</strong>ber 2011;<br />

4.2 2 August 2011 (being the last Business Day prior <strong>to</strong> the commencement of the Offer Period in respect of <strong>Evolution</strong> <strong>for</strong> the purposes<br />

of the City Code in connection with the Offer); and<br />

4.3 30 September 2011 (the latest practicable date prior <strong>to</strong> publication of this document):<br />

Date <strong>Evolution</strong> Shares <strong>Investec</strong> Shares<br />

30 September 2011 80.00p 349.60p<br />

2 August 2011 73.50p 462.30p<br />

1 August 2011 78.50p 470.80p<br />

1 July 2011 63.50p 512.50p<br />

1 June 2011 70.50p 505.00p<br />

3 May 2011 72.25p 485.90p<br />

1 April 2011 72.25p 487.70p<br />

1 March 2011 78.50p 468.40p<br />

1 February 2011 68.25p 487.70p<br />

5 Interests and dealings<br />

5.1 Definitions<br />

For the purposes of this paragraph 5:<br />

(i) “acting in concert” with <strong>Investec</strong> or <strong>Evolution</strong>, as the case may be, means any such person acting or deemed <strong>to</strong> be acting in<br />

concert with <strong>Investec</strong> or <strong>Evolution</strong>, as the case may be, <strong>for</strong> the purposes of the City Code;


(ii) “arrangement” includes indemnity or option arrangements, and any agreement or understanding, <strong>for</strong>mal or in<strong>for</strong>mal, of whatever<br />

nature, relating <strong>to</strong> relevant securities which may be an inducement <strong>to</strong> deal or <strong>to</strong> refrain from dealing;<br />

(iii) “connected adviser” includes an organisation which (A) is advising <strong>Investec</strong> or (as the case may be) <strong>Evolution</strong> in relation <strong>to</strong> the<br />

Offer, (B) is corporate broker <strong>to</strong> <strong>Investec</strong> or (as the case may be) <strong>Evolution</strong>, (C) is advising a person acting in concert with <strong>Investec</strong> or (as<br />

the case may be) <strong>Evolution</strong> in relation <strong>to</strong> the Offer or in relation <strong>to</strong> the matter which is the reason <strong>for</strong> that person being a member of the<br />

concert party, in each case above excluding any exempt principal traders and any exempt fund managers;<br />

(iv) “dealing” or “dealt” includes:<br />

(A) acquiring or disposing of relevant securities, of the right (whether conditional or absolute) <strong>to</strong> exercise or direct the exercise of the<br />

voting rights attaching <strong>to</strong> relevant securities, or of general control of relevant securities;<br />

(B) taking, granting, acquiring, disposing of, entering in<strong>to</strong>, closing out, terminating, exercising (<strong>by</strong> either party) or varying an option<br />

(including a traded option contract) in respect of any relevant securities;<br />

(C) subscribing or agreeing <strong>to</strong> subscribe <strong>for</strong> relevant securities;<br />

(D) exercising or converting, whether in respect of new or existing securities, any relevant securities carrying conversion or subscription<br />

rights;<br />

(E) acquiring, disposing of, entering in<strong>to</strong>, closing out, exercising (<strong>by</strong> either party) any rights under, or varying, a derivative referenced,<br />

directly or indirectly, <strong>to</strong> relevant securities;<br />

(F) entering in<strong>to</strong>, terminating or varying the terms of any agreement <strong>to</strong> purchase or sell relevant securities; and<br />

(G) any other action resulting, or which may result, in an increase or decrease in the number of relevant securities in which a person is<br />

interested or in respect of which he has a short position;<br />

(v) “derivative” includes any financial product the value of which, in whole or in part, is determined directly or indirectly <strong>by</strong> reference<br />

<strong>to</strong> the price of an underlying security;<br />

(vi) “disclosure period” means the period commencing on 3 August 2010 (being the date 12 months prior <strong>to</strong> the commencement of<br />

the Offer Period in respect of <strong>Evolution</strong> <strong>for</strong> the purposes of the City Code in connection with the Offer) and ending on the 29 September<br />

2011 being the latest practicable date prior <strong>to</strong> publication of this document;<br />

(vii) “a person has an interest” or is “interested” in relevant securities if he has long economic exposure, whether absolute or<br />

conditional, <strong>to</strong> changes in the price of those securities and in particular includes if a person:<br />

(A) owns them;<br />

(B) has the right (whether conditional or absolute) <strong>to</strong> exercise, or direct the exercise of the voting rights attaching <strong>to</strong> relevant securities<br />

or has general control of them;<br />

(C) <strong>by</strong> virtue of any agreement <strong>to</strong> purchase, option or derivative<br />

(D) has the right or option <strong>to</strong> acquire relevant securities or call <strong>for</strong> their delivery or is under an obligation <strong>to</strong> take delivery of them,<br />

whether the right, option or obligation is conditional or absolute and whether it is in the money or otherwise; or<br />

(E) is party <strong>to</strong> any derivative whose value is determined <strong>by</strong> reference <strong>to</strong> their price and which results, or may result, in his having a long<br />

position in them;<br />

(viii) “relevant securities” means:<br />

(A) <strong>Evolution</strong> Shares and any other securities of <strong>Evolution</strong> conferring voting rights;<br />

(B) equity share capital of <strong>Evolution</strong> or, as the context requires, <strong>Investec</strong> or <strong>Investec</strong> Limited;<br />

(C) securities of <strong>Investec</strong> which carry substantially the same rights as the <strong>Investec</strong> Shares, including shares in <strong>Investec</strong> Limited; and<br />

(D) securities in <strong>Evolution</strong> or, as the context requires, <strong>Investec</strong> or <strong>Investec</strong> Limited carrying conversion or subscription rights in<strong>to</strong> any of<br />

the <strong>for</strong>egoing;<br />

and where the expression “relevant securities of <strong>Investec</strong>” is used in paragraph 5 below, this shall include relevant securities of <strong>Investec</strong><br />

Limited.<br />

(ix) “short position” means any short position (whether conditional or absolute and whether in the money or otherwise) including any<br />

short position under a derivative any agreement <strong>to</strong> sell or any delivery obligation or right <strong>to</strong> require another person <strong>to</strong> purchase or take<br />

delivery.<br />

5.2 Interests in <strong>Evolution</strong> relevant securities<br />

As at the close of business on 29 September 2011 (the latest practicable date prior <strong>to</strong> the publication of this document):<br />

(i) <strong>Investec</strong> Wealth held 145,000 <strong>Evolution</strong> Shares on behalf of discretionary clients.<br />

37


(ii) BAML has a short position in respect of 1,229 <strong>Evolution</strong> Shares.<br />

(iii) <strong>The</strong> following <strong>Evolution</strong> Direc<strong>to</strong>rs and their respective related parties had an interest in, a right <strong>to</strong> subscribe in or a short position in<br />

certain <strong>Evolution</strong> relevant securities as follows:<br />

38<br />

Name<br />

Nature of interest or rights concerned<br />

Number of<br />

<strong>Evolution</strong> Shares<br />

Alex Snow Legal and beneficial owner 5,634,545<br />

Award over <strong>Evolution</strong> Shares granted under the ESIP, with a<br />

vesting date of 8.04.12<br />

Award over <strong>Evolution</strong> Shares granted under the ESIP, with a<br />

vesting date of 25.03.13<br />

Award over <strong>Evolution</strong> Shares granted under the ESIP, with an<br />

exercise price of 1p per share and a vesting date of 1.07.14<br />

Beneficial interest in <strong>Evolution</strong> Shares granted under the JSOP<br />

in respect of which value can be realised in 2013, 2014 and<br />

2015 subject <strong>to</strong> per<strong>for</strong>mance conditions<br />

175,179 (1)<br />

378,151 (1)<br />

1,285,000 (2)<br />

2,333,333<br />

Philip Howell Legal and beneficial owner 5,839<br />

Award over <strong>Evolution</strong> Shares granted under the ESIP, with a<br />

vesting date of 21.02.11<br />

Award over <strong>Evolution</strong> Shares granted under the ESIP, with a<br />

vesting date of 21.02.12<br />

Award over <strong>Evolution</strong> Shares granted under the ESIP, with a<br />

vesting date of 21.02.13<br />

Award over <strong>Evolution</strong> Shares granted under the ESIP, with a<br />

vesting date of 24.03.14<br />

50,000 (1)<br />

50,000 (1)<br />

50,000 (1)<br />

132,743 (1)<br />

Chris Chambers Legal and beneficial owner 126,000<br />

Ian MacLaurin Legal and beneficial owner 125,800<br />

Martin Gray Legal and beneficial owner 35,000<br />

Peter Gibbs Legal and beneficial owner 100,000<br />

Notes:<br />

(1) <strong>The</strong>se awards au<strong>to</strong>matically vest on a change of control of <strong>Evolution</strong> on a time pro rated basis<br />

(2) This option au<strong>to</strong>matically vests in full on a change of control of <strong>Evolution</strong><br />

(iv) <strong>The</strong> following persons acting in concert with <strong>Evolution</strong> had an interest in, a right <strong>to</strong> subscribe in or a short position in certain <strong>Evolution</strong><br />

relevant securities as follows:<br />

Name<br />

Nature of interest or rights concerned<br />

Number of<br />

<strong>Evolution</strong> Shares<br />

Williams de Broë Held on behalf of clients 10,718,731 (1)<br />

Capita Trustees Limited Held <strong>for</strong> beneficiaries including participants in the <strong>Evolution</strong><br />

Share Schemes<br />

15,112,379<br />

Capita IRG Trustee Limited Held <strong>for</strong> beneficiaries under the SIP 2,831,496<br />

Note:<br />

(1) Of these <strong>Evolution</strong> Shares, 273,543 are held on behalf of advisory clients, 468,085 are held on behalf of advisory managed clients, 1,058,643<br />

are held on behalf of discretionary clients and 8,918,460 are held on behalf of execution only clients.


5.3 Interests in <strong>Investec</strong> relevant securities<br />

As at the close of business on 29 September 2011 (the latest practicable date prior <strong>to</strong> the publication of this document):<br />

(i) <strong>Investec</strong> Direc<strong>to</strong>rs and their respective related parties had an interest in, a right <strong>to</strong> subscribe in or a short position in certain <strong>Investec</strong><br />

and <strong>Investec</strong> Limited relevant securities (excluding options and awards as set out in paragraph 5.3(ii) below) as follows:<br />

Name<br />

Number of<br />

<strong>Investec</strong> Shares<br />

Number of<br />

<strong>Investec</strong> Limited Shares<br />

Stephen Koseff 4,839,133 1,809,330<br />

Bernard Kan<strong>to</strong>r 48,525 3,801,000<br />

Glynn Burger 2,402,135 1,037,076<br />

Hendrik du Toit – 604,740<br />

Hugh S Herman 1,369,915 760,470<br />

Sam E Abrahams 20,000 –<br />

George F O Al<strong>for</strong>d 10,000 –<br />

Haruko Fukuda OBE 5,000 –<br />

Ian R Kan<strong>to</strong>r 3,509,545 325<br />

Sir David Prosser 10,000 –<br />

Peter R S Thomas 195,800 500<br />

Bradley Fried – 400,000<br />

Peregrine KO Crosthwaite 132,908 –<br />

(ii) <strong>The</strong> following options and awards over relevant securities of <strong>Investec</strong> had been granted <strong>to</strong> <strong>Investec</strong> Direc<strong>to</strong>rs and their respective<br />

related parties as follows:<br />

Name<br />

Scheme<br />

Number of<br />

<strong>Investec</strong> Shares<br />

under option<br />

Exercise price<br />

Exercise period s<br />

Stephen Koseff ISMP 300,000 £0.00 75 per cent. of the grant made on<br />

25.06.09 is exercisable on 25.06.13 and<br />

25 per cent. on 25.06.14<br />

ISMP 750,000 £0.00 75 per cent. of the grant made on 1.07.10<br />

is exercisable on 1.07.14 and 25 per cent.<br />

on 1.07.15<br />

Bernard Kan<strong>to</strong>r ISMP 300,000 £0.00 75 per cent. of the grant made on<br />

25.06.09 is exercisable on 25.06.13 and<br />

25 per cent. on 25.06.14<br />

ISMP 750,000 £0.00 75 per cent. of the grant made on 1.07.10<br />

is exercisable on 1.07.14 and 25 per cent.<br />

on 1.07.15<br />

ISOP 9,455 £1.59 Vesting scale in terms of the scheme rules.<br />

Earliest exercise date is 20.12.11 and the<br />

latest exercise date is 20.03.12 (subject <strong>to</strong><br />

per<strong>for</strong>mance conditions)<br />

Glynn Burger ISMP 300,000 £0.00 75 per cent. of the grant made on<br />

25.06.09 is exercisable on 25.06.13 and<br />

25 per cent. on 25.06.14<br />

ISMP 750,000 £0.00 75 per cent. of the grant made on 1.07.10<br />

is exercisable on 1.07.14 and 25 per cent.<br />

on 1.07.15<br />

39


40<br />

Hendrik du Toit ISOP 9,455 £1.59 Vesting scale in terms of the scheme rules.<br />

Earliest exercise date is 20.12.11 and the<br />

latest exercise date is 20.03.12 (subject <strong>to</strong><br />

per<strong>for</strong>mance conditions)<br />

Notes:<br />

ISOP: <strong>Investec</strong> <strong>plc</strong> Share Option Plan 2002<br />

ISMP: Share Matching Plan 2005<br />

LTIP: Long-term Incentive Plans<br />

LTIP 93,750 £0.00 75 per cent. is exercisable on 25.06.11<br />

and the remaining 25 per cent. on<br />

25.06.12<br />

LTIP 250,000 £0.00 75 per cent. of the grant made on<br />

25.06.09 is exercisable on 25.06.13 and<br />

25 per cent. on 25.06.14<br />

LTIP 750,000 £0.00 75 per cent. of the grant made on 1.07.10<br />

is exercisable on 1.07.14 and 25 per cent.<br />

on 1.07.15<br />

(iii) <strong>The</strong> following persons acting in concert with <strong>Investec</strong> had an interest in, a right <strong>to</strong> subscribe in or a short position in certain <strong>Investec</strong><br />

relevant securities as follows:<br />

Name<br />

Number of<br />

<strong>Investec</strong> Shares<br />

Number of<br />

<strong>Investec</strong> Limited Shares<br />

<strong>Investec</strong> Bank Switzerland 77,148 14,800<br />

<strong>Investec</strong> Bank Channel Islands 5,058,578 3,908,651<br />

<strong>Investec</strong> Wealth & Investment 1,302,430 -<br />

Hargreave Hale 14,788 156,900<br />

<strong>Investec</strong> Asset Management 8,645,953 7,308,024<br />

<strong>Investec</strong> Bank Limited 6,536,403 841,553<br />

Options<br />

Party<br />

Security<br />

Strike Price<br />

Maturity<br />

Number of<br />

<strong>Investec</strong> Shares<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 21/10/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 24/10/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 25/10/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 26/10/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 27/10/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 28/10/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 31/10/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 01/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 02/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 03/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 04/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 07/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 08/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 09/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 10/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 11/11/2011 94961 (Short)


Party<br />

Security<br />

Strike Price<br />

Maturity<br />

Number of<br />

<strong>Investec</strong> Shares<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 14/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 15/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 16/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 17/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 18/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 21/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 22/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 23/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 24/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 25/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 28/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 29/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 30/11/2011 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 01/12/2011 94968 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 56 15/12/2011 2,000<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 58 15/12/2011 2,000<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 19/04/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 20/04/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 23/04/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 24/04/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 25/04/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 26/04/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 30/04/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 02/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 03/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 04/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 07/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 08/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 09/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 10/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 11/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 14/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 15/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 16/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 17/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 18/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 21/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 22/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 23/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 24/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 25/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 28/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 29/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 30/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 31/05/2012 94961 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 01/06/2012 94968 (Short)<br />

41


42<br />

Party<br />

Security<br />

Strike Price<br />

Maturity<br />

Number of<br />

<strong>Investec</strong> Shares<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 22/10/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 23/10/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 24/10/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 25/10/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 26/10/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 29/10/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 30/10/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 31/10/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 01/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 02/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 05/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 06/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 07/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 08/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 09/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 12/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 13/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 14/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 15/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 16/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 19/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 20/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 21/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 22/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 23/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 26/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 27/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 28/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 29/11/2012 81395 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 30/11/2012 81406 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 19/04/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 22/04/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 23/04/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 24/04/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 25/04/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 26/04/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 29/04/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 30/04/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 02/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 03/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 06/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 07/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 08/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 09/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 10/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 13/05/2013 75969 (Short)


Party<br />

Security<br />

Strike Price<br />

Maturity<br />

Number of<br />

<strong>Investec</strong> Shares<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 14/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 15/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 16/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 17/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 20/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 21/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 22/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 23/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 24/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 27/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 28/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 29/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 30/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 31/05/2013 75969 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 21/10/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 22/10/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 23/10/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 24/10/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 25/10/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 28/10/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 29/10/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 30/10/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 31/10/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 01/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 04/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 05/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 06/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 07/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 08/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 11/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 12/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 13/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 14/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 15/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 18/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 19/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 20/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 21/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 22/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 25/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 26/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 27/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 28/11/2013 65116 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 29/11/2013 65124 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 15/04/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 16/04/2014 54264 (Short)<br />

43


44<br />

Party<br />

Security<br />

Strike Price<br />

Maturity<br />

Number of<br />

<strong>Investec</strong> Shares<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 17/04/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 22/04/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 23/04/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 24/04/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 25/04/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 29/04/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 30/04/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 02/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 05/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 06/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 07/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 08/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 09/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 12/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 13/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 14/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 15/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 16/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 19/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 20/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 21/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 22/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 23/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 26/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 27/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 28/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 29/05/2014 54264 (Short)<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 42 30/05/2014 54251 (Short)<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 01/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 01/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 02/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 02/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 03/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 03/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 04/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 04/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 05/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 05/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 08/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 08/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 10/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 10/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 11/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 11/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 12/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 12/08/2016 276399


Party<br />

Security<br />

Strike Price<br />

Maturity<br />

Number of<br />

<strong>Investec</strong> Shares<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 15/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 15/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 16/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 16/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 17/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 17/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 18/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 18/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 19/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 19/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 22/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 22/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 23/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 23/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 24/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 24/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 25/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 25/08/2016 276399<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 26/08/2016 276397<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 26/08/2016 276397<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 30/07/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 30/07/2018 306166<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 31/07/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 31/07/2018 306166<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 01/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 01/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 02/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 02/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 03/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 03/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 06/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 06/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 07/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 07/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 08/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 08/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 10/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 10/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 13/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 13/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 14/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 14/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 15/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 15/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 16/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 16/08/2018 306166<br />

45


46<br />

Party<br />

Security<br />

Strike Price<br />

Maturity<br />

Number of<br />

<strong>Investec</strong> Shares<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 17/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 17/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 20/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 20/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 21/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 21/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 22/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 22/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 23/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 23/08/2018 306166<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 49 24/08/2018 306173<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 54 24/08/2018 306173<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 27/08/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 27/08/2018 303061<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 28/08/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 28/08/2018 303061<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 29/08/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 29/08/2018 303061<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 30/08/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 30/08/2018 303061<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 31/08/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 31/08/2018 303061<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 03/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 03/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 04/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 04/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 05/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 05/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 06/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 06/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 07/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 07/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 10/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 10/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 11/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 11/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 12/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 12/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 13/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 13/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 14/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 14/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 17/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 17/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 18/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 18/09/2018 303061


Party<br />

Security<br />

Strike Price<br />

Maturity<br />

Number of<br />

<strong>Investec</strong> Shares<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 19/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 19/09/2018 303061<br />

<strong>Investec</strong> Bank Limited Put Option ZAR 51 20/09/2018 303067<br />

<strong>Investec</strong> Bank Limited Call Option ZAR 53 20/09/2018 303067<br />

Options<br />

Name<br />

Security<br />

Strike Price<br />

Maturity<br />

Number of <strong>Investec</strong><br />

Limited Shares<br />

<strong>Investec</strong> Bank <strong>plc</strong> Put Option ZAR 42 15/12/2011 4760 (Short)<br />

<strong>Investec</strong> Bank <strong>plc</strong> Put Option ZAR 46 15/12/2011 2500 (Short)<br />

<strong>Investec</strong> Bank <strong>plc</strong> Put Option ZAR 75 16/07/2012 50000 (Short)<br />

<strong>Investec</strong> Bank <strong>plc</strong> Call Option ZAR 75 16/07/2012 50000 (Short)<br />

Futures<br />

Name<br />

Security<br />

Strike Price<br />

Maturity<br />

Number of <strong>Investec</strong><br />

Limited Shares<br />

<strong>Investec</strong> Bank <strong>plc</strong> Futures N/A 15/12/2011 715<br />

<strong>Investec</strong> Bank <strong>plc</strong> Futures N/A 15/12/2011 9346 (Short)<br />

(iv) Other than as disclosed above, the following persons acting in concert with <strong>Investec</strong> had an interest in, a right <strong>to</strong> subscribe in or a<br />

short position in certain <strong>Investec</strong> and <strong>Investec</strong> Limited relevant securities as follows:<br />

Name<br />

Nature of interest<br />

or rights concerned Number of <strong>Investec</strong> Shares<br />

BAML Long position 997<br />

Name<br />

Short position 491,296<br />

Nature of interest<br />

or rights concerned Number of <strong>Investec</strong> Limited Shares<br />

BAML Short position 3,311<br />

(v) <strong>The</strong> following persons acting in concert with <strong>Evolution</strong> had an interest in, a right <strong>to</strong> subscribe in or a short position in certain <strong>Investec</strong><br />

relevant securities as follows:<br />

Name<br />

Nature of interest<br />

or rights concerned<br />

Number of <strong>Investec</strong> Shares<br />

Williams de Broë Held on behalf of clients 11,513<br />

Note:<br />

(1) Of these <strong>Investec</strong> Shares, 4,746 are held on behalf of advisory clients, 2,315 are held on behalf of discretionary clients and 4,452 are held on<br />

behalf of execution only clients.<br />

(vi) <strong>The</strong> following persons acting in concert with <strong>Evolution</strong> had an interest in, a right <strong>to</strong> subscribe in or a short position in certain <strong>Investec</strong><br />

Limited relevant securities as follows:<br />

Name<br />

Nature of interest<br />

or rights concerned<br />

Number of <strong>Investec</strong> Limited Shares<br />

Credit Suisse Long position 111,318<br />

Short position 110,512<br />

47


5.4 Dealings<br />

(i) <strong>Evolution</strong>, the following <strong>Evolution</strong> Direc<strong>to</strong>rs, persons acting in concert with <strong>Evolution</strong> and persons with whom <strong>Evolution</strong> or any person<br />

acting in concert with <strong>Evolution</strong> has an arrangement have dealt in the following <strong>Evolution</strong> relevant securities between the start of<br />

the Offer Period and 29 September 2011 (being the latest practicable date prior <strong>to</strong> the publication of this document), as listed<br />

below:<br />

48<br />

Name<br />

Date of dealing<br />

Price paid<br />

Nature of<br />

interest in<br />

relevant<br />

securities<br />

Number of<br />

relevant<br />

securities of<br />

<strong>Evolution</strong><br />

Alex Snow 5.08.11 79.60p acquisition 314<br />

6.09.11 92.00p acquisition 272<br />

14.09.11 Nil grant of awards<br />

under the ESIP<br />

1,285,000<br />

Philip Howell 5.08.11 79.60p acquisition 314<br />

Capita IRG Trustee Limited (as trustees<br />

of the SIP)<br />

Capita Trustees Limited (as trustees of<br />

the <strong>Evolution</strong> Employee’s Share Trust) (3)<br />

6.09.11 92.00p acquisition 272<br />

5.08.11 79.60p acquisition 31,680 (1)<br />

6.09.11 92.00p acquisition 26,056 (2)<br />

5.08.11 80.00p disposal 237,657<br />

8.08.11 81.00p disposal 29,705<br />

16.08.11 83.75p disposal 56.673<br />

16.08.11 83.75p disposal 38,130<br />

19.09.11 88.85p disposal 76,260<br />

19.09.11 88.85p disposal 25,421<br />

19.09.11 88.85p disposal 25,421<br />

21.09.11 88.25p disposal 30,970<br />

22.09.11 82.75p disposal 200,000<br />

22.09.11 82.75p disposal 30,000<br />

22.09.11 82.75p disposal 30,000<br />

27.09.11 82.25p disposal 11,795<br />

29.09.11 82.00p disposal 13,275<br />

Williams de Broë (on behalf of clients) 04.08.11 80.00p disposal 4,250<br />

22.08.11 87.90p acquisition 3,320<br />

02.09.11 92.84p acquisition 13,440<br />

05.09.11 91.00p disposal 8,476<br />

05.09.11 92.00p disposal 1,524<br />

08.09.11 92.75p disposal 15,000<br />

09.09.11 94.78p disposal 5,000<br />

09.09.11 94.75p disposal 2,890<br />

13.09.11 90.25p disposal 40,000<br />

13.09.11 90.00p disposal 39,470<br />

15.09.11 91.25p disposal 20,701<br />

15.09.11 91.31p disposal 10,000<br />

15.09.11 91.25p disposal 8,000


Name<br />

Note:<br />

Date of dealing<br />

(1) This figure includes the shares acquired <strong>by</strong> Alex Snow and Philip Howell on 5.08.11<br />

(2) This figure includes the shares acquired <strong>by</strong> Alex Snow and Philip Howell on 6.09.11<br />

Price paid<br />

Nature of<br />

interest in<br />

relevant<br />

securities<br />

Number of<br />

relevant<br />

securities of<br />

<strong>Evolution</strong><br />

19.09.11 88.84p disposal 2,000<br />

23.09.11 81.00p disposal 40,039<br />

23.09.11 80.75p disposal 112,304<br />

23.09.11 80.77p disposal 10,000<br />

28.09.11 82.75p disposal 20,000<br />

28.09.11 82.50p disposal 11,500<br />

28.09.11 82.50p disposal 38,500<br />

29.09.11 82.50p disposal 25,000<br />

29.09.11 81.75p disposal 17,000<br />

29.09.11 81.75p disposal 7,000<br />

(3) Dealings undertaken on exercise of employee options or <strong>to</strong> fund the tax and national insurance liabilities arising from the exercise of employee<br />

options<br />

(ii) <strong>Investec</strong> and persons acting in concert with <strong>Investec</strong> have dealt in the following <strong>Evolution</strong> relevant securities in the disclosure period:<br />

Transaction Period<br />

Transaction<br />

Number of<br />

<strong>Evolution</strong> Shares<br />

High Price<br />

Low Price<br />

3.8.10 – 2.11.10 Sell 5,574 85.26p 85.26p<br />

3.11.10 – 2.2.11 Buy 7,200 76.00p 76.00p<br />

Sell 1,500 76.06p 76.06p<br />

3.2.11 – 2.5.11 Buy 314,362 76.85p 76.85p<br />

Sell 628,724 77.00p 76.85p<br />

3.5.11 – 2.6.11 Buy 325,406 71.63p 71.63p<br />

Sell 328,021 71.63p 70.50p<br />

3.7.11 – 2.8.11 Sell 8,850 78.25p 65.30p<br />

3.8.11 – 29.9.11 Buy 30,000 87.80p 87.80p<br />

Note:<br />

Sell 65,000 86.50p 80.00p<br />

Dealings aggregated in accordance with Note 2 of Rule 24.4 of the City Code. Purchases and sales are aggregated separately and are not netted<br />

off. <strong>The</strong> highest and lowest prices per share have been stated. A full list of dealings is on display as set out in paragraph 14 of Part VI of this<br />

document.<br />

49


(iii) Other than as disclosed above, the following parties acting in concert with <strong>Investec</strong> have dealt in the following <strong>Evolution</strong> relevant<br />

securities in the disclosure period:<br />

50<br />

Transaction<br />

Period<br />

Party<br />

Transaction<br />

Number of<br />

<strong>Evolution</strong><br />

Shares<br />

High Price<br />

Low Price<br />

3.08.10 – 2.11.10 BAML Buy 12,244 £0.88 £0.80<br />

Sell 14,047 £0.92 £0.82<br />

3.11.10 – 2.02.11 BAML Buy 2,120 £0.84 £0.70<br />

Sell 300 £0.70 £0.69<br />

3.02.11 – 2.05.11 BAML Buy 19,100 £0.79 £0.68<br />

Sell 17,729 £0.80 £0.69<br />

3.05.11 – 2.06.11 BAML Buy 1,100 £0.71 £0.71<br />

Sell 6,100 £0.73 £0.71<br />

3.06.11 – 2.07.11 BAML Buy 3,600 £0.68 £0.65<br />

3.07.11 – 2.08.11 BAML Buy 8,000 £0.74 £0.65<br />

Sell 6,700 £0.79 £0.66<br />

3.08.11 – 29.09.11 BAML Buy 600 £0.78 £0.78<br />

Note:<br />

Sell 3,100 £0.83 £0.80<br />

Dealings aggregated in accordance with Note 2 of Rule 24.4 of the City Code. Purchases and sales are aggregated separately and are not netted<br />

off. <strong>The</strong> highest and lowest prices per share have been stated. A full list of dealings is on display as set out in paragraph 14 of Part VI of this<br />

document.<br />

(iv) <strong>The</strong> following <strong>Investec</strong> Direc<strong>to</strong>rs and their respective related parties have dealt in the following <strong>Investec</strong> relevant securities in the<br />

disclosure period:<br />

Name Date of dealing Price paid<br />

Nature of interest in<br />

relevant securities<br />

Number of<br />

<strong>Investec</strong> Shares<br />

George F O Al<strong>for</strong>d 16.08.10 £4.66 Purchase 6,900<br />

A Tapnack (1) 3.09.10 £4.82 Sale pursuant <strong>to</strong><br />

exercise of nil cost<br />

options<br />

Hendrik du Toit 27.06.11 £4.75 On market sale<br />

following the exercise<br />

of options<br />

Glynn Burger 28.06.11 n/a Per<strong>for</strong>mance<br />

conditions not met –<br />

<strong>for</strong>feiture of awards<br />

Note:<br />

(1) Alan Tapnack resigned from the boards of <strong>Investec</strong> and <strong>Investec</strong> Limited with effect from 15 December 2010.<br />

50,000<br />

281,250<br />

150,000


(v) <strong>The</strong> following <strong>Investec</strong> Direc<strong>to</strong>rs and their respective related parties have dealt in the following <strong>Investec</strong> Limited relevant securities<br />

in the disclosure period:<br />

Name Date of dealing Price paid<br />

Nature of interest in<br />

relevant securities<br />

Number of <strong>Investec</strong><br />

Limited Shares<br />

Bernard Kan<strong>to</strong>r 3.09.10 ZAR 56.67 Sale 1,062,500<br />

Hugh S Herman 13.06.11 ZAR 54.95 Unwind of European<br />

call options as<br />

originally purchased<br />

and disclosed on<br />

11.06.08<br />

Glynn Burger 13.06.11 ZAR 54.95 Unwind of European<br />

call options as<br />

originally purchased<br />

and disclosed on<br />

11.06.08<br />

Bernard Kan<strong>to</strong>r 13.06.11 ZAR 54.95 Unwind of European<br />

call options as<br />

originally purchased<br />

and disclosed on<br />

11.06.08<br />

Stephen Koseff 13.06.11 ZAR 54.95 Unwind of European<br />

call options as<br />

originally purchased<br />

and disclosed on<br />

11.06.08<br />

M Peter Malungani 11.08.11 ZAR 51.55 Reduction in<br />

attributable interest<br />

Peu’s disposal of<br />

<strong>Investec</strong> Limited<br />

shares<br />

(vi) Persons acting in concert with <strong>Investec</strong> have dealt in the following <strong>Investec</strong> relevant securities in the disclosure period:<br />

Transaction Period Transaction<br />

27,542<br />

56,467<br />

454,288<br />

139,005<br />

3,288,890<br />

Number of<br />

<strong>Investec</strong> Shares High Price Low Price<br />

3.08.10 – 2.11.10 Buy 11,127,708 ZAR 57.11 ZAR 51.61<br />

£5.17 £4.49<br />

Sell 20,875,204 ZAR 57.00 ZAR 51.61<br />

£5.16 £4.54<br />

3.11.10 – 2.02.11 Buy 12,829,736 ZAR 58.28 ZAR 52.78<br />

£5.37 £4.72<br />

Sell 17,463,831 ZAR 58.00 ZAR 29.45<br />

£5.37 £4.72<br />

3.02.11 – 2.05.11 Buy 21,223,155 ZAR 57.46 ZAR 49.58<br />

£5.02 £4.43<br />

Sell 13,845,094 ZAR 58.24 ZAR 49.54<br />

£5.01 £4.43<br />

3.05.11 – 2.06.11 Buy 7,409,273 ZAR 57.58 ZAR 51.75<br />

£5.13 £4.61<br />

Sell 2,526,030 ZAR 57.65 ZAR 51.74<br />

£5.10 £4.60<br />

51


52<br />

Transaction Period Transaction<br />

Number of<br />

<strong>Investec</strong> Shares High Price Low Price<br />

3.06.11 – 2.07.11 Buy 4,683,371 ZAR 56.52 ZAR 51.91<br />

£5.12 £4.71<br />

Sell 2,173,634 ZAR 56.50 ZAR 51.91<br />

£5.11 £4.71<br />

3.07.11 – 2.08.11 Buy 1,543,417 ZAR 56.50 ZAR 50.10<br />

£5.26 £4.69<br />

Sell 1,294,561 ZAR 56.36 ZAR 51.10<br />

£5.26 £4.74<br />

3.08.11 – 29.09.11 Buy 7,430,809 ZAR 52.00 ZAR 43.97<br />

Note:<br />

£4.59 £3.70<br />

Sell 22,593,340 ZAR 53.61 ZAR 44.39<br />

£4.62 £3.70<br />

Dealings aggregated in accordance with Note 2 of Rule 24.4 of the City Code. Purchases and sales are aggregated separately and are not netted<br />

off. <strong>The</strong> highest and lowest prices per share have been stated. A full list of dealings is on display as set out in paragraph 14 of Part VI of this<br />

document.<br />

(vii) <strong>Investec</strong> and persons acting in concert with <strong>Investec</strong> have dealt in the following <strong>Investec</strong> Limited relevant securities in the disclosure<br />

period:<br />

Transaction Period Transaction<br />

Number of <strong>Investec</strong><br />

Limited Shares High Price Low Price<br />

3.08.10 – 2.11.10 Buy 1,739,365 ZAR 59.47 ZAR 53.56<br />

Sell 2,383,744 ZAR 59.17 ZAR 53.50<br />

3.11.10 – 2.02.11 Buy 2,199,078 ZAR 60.38 ZAR 34.93<br />

Sell 1,044,238 ZAR 60.30 ZAR 29.45<br />

3.02.11 – 2.05.11 Buy 2,055,742 ZAR 57.75 ZAR 49.50<br />

Sell 2,528,614 ZAR 57.60 ZAR 49.37<br />

3.05.11 – 2.06.11 Buy 4,235,712 ZAR 57.32 ZAR 51.19<br />

Sell 942,211 ZAR 57.32 ZAR 51.22<br />

3.06.11 – 2.07.11 Buy 777,214 ZAR 57.40 ZAR 52.37<br />

Sell 1,841,951 ZAR 57.19 ZAR 52.83<br />

3.07.11 – 2.08.11 Buy 645,688 ZAR 57.45 ZAR 51.51<br />

Sell 340,953 ZAR 57.51 ZAR 51.84<br />

3.08.11 – 29.09.11 Buy 1,649,105 ZAR 51.95 ZAR 43.97<br />

Note:<br />

Sell 4,085,738 ZAR 51.95 ZAR 44.05<br />

Dealings aggregated in accordance with Note 2 of Rule 24.4 of the City Code. Purchases and sales are aggregated separately and are not netted<br />

off. <strong>The</strong> highest and lowest prices per share have been stated. A full list of dealings is on display as set out in paragraph 14 of Part VI of this<br />

document.


(viii) Other than as disclosed above, the following parties acting in concert with <strong>Investec</strong> have dealt in the following <strong>Investec</strong> Shares in<br />

the disclosure period:<br />

Transaction Period Party Transaction<br />

Number of<br />

<strong>Investec</strong><br />

Shares High Price Low Price<br />

3.08.10 – 2.11.10 BAML Buy 5,157,718 £5.20 £4.51<br />

Sell 7,700,086 £5.22 £4.51<br />

3.11.10 – 2.02.11 BAML Buy 11,181,660 £5.38 £4.70<br />

Sell 10,470,966 £5.38 £4.70<br />

3.02.11 – 2.05.11 BAML Buy 2,339,068 £5.01 £4.39<br />

Sell 2,463,781 £5.01 £4.39<br />

Buy 167 USD 7.94 USD 7.94<br />

3.05.11 – 2.06.11 BAML Buy 4,958,384 £5.23 £4.60<br />

Sell 4,387,564 £5.23 £4.62<br />

3.06.11 – 2.07.11 BAML Buy 3,387,171 £5.13 £4.72<br />

Sell 3,740,358 £5.13 £4.73<br />

3.07.11 – 2.08.11 BAML Buy 2,197,062 £5.27 £4.62<br />

3.08.11 – 29.09.11 BAML Buy<br />

Note:<br />

Sell 2,077,421 £5.27 £4.62<br />

Sell<br />

1,949,327<br />

2,326,661<br />

Dealings aggregated in accordance with Note 2 of Rule 24.4 of the City Code. Purchases and sales are aggregated separately and are not netted<br />

off. <strong>The</strong> highest and lowest prices per share have been stated. A full list of dealings is on display as set out in paragraph 14 of Part VI of this<br />

document.<br />

(ix) Other than as disclosed above, the following parties acting in concert with <strong>Investec</strong> have dealt in the following <strong>Investec</strong> Limited<br />

Shares in the disclosure period:<br />

Transaction Period Party Transaction<br />

£4.78<br />

£4.78<br />

£3.54<br />

£3.54<br />

Number of<br />

<strong>Investec</strong> Limited<br />

Shares High Price Low Price<br />

03.08.10 – 02.11.10 BAML Buy 2,369,484 ZAR 59.47 ZAR 53.51<br />

Sell 354,437 ZAR 59.17 ZAR 54.10<br />

03.11.10 – 02.02.11 BAML Buy 2,542,029 ZAR 60.22 ZAR 53.70<br />

Sell 1,532,620 ZAR 59.98 ZAR 54.07<br />

03.02.11 – 02.05.11 BAML Buy 3,176,380 ZAR 57.72 ZAR 49.48<br />

Sell 1,239,828 ZAR 57.00 ZAR 49.49<br />

03.05.11 – 02.06.11 BAML Buy 4,023,081 ZAR 57.30 ZAR 51.14<br />

Sell 2,028,938 ZAR 57.32 ZAR 51.15<br />

03.06.11 – 02.07.11 BAML Buy 1,930,607 ZAR 56.94 ZAR 53.00<br />

Sell 1,479,361 ZAR 56.94 ZAR 53.00<br />

03.07.11 – 02.08.11 BAML Buy 1,300,757 ZAR 57.52 ZAR 52.18<br />

Sell 653,095 ZAR 57.10 ZAR 52.19<br />

03.08.11 – 29.09.11 BAML Buy 1,053,366 ZAR 51.50 ZAR 43.97<br />

Notes:<br />

(1) Relates <strong>to</strong> only one trade<br />

Sell 927,998 ZAR 51.44 ZAR 43.99<br />

Dealings aggregated in accordance with Note 2 of Rule 24.4 of the City Code. Purchases and sales are aggregated separately and are not netted<br />

off. <strong>The</strong> highest and lowest prices per share have been stated. A full list of dealings is on display as set out in paragraph 14 of Part VI of this<br />

document.<br />

53


(x) <strong>The</strong> following dealings in futures and options of <strong>Investec</strong> <strong>by</strong> parties acting in concert with <strong>Investec</strong> have taken place during the<br />

disclosure period:<br />

54<br />

Futures<br />

Transaction<br />

Period Description Written High Price Low Price Purchased High Price Low Price<br />

3.08.10<br />

— 2.11.10<br />

3.08.10<br />

— 2.11.10<br />

3.11.10<br />

— 2.02.11<br />

3.08.10<br />

— 2.11.10<br />

3.11.10<br />

— 2.02.11<br />

3.02.11<br />

— 2.05.11<br />

3.02.11<br />

— 2.05.11<br />

3.05.11<br />

— 2.06.11<br />

3.06.11<br />

— 2.07.11<br />

3.06.11<br />

— 2.07.11<br />

3.07.11<br />

— 2.08.11<br />

3.08.11<br />

— 29.09.11<br />

3.02.11<br />

— 2.05.11<br />

Futures due<br />

16.09.10<br />

Futures due<br />

15.12.10<br />

Futures due<br />

15.12.10<br />

Futures due<br />

17.03.11<br />

Futures due<br />

17.03.11<br />

Futures due<br />

17.03.11<br />

Futures due<br />

15.06.11<br />

Futures due<br />

15.06.11<br />

Futures due<br />

15.06.11<br />

Futures due<br />

15.09.11<br />

Futures due<br />

15.09.11<br />

Futures due<br />

15.09.11<br />

Futures due<br />

15.12.11<br />

278,873 ZAR 58.17 ZAR 52.42 2,900 ZAR 59.00 ZAR 53.00<br />

799,885 ZAR 57.99 ZAR 54.26 4,000 ZAR 58.00 ZAR 52.00<br />

637,900 ZAR 56.63 ZAR 53.89 508 ZAR 59.00 ZAR 53.57<br />

16,525 ZAR 58.90 ZAR 55.00 236 ZAR 62.00 ZAR 44.00<br />

810,802 ZAR 57.85 ZAR 54.31 — — —<br />

477,580 ZAR 57.27 ZAR 51.35 — — —<br />

35,069 ZAR 52.66 ZAR 51.23 2,300 ZAR 51.00 ZAR 50.00<br />

17,382 ZAR 54.05 ZAR 53.44 — — —<br />

148 ZAR 54.74 ZAR 54.74 — — —<br />

17,419 ZAR 55.36 ZAR 54.47 — — —<br />

8,766 ZAR 55.45 ZAR 55.45 1,000 ZAR 59.00 ZAR 59.00<br />

284 ZAR 51.00 ZAR 51.00 568 ZAR 58.00 ZAR 43.00<br />

— — — 5,475 ZAR 51.89 ZAR 42.00<br />

Options<br />

Transaction<br />

Period Description Written High Price Low Price Purchased High Price Low Price<br />

3.08.10 Call options 100,000 ZAR 80.00 ZAR 80.00 — — —<br />

– 2.11.10 Put options — — — 100,000 ZAR 80.00 ZAR 80.00<br />

3.02.11 Call options 50,000 ZAR 80.00 ZAR 80.00 — — —<br />

– 2.05.11 Put options — — — 50,000 ZAR 80.00 ZAR 80.00<br />

3.05.11 Call options — — — 25,000 ZAR 62.00 ZAR 62.00<br />

– 2.06.11 Put options 25,000 ZAR 52.00 ZAR 52.00 — — —<br />

3.07.11 Call options 50,000 ZAR 75.00 ZAR 75.00 — — —<br />

– 2.08.11<br />

Put options — — — 50,000 ZAR 75.00 ZAR 75.00<br />

Call options 78 £5.60 £5.20 31 £4.40 £5.20<br />

3.08.11 Call options 50,000 ZAR 62.00 ZAR 52.00 — — —<br />

– 29.09.11 Put options — — — 50,000 ZAR 52.00 ZAR 52.00<br />

Note:<br />

Dealings aggregated in accordance with Note 2 of Rule 24.4 of the City Code. Purchases and sales are aggregated separately and are not netted<br />

off. <strong>The</strong> highest and lowest prices per share have been stated. A full list of dealings is on display as set out in paragraph 14 of Part VI of this<br />

document.


(xi) <strong>The</strong> following dealings in futures and options of <strong>Investec</strong> Limited <strong>by</strong> parties acting in concert with <strong>Investec</strong> have taken place during<br />

the disclosure period:<br />

Futures<br />

Transaction<br />

Period Description Written High Price Low Price Purchased High Price Low Price<br />

3.08.10<br />

– 2.11.10<br />

3.08.10<br />

– 2.11.10<br />

3.11.10<br />

– 2.02.11<br />

3.08.10<br />

– 2.11.10<br />

3.11.10<br />

– 2.02.11<br />

3.02.11<br />

– 2.05.11<br />

3.08.10<br />

– 2.11.10<br />

3.11.10<br />

– 2.02.11<br />

3.02.11<br />

– 2.05.11<br />

3.06.11<br />

– 2.07.11<br />

3.02.11<br />

– 2.05.11<br />

3.06.11<br />

– 2.07.11<br />

Futures due<br />

16.09.10<br />

Futures due<br />

15.12.10<br />

Futures due<br />

15.12.10<br />

Futures due<br />

17.03.11<br />

Futures due<br />

17.03.11<br />

Futures due<br />

17.03.11<br />

Futures due<br />

15.06.11<br />

Futures due<br />

15.06.11<br />

Futures due<br />

15.06.11<br />

Futures due<br />

15.06.11<br />

Futures due<br />

15.09.11<br />

Futures due<br />

15.09.11<br />

12,398 ZAR 57.72 ZAR 54.65 — — —<br />

31,386 ZAR 58.05 ZAR 56.63 — — —<br />

33,426 ZAR 58.90 ZAR 55.11 — — —<br />

1,784 ZAR 58.92 ZAR 58.12 — — —<br />

36,592 ZAR 58.30 ZAR 56.27 — — —<br />

16,930 ZAR 55.57 ZAR 52.32 10 ZAR 49.50 ZAR 49.50<br />

— — — 5,591 ZAR 59.89 ZAR 55.00<br />

— — — 1,339 ZAR 57.90 ZAR 57.90<br />

6,998 ZAR 58.00 ZAR 47.00 4,831 ZAR 55.00 ZAR 52.00<br />

— — — 10 ZAR 54.92 ZAR 54.92<br />

— — — 16,720 ZAR 46.00 ZAR 46.00<br />

918 ZAR 55.83 ZAR 55.83 — — —<br />

Options<br />

Transaction<br />

Period Description Written High Price Low Price Purchased High Price Low Price<br />

3.08.10<br />

– 2.11.10<br />

3.11.10<br />

– 2.02.11<br />

3.02.11<br />

– 2.05.11<br />

3.05.11<br />

– 2.06.11<br />

3.06.11<br />

– 2.07.11<br />

3.07.11<br />

–2.08.11<br />

Call options 1,650,090 ZAR 54.00 ZAR 40.00 556,345 ZAR 53.00 ZAR 40.00<br />

Call options 3,513,571 ZAR 42.00 ZAR 42.00 16,274,109 ZAR 53.00 ZAR 54.00<br />

Call options 7,295,738 ZAR 42.00 ZAR 42.00<br />

Call options 1,942,632 ZAR 42.00 ZAR 42.00 899 ZAR 43.00 ZAR 43.00<br />

Call options 1,248,059 ZAR 42.00 ZAR 42.00 — — —<br />

Put options 2,143,169 ZAR 49.00 ZAR 49.00<br />

Put options 9,432,157 ZAR 51.00 ZAR 49.00<br />

3.08.11 Put options 5,251,579 ZAR 51.00 ZAR 51.00<br />

– 29.09.11<br />

Note:<br />

Dealings aggregated in accordance with Note 2 of Rule 24.4 of the City Code. Purchases and sales are aggregated separately and are not netted<br />

off. <strong>The</strong> highest and lowest prices per share have been stated. A full list of dealings is on display as set out in paragraph 14 of Part VI of this<br />

document.<br />

55


(xii) <strong>The</strong> following persons acting in concert with <strong>Evolution</strong> have dealt in the following <strong>Investec</strong> Limited relevant securities in the disclosure<br />

period:<br />

56<br />

Name Date of dealing<br />

Credit Suisse 3.08.11 –<br />

29.08.11<br />

Credit Suisse 3.08.11 –<br />

29.08.11<br />

Note:<br />

Highest price<br />

paid<br />

Lowest price<br />

paid<br />

Nature of<br />

interest in<br />

relevant<br />

securities<br />

Number of<br />

<strong>Investec</strong> Limited<br />

relevant<br />

securities<br />

ZAR 49.99 ZAR 43.99 Purchase 2,205,757<br />

ZAR 50.40 ZAR 43.85 Sale 2,313,069<br />

Dealings aggregated in accordance with Note 2 of Rule 24.4 of the City Code. Purchases and sales are aggregated separately and are not netted off.<br />

<strong>The</strong> highest and lowest prices per share have been stated. A full list of dealings is on display as set out in paragraph 14 of Part VI of this document.<br />

5.5 Interests and Dealings – General<br />

Save as disclosed in this paragraph 5, as at the last day of the disclosure period,<br />

(i) none of:<br />

(a) <strong>Investec</strong>;<br />

(b) the <strong>Investec</strong> Direc<strong>to</strong>rs or their respective related parties;<br />

(c) any person acting in concert with <strong>Investec</strong>;<br />

(d) the <strong>Evolution</strong> Direc<strong>to</strong>rs or their respective related parties;<br />

(e) any person acting in concert with <strong>Evolution</strong>,<br />

had an interest in, a right <strong>to</strong> subscribe in respect of, or any short position in relation <strong>to</strong> <strong>Evolution</strong> relevant securities (whether<br />

conditional or absolute and whether in the money or otherwise), including any short position under a derivative, any agreement <strong>to</strong><br />

sell or any delivery obligations or right <strong>to</strong> require another person <strong>to</strong> purchase or take delivery, nor had any of the persons referred <strong>to</strong><br />

in paragraphs (a) <strong>to</strong> (c) above dealt in any <strong>Evolution</strong> relevant securities during the disclosure period, nor had any of the persons<br />

referred <strong>to</strong> in paragraphs (d) and (e) above dealt in any <strong>Evolution</strong> relevant securities during the period from the commencement of<br />

the Offer Period up until 29 September 2011 (the latest practicable date prior <strong>to</strong> the publication of this document).<br />

(ii) none of:<br />

(a) <strong>Evolution</strong>; or<br />

(b) the <strong>Evolution</strong> Direc<strong>to</strong>rs or their respective related parties,<br />

had an interest in, a right <strong>to</strong> subscribe in respect of, or any short position in relation <strong>to</strong> <strong>Investec</strong> relevant securities (whether<br />

conditional or absolute and whether in the money or otherwise), including any short position under a derivative, any agreement <strong>to</strong><br />

sell or any delivery obligations or right <strong>to</strong> require another person <strong>to</strong> purchase or take delivery, nor had any of the <strong>for</strong>egoing dealt in<br />

any <strong>Investec</strong> relevant securities between the start of the Offer Period and 29 September 2011 (being the latest practicable date<br />

prior <strong>to</strong> the publication of this document).<br />

(iii) none of <strong>Evolution</strong> or any person acting in concert with <strong>Evolution</strong> has any arrangement.<br />

(iv) save <strong>for</strong> the irrevocable undertakings described in paragraph 6 below, none of <strong>Investec</strong> or any person acting in concert with <strong>Investec</strong><br />

has any arrangement.<br />

(v) none of <strong>Evolution</strong> or any person acting in concert with <strong>Evolution</strong> has borrowed or lent any <strong>Evolution</strong> relevant securities (including <strong>for</strong><br />

these purposes any financial collateral arrangements) between the start of the Offer Period and 29 September 2011 (being the<br />

latest practicable date prior <strong>to</strong> the publication of this document), save <strong>for</strong> any borrowed shares which have been either on-lent or<br />

sold.<br />

(vi) none of <strong>Investec</strong> or any person acting in concert with <strong>Investec</strong> has borrowed or lent any <strong>Evolution</strong> relevant securities (including <strong>for</strong><br />

these purposes any financial collateral arrangements) during the disclosure period, save <strong>for</strong> any borrowed shares which have been<br />

either on-lent or sold.<br />

(vii) none of <strong>Evolution</strong> or any person acting in concert with <strong>Evolution</strong> has borrowed or lent any <strong>Investec</strong> relevant securities (including <strong>for</strong><br />

these purposes any financial collateral arrangements) between the start of the Offer Period and 29 September 2011 (being the<br />

latest practicable date prior <strong>to</strong> the publication of this document, save <strong>for</strong> any borrowed shares which have been either on-lent or<br />

sold.<br />

(viii) none of <strong>Investec</strong> or any person acting in concert with <strong>Investec</strong> has borrowed or lent any <strong>Investec</strong> relevant securities (including <strong>for</strong><br />

these purposes any financial collateral arrangements) during the disclosure period, save <strong>for</strong> any borrowed shares which have been<br />

either on-lent or sold.


6 Irrevocable Undertakings and Letters of Intent<br />

6.1 <strong>The</strong> following <strong>Evolution</strong> Direc<strong>to</strong>rs have given <strong>to</strong> <strong>Investec</strong> irrevocable undertakings <strong>to</strong> vote or procure the vote in favour of the Offer:<br />

Name<br />

Number of<br />

<strong>Evolution</strong> Shares<br />

% of issued share<br />

capital of <strong>Evolution</strong><br />

Martin Gray 35,000 0.015<br />

Alex Snow 5,634,545 2.422<br />

Philip Howell 5,839 0.003<br />

Peter Gibbs 100,000 0.043<br />

Chris<strong>to</strong>pher Chambers 126,000 0.054<br />

Roger Perkin Nil –<br />

Lord MacLaurin 125,800 0.054<br />

Total 6,027,184 2.591<br />

In addition the <strong>Evolution</strong> Direc<strong>to</strong>rs have agreed that the undertaking <strong>to</strong> vote in favour of the Scheme at the Court Meeting and the<br />

resolutions and the General Meeting will extend <strong>to</strong> <strong>Evolution</strong> Shares issued <strong>to</strong> them be<strong>for</strong>e the meetings on the exercise of any<br />

options they hold.<br />

<strong>The</strong> undertakings given <strong>by</strong> the <strong>Evolution</strong> Direc<strong>to</strong>rs cease <strong>to</strong> be binding if the Scheme is withdrawn or lapses, unless <strong>Investec</strong><br />

exercises its right <strong>to</strong> announce a Takeover Offer <strong>for</strong> the entire issued share capital of <strong>Evolution</strong>, in which case it shall cease <strong>to</strong> have<br />

effect on the withdrawal or lapsing of the Takeover Offer.<br />

<strong>The</strong> irrevocable undertakings are governed <strong>by</strong> English law.<br />

6.2 <strong>The</strong> following <strong>Evolution</strong> Shareholder has given <strong>to</strong> <strong>Investec</strong> an irrevocable undertaking <strong>to</strong> vote or procure the vote in favour of the<br />

Offer:<br />

Name<br />

Number of<br />

<strong>Evolution</strong> Shares<br />

% of issued share<br />

capital of <strong>Evolution</strong><br />

Landsdowne Partners 12,809,506 5.51%<br />

Total 12,809,506 5.51%<br />

This undertaking will lapse and be of no effect if, inter alia, the Offer is not made <strong>by</strong> the publication of the Offer document or Scheme<br />

document, as the case may be, <strong>by</strong> 31 March 2012 (or such later date as the Panel may permit), the Offer does not become or is<br />

not declared unconditional in all respects, if the Implementation Agreement terminates, or if a third party announces a firm intention<br />

<strong>to</strong> make an <strong>offer</strong> under Rule 2.5 of the Code <strong>for</strong> all of the issued share capital of <strong>Evolution</strong> which values an <strong>Evolution</strong> Share at more<br />

than 10 per cent. of the value of the Offer (the “Higher Competing Offer”) and <strong>Investec</strong> does not increase its <strong>offer</strong> <strong>to</strong> within 10<br />

per cent. of the Higher Competing Offer within 14 days of the Higher Competing Offer being announced.<br />

This irrevocable undertaking is governed <strong>by</strong> English law.<br />

6.3 <strong>The</strong> following <strong>Evolution</strong> Shareholders have given <strong>to</strong> <strong>Investec</strong> letters of intent <strong>to</strong> vote in favour of the Offer:<br />

Name<br />

Number of<br />

<strong>Evolution</strong> Shares<br />

% of issued share<br />

capital of <strong>Evolution</strong><br />

Schroder Investment Management Limited 9,698,872 (1) 4.17<br />

Aber<strong>for</strong>th Partners 14,436,777 6.20<br />

BlackRock Investment Management (UK) Limited 20,935,457 (1) 9.00<br />

Majedie Asset Management Limited 6,266,555 (1) 2.70<br />

Total 51,337,661 22.06<br />

(1) Shareholding as at 8 September 2011.<br />

57


7 Service contracts and letters of appointment of the <strong>Evolution</strong> Direc<strong>to</strong>rs<br />

7.1 <strong>The</strong> following service contracts exist between executive <strong>Evolution</strong> Direc<strong>to</strong>rs and <strong>Evolution</strong> or its subsidiaries:<br />

(a) Mr Snow has a service agreement with <strong>Evolution</strong> and Mr Howell has a service agreement with Williams de Broë, both of which are<br />

terminable <strong>by</strong> either party on not less than 12 months’ notice. Once notice <strong>to</strong> terminate has been given <strong>by</strong> either party, <strong>Evolution</strong><br />

(or Williams de Broë, as the case may be) has the right in its absolute discretion <strong>to</strong> terminate the relevant direc<strong>to</strong>r’s employment <strong>by</strong><br />

making a payment in lieu of notice required or any unexpired part of such notice.<br />

(b) <strong>The</strong> following are the details of the benefits and emoluments <strong>to</strong> which the executive <strong>Evolution</strong> Direc<strong>to</strong>rs are entitled under their<br />

respective engagement terms with <strong>Evolution</strong> or its subsidiaries:<br />

58<br />

Name of Direc<strong>to</strong>r Date of Contract Current Annual Salary Other Benefits<br />

A. Snow 13 November 2003, as<br />

amended on 27 July 2011<br />

£500,000 Private medical cover <strong>for</strong><br />

spouse and family, car<br />

allowance of £10,000 per<br />

annum, death in service<br />

benefit, critical illness cover<br />

and life assurance<br />

P. Howell 10 November 2009 £100,000 Private medical cover <strong>for</strong><br />

spouse and family, car<br />

allowance of £10,000 per<br />

annum, death in service<br />

benefit, critical illness cover<br />

and life assurance<br />

(c) <strong>The</strong> current annual salary of Mr Snow was increased from £100,000 <strong>to</strong> £500,000 with effect from 1 July 2011. This followed a<br />

decision <strong>by</strong> the remuneration committee of the board of <strong>Evolution</strong> <strong>to</strong> re-align Mr Snow’s remuneration so as <strong>to</strong> move away from the<br />

previous heavy emphasis on bonus payments. <strong>The</strong> new level of remuneration is stated as being fixed <strong>for</strong> 3 years with an option <strong>to</strong><br />

defer a portion of salary in<strong>to</strong> shares in the ESIP.<br />

(d) In addition, Mr Snow has been granted awards over and options <strong>to</strong> acquire <strong>Evolution</strong> Shares pursuant <strong>to</strong> the <strong>Evolution</strong> Share<br />

Schemes, and details of outstanding awards and options granted <strong>to</strong> Mr Snow are set out in paragraph 5.2(ii) of this Part VI.<br />

(e) On 14 September 2011, Mr Snow was granted call rights over 1,285,000 <strong>Evolution</strong> Shares under the ESIP. <strong>The</strong>se awards, which<br />

were granted <strong>for</strong> nil consideration, have an exercise price of 1 pence per share. <strong>The</strong> awards were granted subject <strong>to</strong> per<strong>for</strong>mance<br />

conditions which include continued employment up <strong>to</strong> the date of exercise of call rights and achievement in aggregate of the<br />

<strong>Evolution</strong> <strong>Group</strong>’s internal <strong>for</strong>ecast statu<strong>to</strong>ry profit be<strong>for</strong>e tax <strong>for</strong> the three years <strong>to</strong> 31 December 2013 and will vest in July 2014.<br />

<strong>The</strong> options also vest au<strong>to</strong>matically on a change of control of <strong>Evolution</strong>. <strong>The</strong>se awards were granted following agreement in principle<br />

<strong>by</strong> <strong>Evolution</strong>’s remuneration committee in May 2011 <strong>to</strong> provide long term incentive arrangements <strong>for</strong> the Chief Executive following<br />

the lapse of options granted in 2009 under the ESIP. <strong>The</strong> awards granted in 2009 were also subject <strong>to</strong> au<strong>to</strong>matic vesting on change<br />

of control. On 25 July 2011, the remuneration committee of <strong>Evolution</strong> agreed <strong>to</strong> enter in<strong>to</strong> a commitment <strong>to</strong> make awards <strong>to</strong> Alex<br />

Snow under the ESIP over 2,000,000 <strong>Evolution</strong> Shares subject <strong>to</strong> the per<strong>for</strong>mance conditions set out above (including au<strong>to</strong>matic<br />

vesting on change of control) once <strong>Evolution</strong> was no longer in a close period. In light of the announcement of the Offer on 9<br />

September 2011, Alex Snow requested that the remuneration committee reduce the quantum of the award from 2,000,000 <strong>to</strong><br />

1,285,000 <strong>Evolution</strong> Shares. <strong>The</strong> remuneration committee of <strong>Evolution</strong> agreed <strong>to</strong> this request, although it also resolved <strong>to</strong> reconsider<br />

the granting of further awards in due course should a change of control not take place.<br />

(f) Williams de Broë operates a discretionary executive direc<strong>to</strong>r’s bonus scheme. Mr Howell is entitled <strong>to</strong> a minimum of 40 per cent.<br />

of the available executive direc<strong>to</strong>r’s bonus pool <strong>for</strong> the calendar years 2010, 2011 and 2012. <strong>The</strong> executive direc<strong>to</strong>r’s bonus pool<br />

is calculated as 10 per cent. of the statu<strong>to</strong>ry profit be<strong>for</strong>e tax (excluding the executive bonus pool) of Williams de Broë as declared<br />

in the annual report and accounts of <strong>Evolution</strong>.<br />

(g) In addition, Mr Howell has been granted awards over <strong>Evolution</strong> Shares pursuant <strong>to</strong> the <strong>Evolution</strong> Share Schemes, and details of<br />

outstanding awards granted <strong>to</strong> Mr Howell are set out in paragraph 5.2(ii) of this Part VI.<br />

(h) Mr Howell also participates in the WdeB GSOP and has subscribed <strong>for</strong> B ordinary shares of £0.10 each in Williams de Broë as<br />

follows:<br />

(i) on 25 March 2010, 4,000 B ordinary shares, at a price of £10 per share;<br />

(ii) on 1 September 2010, 300 B ordinary shares, at a price of £10 per share.<br />

7.2 <strong>The</strong> following letters of appointment exist between the non-executive <strong>Evolution</strong> Direc<strong>to</strong>rs and <strong>Evolution</strong>:<br />

(a) Mr Gibbs, Mr Chambers, Lord MacLaurin of Knebworth and Mr Perkin are each engaged <strong>by</strong> <strong>Evolution</strong> as non-executive direc<strong>to</strong>rs<br />

pursuant <strong>to</strong> engagement letters under which they are entitled <strong>to</strong> receive fees of £60,000 per annum. Mr Gibbs is entitled <strong>to</strong> an<br />

additional £15,000 per annum in his capacity as a senior non-executive direc<strong>to</strong>r. Mr Perkin receives an additional £15,000 per<br />

annum in his capacity as Chairman of the audit committee of the board of <strong>Evolution</strong>. As of June 2011, Mr Chambers receives an<br />

additional £15,000 per annum in his capacity as Chairman of the remuneration committee of the board of <strong>Evolution</strong>. <strong>The</strong>ir


engagements are each subject <strong>to</strong> a notice period of three months and their appointment can be terminated without any entitlement<br />

<strong>to</strong> compensation where such early termination arises because the relevant direc<strong>to</strong>r is not reappointed, is removed at a general<br />

meeting of <strong>Evolution</strong>, the direc<strong>to</strong>r vacates office pursuant <strong>to</strong> a provision of <strong>Evolution</strong>’s Articles, is adjudged bankrupt, is guilty of<br />

misconduct or commits a serious breach of his obligations, is in the reasonably opinion of the board of <strong>Evolution</strong> guilty of bringing<br />

himself or <strong>Evolution</strong> in<strong>to</strong> disrepute, he becomes incapacitated from per<strong>for</strong>ming his duties <strong>for</strong> 90 days in aggregate in any 12 month<br />

period or becomes prohibited in law from being a direc<strong>to</strong>r.<br />

(b) Mr Gray is engaged as non-executive Chairman of <strong>Evolution</strong> pursuant <strong>to</strong> an engagement letter on terms equivalent <strong>to</strong> those referred<br />

<strong>to</strong> in (a) above, save that he is entitled <strong>to</strong> an annual fee of £125,000 per annum and is subject <strong>to</strong> a notice period of 2 months.<br />

7.3 Save as disclosed above, there are no service contracts or letters of appointment between any <strong>Evolution</strong> Direc<strong>to</strong>r, or proposed<br />

direc<strong>to</strong>r of <strong>Evolution</strong>, and any member of the <strong>Evolution</strong> <strong>Group</strong> and, save as disclosed above, no such contract or letter of appointment<br />

has been entered in<strong>to</strong> or amended within the six months preceding the date of this document.<br />

8 Material contracts<br />

8.1 Confidentiality Agreement<br />

<strong>Evolution</strong> and <strong>Investec</strong> have entered in<strong>to</strong> a confidentiality agreement on 10 August 2011 (the “Confidentiality Agreement”). In the<br />

course of discussions relating <strong>to</strong> the Offer, each of <strong>Investec</strong> and <strong>Evolution</strong> has received or will receive confidential in<strong>for</strong>mation relating <strong>to</strong><br />

the other party. Pursuant <strong>to</strong> the Confidentiality Agreement, each of <strong>Investec</strong> and <strong>Evolution</strong> has undertaken <strong>to</strong> keep secret and confidential<br />

such in<strong>for</strong>mation and not <strong>to</strong> disclose it <strong>to</strong> third parties (other than <strong>to</strong> its advisers or its direc<strong>to</strong>rs or employees) unless required <strong>by</strong> law or<br />

regulation. <strong>The</strong>se confidentiality obligations will remain in <strong>for</strong>ce <strong>for</strong> a period of two years from the date of the Confidentiality Agreement.<br />

8.2 <strong>Investec</strong>’s material contracts<br />

Save <strong>for</strong> the Implementation Agreement (further details of which are set out in paragraph 9 of this Part VI), no contracts have been<br />

entered in<strong>to</strong> <strong>by</strong> <strong>Investec</strong> or any member of the <strong>Investec</strong> <strong>Group</strong>, otherwise than in the ordinary course of business since 3 August 2009<br />

(being the date two years prior <strong>to</strong> the commencement of the Offer Period) which are, or may be, material.<br />

8.3 <strong>Evolution</strong>’s material contracts<br />

In addition <strong>to</strong> the Implementation Agreement described in paragraph 9 of this Part VI, the following contracts, not being contracts<br />

entered in<strong>to</strong> in the ordinary course of business, have been entered in<strong>to</strong> <strong>by</strong> <strong>Evolution</strong> and its subsidiaries since 3 August 2009 (being the<br />

date two years prior <strong>to</strong> the commencement of the Offer Period) which are, or may be, material:<br />

(a) Pursuant <strong>to</strong> a sale and purchase agreement dated 5 August 2011 and made between BNP Paribas Wealth Management S.A<br />

(“BNPPWM”) and Williams de Broë (the “PIM Acquisition Agreement”), Williams de Broë has conditionally agreed <strong>to</strong> acquire the<br />

entire issued share capital of BNP Paribas Private Investment Management (“PIM”) from BNPPWM <strong>for</strong> an aggregate consideration<br />

of £5million plus the value of the adjusted net assets of PIM as at the date of completion. <strong>The</strong> acquisition of PIM is conditional on<br />

consent <strong>for</strong> change of control of PIM being granted <strong>by</strong> the FSA and it is expected that such consent will be obtained and the PIM<br />

Acquisition Agreement will be completed prior <strong>to</strong> the end of the current financial year. Under the terms of the PIM Acquisition<br />

Agreement, BNPPWM has provided certain indemnities and cus<strong>to</strong>mary warranties in relation <strong>to</strong> the business of PIM, subject <strong>to</strong><br />

certain limitations. On completion of the PIM Acquisition Agreement, Williams de Broë and BNPPWM will enter in<strong>to</strong> a transitional<br />

services agreement pursuant <strong>to</strong> which BNPPWM will provide certain agreed services <strong>to</strong> Williams de Broë <strong>for</strong> a period of up <strong>to</strong> five<br />

months following completion. A monthly charge of £300,000 will be payable <strong>for</strong> these services.<br />

(b) Pursuant <strong>to</strong> a subscription and shareholders’ agreement dated 11 November 2009 and made between <strong>Evolution</strong> and Ali Mortazavi<br />

(“Mortazavi”) (the “Darwin Joint Venture Agreement”), <strong>Evolution</strong> agreed <strong>to</strong> set up a joint venture with Mr Mortazavi in relation<br />

<strong>to</strong> the <strong>for</strong>mation and operation of Darwin Strategic, a vehicle through which <strong>Evolution</strong> seeks <strong>to</strong> provide a range of equity funding<br />

alternatives <strong>to</strong> quoted (primarily AIM-listed) companies. On <strong>for</strong>mation, Darwin Strategic was owned as <strong>to</strong> 52 per cent. <strong>by</strong> <strong>Evolution</strong><br />

and as <strong>to</strong> 48 per cent. <strong>by</strong> Mr Mortazavi, although since completion of the Darwin Joint Venture Agreement, certain of the shares<br />

owned <strong>by</strong> Mr Mortazavi have been sold <strong>to</strong> other employees of Darwin Strategic. <strong>The</strong> equity investment in Darwin Strategic <strong>by</strong><br />

<strong>Evolution</strong> under the terms of the Darwin Joint Venture Agreement amounted <strong>to</strong> £2million. <strong>The</strong> Darwin Joint Venture Agreement sets<br />

out the terms <strong>for</strong> the operational conduct of the Darwin Strategic business. Pursuant <strong>to</strong> Darwin Strategic’s articles of association,<br />

in the event of a change of control of <strong>Evolution</strong>, the other shareholders have a right <strong>to</strong> acquire <strong>Evolution</strong>’s interest in Darwin Strategic<br />

at a price per share equal <strong>to</strong> the fair market value of Darwin Strategic at the time such change of control occurs.<br />

8.4 Agreement relating <strong>to</strong> <strong>Evolution</strong> Securities China Limited<br />

Although not falling within the scope of a material contract of <strong>Evolution</strong> or its subsidiaries <strong>to</strong> be disclosed under Rule 25.7(a) of the Code,<br />

<strong>Evolution</strong> entered in<strong>to</strong> an investment agreement dated 6 March 2009 (the “Investment Agreement”) with First Eastern Financial<br />

Holdings Limited (“FEH”) and <strong>Evolution</strong> Securities China Limited (“ESCL”), pursuant <strong>to</strong> which each of <strong>Evolution</strong> and FEH agreed <strong>to</strong> invest<br />

in ESCL such that following completion of the Investment Agreement, FEH would own 51 per cent. of the issued ordinary share capital<br />

of ESCL. <strong>Evolution</strong> currently holds 48.47 per cent. of the issued ordinary share capital of ESCL. Under the terms of the Investment<br />

Agreement, amongst other provisions, FEH has a right, in certain circumstances, <strong>to</strong> require that <strong>Evolution</strong> sells <strong>to</strong> FEH such number of<br />

ordinary shares in ESCL as would increase its holding <strong>to</strong> 75 per cent.. Circumstances in which this right may be exercised includes where<br />

any person or persons (other than FEH) acquires <strong>Evolution</strong> Shares which would entitle it <strong>to</strong> cast 30 per cent. or more of the votes at an<br />

annual general meeting of <strong>Evolution</strong> from time <strong>to</strong> time. Accordingly, if the Scheme becomes effective, FEH will have a right <strong>to</strong> require<br />

<strong>Evolution</strong> <strong>to</strong> sell ordinary shares in ESCL sufficient <strong>to</strong> increase FEH’s holding in ESCL <strong>to</strong> 75 per cent. of the issued ordinary shares. As at<br />

the date of this document, <strong>Evolution</strong> has not received any indication as <strong>to</strong> whether or not FEH intends <strong>to</strong> exercise this right following the<br />

Effective Date.<br />

59


9 Implementation Agreement<br />

<strong>Evolution</strong> and <strong>Investec</strong> have entered in<strong>to</strong> the Implementation Agreement which contains certain obligations in relation <strong>to</strong> the<br />

implementation of the Scheme and the conduct of <strong>Evolution</strong>’s operations prior <strong>to</strong> the Effective Date or termination of such agreement.<br />

In particular, the Implementation Agreement contains the following principal provisions:<br />

Non-Solicitation arrangements<br />

<strong>Evolution</strong> has undertaken, amongst other things (subject <strong>to</strong> the overriding fiduciary duties of the <strong>Evolution</strong> Direc<strong>to</strong>rs), not <strong>to</strong>, and <strong>to</strong><br />

procure that members of its <strong>Group</strong> do not, make any initial or further approach <strong>to</strong>, entertain any approach from, or enter in<strong>to</strong> or continue<br />

negotiations with, any other person with a view <strong>to</strong> a Third Party Transaction taking place.<br />

<strong>Evolution</strong> has also undertaken <strong>to</strong> notify <strong>Investec</strong> immediately in writing of any approach that is made <strong>to</strong> it or any member of <strong>Evolution</strong>’s<br />

<strong>Group</strong> regarding any Third Party Transaction.<br />

Break fee arrangements<br />

<strong>Evolution</strong> has agreed <strong>to</strong> pay <strong>Investec</strong> a break fee of £2.3 million if:<br />

(a) the Scheme document is not posted <strong>by</strong> <strong>Evolution</strong> within 28 days of the date of this announcement or, if permitted <strong>by</strong> the Panel,<br />

such later date as <strong>Evolution</strong> and <strong>Investec</strong> may agree;<br />

(b) the <strong>Evolution</strong> Direc<strong>to</strong>rs withdraw or adversely modify or qualify their recommendation (or intention <strong>to</strong> recommend) <strong>to</strong> <strong>Evolution</strong><br />

Shareholders <strong>to</strong> vote in favour of the Scheme and/or the General Meeting Resolution (or if applicable <strong>to</strong> accept the Offer) or they at<br />

any time decide not <strong>to</strong> proceed with the Scheme; or<br />

(c) a Third Party Transaction is announced prior <strong>to</strong> the Offer lapsing or being withdrawn and the Third Party Transaction referred <strong>to</strong> in<br />

such announcement or any other Third Party Transaction is either: (i) recommended <strong>by</strong> the <strong>Evolution</strong> Direc<strong>to</strong>rs; or (ii) becomes or is<br />

declared unconditional in all respects or is completed.<br />

Termination provisions<br />

<strong>The</strong> Implementation Agreement may, subject <strong>to</strong> compliance with the City Code and the requirements of the Panel, terminate in certain<br />

circumstances, including:<br />

(a) if a Condition becomes incapable of satisfaction or is invoked so as <strong>to</strong> cause the Offer not <strong>to</strong> proceed in circumstances where such<br />

invocation is in accordance with the Code;<br />

(b) if <strong>Evolution</strong> Shareholders do not vote <strong>to</strong> approve the Offer at the Court Meeting or the General Meeting Resolution are not approved<br />

at the General Meeting;<br />

(c) if the Scheme Court Order is not granted or (save as the parties may agree in writing) the Effective Date has not occurred on or<br />

be<strong>for</strong>e 31 March 2012;<br />

(d) <strong>by</strong> notice in writing from <strong>Investec</strong> <strong>to</strong> <strong>Evolution</strong> if the <strong>Evolution</strong> Direc<strong>to</strong>rs have withdrawn or adversely modified or qualified their<br />

recommendation <strong>to</strong> <strong>Evolution</strong> Shareholders <strong>to</strong> vote in favour of the Scheme and the General Meeting Resolution and either (i) the<br />

Panel consents <strong>to</strong> <strong>Investec</strong> withdrawing its <strong>offer</strong> (while structured as a Scheme) or (ii) a Third Party Transaction becomes or is<br />

declared wholly unconditional or is completed; or<br />

(e) if <strong>Investec</strong> elects <strong>to</strong> implement the Offer <strong>by</strong> way of a Takeover Offer, and if the Takeover Offer once announced under Rule 2.5 of<br />

the Code lapses in accordance with its terms (with the consent of the Panel) or is withdrawn.<br />

Timetable<br />

It has been agreed that the Effective Date will not occur prior <strong>to</strong> 7 December 2011.<br />

10 Significant Change<br />

10.1 Save as disclosed in this document, the <strong>Evolution</strong> Direc<strong>to</strong>rs are not aware of any significant change in the financial or trading<br />

position of <strong>Evolution</strong> which has occurred since 30 June 2011, being the date <strong>to</strong> which the last published interim financial in<strong>for</strong>mation of<br />

<strong>Evolution</strong> was prepared.<br />

10.2 Save as disclosed in this document, the <strong>Investec</strong> Direc<strong>to</strong>rs are not aware of any significant change in the financial or trading<br />

position of <strong>Investec</strong> since 31 March 2011, being the date <strong>to</strong> which the last published audited financial in<strong>for</strong>mation of <strong>Investec</strong> was<br />

prepared.<br />

11 Sources and bases of selected financial in<strong>for</strong>mation<br />

In this document:<br />

11.1 Unless otherwise stated:<br />

(i) <strong>The</strong> value placed <strong>by</strong> the Offer on the entire issued share capital of <strong>Evolution</strong> is based on 232,680,307 <strong>Evolution</strong> Shares in issue on<br />

8 September 2011, being the last dealing day prior <strong>to</strong> the date on which the Offer was announced. <strong>The</strong> value of the Offer as at the<br />

date of announcement is also based on the mid-market price of <strong>Investec</strong> Shares as quoted <strong>by</strong> Fidessa at 10.40 am on 8 September<br />

2011, being the time at which the <strong>Evolution</strong> board agreed in principle <strong>to</strong> give their recommendation;<br />

(ii) the financial in<strong>for</strong>mation relating <strong>to</strong> <strong>Evolution</strong> stated as at or in respect of the period ended 30 June 2011 is extracted from the<br />

unaudited half-yearly condensed consolidated financial statements of <strong>Evolution</strong> <strong>for</strong> the six months ended 30 June 2011;<br />

60


(iii) the financial in<strong>for</strong>mation relating <strong>to</strong> <strong>Evolution</strong> stated as at or in respect of the period ended 31 December 2010 is extracted from<br />

the audited consolidated financial statements of <strong>Evolution</strong> <strong>for</strong> the financial year ended 31 December 2010 prepared in accordance<br />

with IFRS; and<br />

(iv) the financial in<strong>for</strong>mation relating <strong>to</strong> <strong>Investec</strong> stated as at or in respect of the period ended 31 March 2011 is extracted from the<br />

audited consolidated financial statements of the <strong>Investec</strong> <strong>Group</strong> <strong>for</strong> the financial year ended 31 March 2011.<br />

11.2 As at the close of business on 30 September 2011 (being the latest practicable date prior <strong>to</strong> the publication of this document)<br />

<strong>Investec</strong> had in issue 542,424,043 ordinary shares of £0.0002 each and <strong>Evolution</strong> had in issue 232,680,307 ordinary shares of 1<br />

pence each.<br />

11.3 Unless otherwise stated, all prices quoted <strong>for</strong> <strong>Evolution</strong> Shares and <strong>Investec</strong> Shares are closing mid-market prices and are<br />

derived from the daily Official List.<br />

11.4 Unless otherwise stated, all share prices are expressed in pence. Where South African Rand has been converted <strong>to</strong> sterling in<br />

this document, an exchange rate of 1GBP <strong>to</strong> 12.35ZAR has been used.<br />

11.5 <strong>The</strong> in<strong>for</strong>mation relating <strong>to</strong> the <strong>Investec</strong> <strong>Group</strong> has been provided <strong>by</strong> the <strong>Investec</strong> Direc<strong>to</strong>rs.<br />

12 Incorporation <strong>by</strong> reference<br />

12.1 Parts of other documents are incorporated <strong>by</strong> reference in, and <strong>for</strong>m part of, this document.<br />

12.2 Part VII (In<strong>for</strong>mation Incorporated <strong>by</strong> Reference) of this document sets out which sections of such documents are incorporated<br />

in<strong>to</strong> this document.<br />

12.3 A person who has received this document may request a copy of such documents incorporated <strong>by</strong> reference. A copy of any<br />

such documents or in<strong>for</strong>mation incorporated <strong>by</strong> reference will not be sent <strong>to</strong> such persons unless requested from Capita at PXS, <strong>The</strong><br />

Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU or <strong>by</strong> telephone of 0871 664 0321. If requested, copies will be provided,<br />

free of charge, within two Business Days of the request.<br />

13 Other in<strong>for</strong>mation<br />

13.1 <strong>Investec</strong> Investment Banking has given and not withdrawn its written consent <strong>to</strong> the issue of this document with the inclusion<br />

of the references <strong>to</strong> its name in the <strong>for</strong>m and context in which they appear.<br />

13.2 Credit Suisse has given and not withdrawn its written consent <strong>to</strong> the issue of this document with the inclusion of the references<br />

<strong>to</strong> its name in the <strong>for</strong>m and context in which they appear.<br />

13.3 <strong>The</strong>re is no agreement, arrangement or understanding where<strong>by</strong> the beneficial ownership of any of the <strong>Evolution</strong> Shares <strong>to</strong> be<br />

issued <strong>to</strong> <strong>Investec</strong> pursuant <strong>to</strong> the Scheme will be transferred <strong>to</strong> any other person, save that <strong>Investec</strong> reserves the right <strong>to</strong> transfer any<br />

such <strong>Evolution</strong> Shares <strong>to</strong> any other member of the <strong>Investec</strong> <strong>Group</strong>.<br />

13.4 <strong>The</strong>re are no arrangements of the kind referred <strong>to</strong> in Note 11 on the definition of acting in concert in the City Code which exist<br />

between <strong>Investec</strong>, or any person acting in concert with <strong>Investec</strong>, and any other person.<br />

13.5 Save as disclosed in this document, no agreement, arrangement or understanding (including any compensation arrangement)<br />

exists between <strong>Investec</strong> or any person acting in concert with <strong>Investec</strong> <strong>for</strong> the purposes of the Offer and any of the direc<strong>to</strong>rs, recent<br />

direc<strong>to</strong>rs, shareholders or recent shareholders of <strong>Evolution</strong>, or any person interested or recently interested in <strong>Evolution</strong> Shares, having<br />

any connection with or dependence upon, or which is conditional on the outcome of the Offer.<br />

13.6 Save as disclosed in this document, the emoluments of the <strong>Investec</strong> Direc<strong>to</strong>rs will not be affected <strong>by</strong> the Offer or any other<br />

associated transaction.<br />

13.7 No proposal exists in connection with the Offer that any payment or other benefit shall be made or given <strong>by</strong> <strong>Investec</strong> <strong>to</strong> any<br />

<strong>Evolution</strong> Direc<strong>to</strong>r as compensation <strong>for</strong> loss of office or as consideration <strong>for</strong>, or in connection with, his or her retirement from office.<br />

13.8 Settlement of the consideration <strong>to</strong> which each Scheme Shareholder is entitled under the Scheme will be implemented in full<br />

in accordance with the terms of the Scheme without regard <strong>to</strong> any lien or right of set-off, counterclaim or other analogous right <strong>to</strong> which<br />

<strong>Investec</strong> may otherwise be or claim <strong>to</strong> be, entitled against any such Scheme Shareholder.<br />

13.9 <strong>The</strong> aggregate fees and expenses which are expected <strong>to</strong> be incurred <strong>by</strong> <strong>Investec</strong> in connection with the Offer are estimated <strong>to</strong><br />

amount <strong>to</strong> between £3.72 million <strong>to</strong> £4.02 million plus applicable VAT. This aggregate number consists of the following categories:<br />

13.9.1 financial and corporate broking advice: £2.75 million plus applicable VAT;<br />

13.9.2 legal advice: between £900,000 <strong>to</strong> £1.2 million plus applicable VAT. Legal fees are estimated as a range as they are charged<br />

<strong>by</strong> reference <strong>to</strong> hourly rates and at the latest practicable date prior <strong>to</strong> the publication of this document, the residual amount of legal work<br />

required in connection with, inter alia, anti-trust and regula<strong>to</strong>ry filings was uncertain;<br />

13.9.3 public relations advice: £20,000 plus applicable VAT; and<br />

13.9.4 other costs and expenses: £50,000 plus applicable VAT.<br />

61


13.10 <strong>The</strong> aggregate fees and expenses which are expected <strong>to</strong> be incurred <strong>by</strong> <strong>Evolution</strong> in connection with the Offer are estimated <strong>to</strong><br />

amount <strong>to</strong> £2.3 million plus applicable VAT. This aggregate number consists of the following categories:<br />

13.10.1 financial and corporate broking advice: £1.89 million plus applicable VAT;<br />

13.10.2 legal advice: £300,000 plus applicable VAT;<br />

13.10.3 public relations advice: £80,000 plus applicable VAT; and<br />

13.10.4 other costs and expenses: £30,000 plus applicable VAT.<br />

14 Documents available <strong>for</strong> inspection<br />

Copies of the following documents will be made available on <strong>Investec</strong>’s website at www.investec.com and on <strong>Evolution</strong>’s website at www.<br />

evg<strong>plc</strong>.com:<br />

14.1 the <strong>Evolution</strong> Articles;<br />

14.2 the <strong>Evolution</strong> Articles as proposed <strong>to</strong> be amended <strong>by</strong> the resolutions set out in the notice of General Meeting set out at Part X<br />

of this document;<br />

14.3 the memorandum and articles of association of <strong>Investec</strong>;<br />

14.4 the material contracts referred <strong>to</strong> in paragraphs 8.1, 8.2 and 8.3 of this Appendix VI;<br />

14.5 the irrevocable undertakings and letters of intent referred <strong>to</strong> in paragraph 6 of this Appendix VI;<br />

14.6 the written consents referred <strong>to</strong> in paragraph 13 of this Appendix VI;<br />

14.7 a full list of the dealings aggregated in paragraphs 5.4(ii), (iii), (vi), (vii), (viii), (ix), (x), (xi) and (xii) of this Appendix VI;<br />

14.8 the Implementation Agreement described in paragraph 9 above; and<br />

14.9 this document (including any documents incorporated herein <strong>by</strong> reference) and the Forms of Proxy.<br />

62


PART VII<br />

INFORMATION INCORPORATED BY REFERENCE<br />

<strong>The</strong> following documents (or parts thereof) are incorporated <strong>by</strong> reference in<strong>to</strong> this document:<br />

Document In<strong>for</strong>mation incorporated <strong>by</strong> reference<br />

Interim Results of <strong>Evolution</strong> <strong>to</strong> 30 June 2011 (available <strong>for</strong><br />

viewing on <strong>Evolution</strong>’s website at www.evg<strong>plc</strong>.com)<br />

Annual Report and Accounts of <strong>Evolution</strong> <strong>for</strong> the financial year<br />

ended 31 December 2010 (available <strong>for</strong> viewing on <strong>Evolution</strong>’s<br />

website at www.evg<strong>plc</strong>.com)<br />

Annual Report and Accounts of <strong>Evolution</strong> <strong>for</strong> the financial year<br />

ended 31 December 2009 (available <strong>for</strong> viewing on <strong>Evolution</strong>’s<br />

website at www.evg<strong>plc</strong>.com)<br />

Annual Report and Accounts of the <strong>Investec</strong> <strong>Group</strong> <strong>for</strong> the year<br />

ended 31 March 2011 (available <strong>for</strong> viewing on <strong>Investec</strong>’s website<br />

at www.investec.com <strong>by</strong> following the links <strong>to</strong> Inves<strong>to</strong>r Relations/<br />

Financial In<strong>for</strong>mation/Reports)<br />

Annual Report and Accounts of the <strong>Investec</strong> <strong>Group</strong> <strong>for</strong> the year<br />

ended 31 March 2010 (available <strong>for</strong> viewing on <strong>Investec</strong>’s website<br />

at www.investec.com <strong>by</strong> following the links <strong>to</strong> Inves<strong>to</strong>r Relations/<br />

Financial In<strong>for</strong>mation/Reports)<br />

Unaudited condensed consolidated interim financial in<strong>for</strong>mation<br />

(pages 11-21)<br />

Audited financial statements<br />

(pages 30-62)<br />

Audited financial statements<br />

pages 41-74)<br />

Audited financial statements<br />

(pages 299-390)<br />

Audited financial statements<br />

(pages 286-372)<br />

<strong>The</strong> in<strong>for</strong>mation is available in “read-only” <strong>for</strong>mat and can be printed from the web address detailed above.<br />

Please see paragraph 12 of Appendix VI (Additional In<strong>for</strong>mation) <strong>for</strong> details of obtaining hard copies of documents incorporated <strong>by</strong><br />

reference in<strong>to</strong> this document.<br />

No incorporation of website in<strong>for</strong>mation<br />

Save as expressly referred <strong>to</strong> herein, neither the content of <strong>Evolution</strong> or <strong>Investec</strong>’s websites, nor the content of any website accessible<br />

from hyperlinks on <strong>Evolution</strong> or <strong>Investec</strong>’s website, is incorporated in<strong>to</strong>, or <strong>for</strong>ms part of, this document.<br />

63


64<br />

PART VIII<br />

DEFINITIONS<br />

<strong>The</strong> following definitions apply throughout this document, unless stated otherwise:<br />

Act or Companies Act means the Companies Act 2006 and shall be construed as a reference <strong>to</strong> it as it may<br />

from time <strong>to</strong> time be, amended, modified or re-enacted<br />

Admission means the admission of the New <strong>Investec</strong> Shares <strong>to</strong> the Official List in accordance with<br />

the Listing Rules and <strong>to</strong> trading on the London S<strong>to</strong>ck Exchange’s main market <strong>for</strong> listed<br />

securities in accordance with the Admission and Disclosure Standards<br />

Admission and<br />

Disclosure Standards<br />

means the requirements contained in the publication “Admission and Disclosure<br />

Standards” (as amended from time <strong>to</strong> time) containing, among other things, the admission<br />

requirements <strong>to</strong> be observed <strong>by</strong> companies seeking admission <strong>to</strong> trading on the London<br />

S<strong>to</strong>ck Exchange’s main market <strong>for</strong> listed securities<br />

Announcement means the announcement <strong>by</strong> <strong>Investec</strong> on 9 September 2011 of its firm intention <strong>to</strong> make<br />

the Offer<br />

Annual Report means the annual report and accounts of <strong>Evolution</strong> <strong>for</strong> the year ended 31 December<br />

2010<br />

Authorisations means material authorisations, orders, recognitions, grants, consents, clearances,<br />

confirmations, certificates, licenses, permissions and approvals<br />

BLUE Form of Proxy means the BLUE <strong>for</strong>m of proxy or <strong>for</strong>m of direction <strong>for</strong> use <strong>by</strong> Scheme Shareholders in<br />

relation <strong>to</strong> the Court Meeting<br />

BNP Paribas Private Investment<br />

Management<br />

BNP Paribas Private Investment Management Limited, a company incorporated in England<br />

and Wales with registered number 02123174 whose registered office is at 5 Aldermanbury<br />

Square, London EC2V 7BP<br />

Business Day means a day on which the London S<strong>to</strong>ck Exchange is open <strong>for</strong> business<br />

Capital Reduction means the proposed reduction of the ordinary share capital of <strong>Evolution</strong> provided <strong>by</strong> the<br />

Scheme under section 641 of the Companies Act<br />

City Code or Code means the City Code on Takeovers and Mergers<br />

Conditions means the conditions <strong>to</strong> the Offer set out in Part IV (Conditions and Further Terms) of this<br />

document and a “Condition” shall mean any one of them<br />

Court means the High Court of Justice in England and Wales<br />

Court Meeting means the meeting of Scheme Shareholders, convened <strong>by</strong> the Court pursuant <strong>to</strong> Part 26<br />

of the Companies Act <strong>to</strong> be held at the offices of Jones Day at 21 Tudor Street, London<br />

EC4Y 0DJ on 27 Oc<strong>to</strong>ber at 11.00 a.m. (or any adjournment thereof), notice of which is<br />

set out at Part IX of this document<br />

Credit Suisse means Credit Suisse Securities (Europe) Limited, acting as exclusive financial adviser <strong>to</strong><br />

<strong>Evolution</strong><br />

CREST means the system <strong>for</strong> the paperless settlement of trades in securities and the holding of<br />

uncertificated securities operated <strong>by</strong> Euroclear in accordance with the Uncertificated<br />

Securities Regulations 2001<br />

CREST Manual means the rules governing the operation of CREST, consisting of the CREST Reference<br />

Manual, the CREST International Manual, the CREST Rules, the Registrars Service<br />

Standards, the Settlement Discipline Rules, the CCSS Operations Manual, the Daily<br />

Timetable, the CREST Application Procedure and the CREST Glossary of Terms (all as<br />

defined in the CREST Glossary of Terms promulgated <strong>by</strong> Euroclear on 15 July 1996 and<br />

as amended from time <strong>to</strong> time)<br />

Darwin Strategic means Darwin Strategic Limited, a company incorporated in England and Wales with<br />

registered number 07069758 whose registered office is 9th Floor, 100 Wood Street,<br />

London EC2V 7AN<br />

Deferred Share a deferred share of 1 pence in the capital of <strong>Evolution</strong>


Disclosed means (i) fairly disclosed in <strong>Evolution</strong>’s Annual Report; (ii) Publicly Announced; or (iii) fairly<br />

disclosed in writing <strong>to</strong> <strong>Investec</strong> or its financial, legal or accounting advisers (specifically in<br />

their capacity as <strong>Investec</strong>’s advisers in relation <strong>to</strong> the Offer) <strong>by</strong> or on behalf of <strong>Evolution</strong><br />

prior <strong>to</strong> the date of the Announcement<br />

Effective Date the date on which the Scheme becomes effective<br />

Enlarged <strong>Group</strong> means the <strong>Evolution</strong> <strong>Group</strong> and the <strong>Investec</strong> <strong>Group</strong><br />

ESIP means the <strong>Evolution</strong> Executive Share Incentive Plan<br />

ESL GSOP means the <strong>Evolution</strong> Securities Limited 2010 Growth Share Ownership Plan<br />

ESOS means the <strong>Evolution</strong> 2001 Executive Share Option Scheme<br />

Euroclear means Euroclear UK & Ireland Limited, incorporated in England and Wales with registered<br />

number 2878738<br />

<strong>Evolution</strong> or Company means <strong>The</strong> <strong>Evolution</strong> <strong>Group</strong> <strong>Plc</strong>, a company incorporated in England and Wales with<br />

registered number 03359425 whose registered office is 9th Floor, 100 Wood Street,<br />

London EC2V 7AN<br />

<strong>Evolution</strong> Articles means the articles of association of <strong>Evolution</strong><br />

<strong>Evolution</strong> Direc<strong>to</strong>rs means the direc<strong>to</strong>rs of <strong>Evolution</strong>, whose names are set out in paragraph 2.1 of Part VI<br />

(Additional In<strong>for</strong>mation) of this document<br />

<strong>Evolution</strong> <strong>Group</strong> or <strong>Group</strong> means <strong>Evolution</strong> and each of its subsidiaries and subsidiary undertakings from time <strong>to</strong><br />

time<br />

<strong>Evolution</strong> Securities means <strong>Evolution</strong> Securities Limited, a company incorporated in England and Wales with<br />

registered number 02316630 whose registered office is 9th Floor, 100 Wood Street,<br />

London EC2V 7AN<br />

<strong>Evolution</strong> Shareholders or<br />

Shareholders<br />

means the holders of <strong>Evolution</strong> Shares<br />

<strong>Evolution</strong> Shares means the existing unconditionally allotted or issued and fully paid ordinary shares of 1<br />

pence each in the capital of <strong>Evolution</strong> and any further such ordinary shares which are<br />

unconditionally allotted or issued be<strong>for</strong>e the Scheme becomes effective<br />

<strong>Evolution</strong> Share Schemes means the ESOS, the ESIP, the JSOP, the ESL GSOP, the WdeB GSOP and the SIP<br />

Excluded Overseas Shareholder means any Overseas Shareholder in respect of whom <strong>Investec</strong> is advised or determines<br />

that issuing New <strong>Investec</strong> Shares pursuant <strong>to</strong> the Scheme would or may infringe the laws<br />

of any jurisdiction or would or may require compliance with any governmental or other<br />

consent or any registration, filing or other <strong>for</strong>mality which cannot be complied with, or<br />

compliance with which <strong>Investec</strong> regards as unduly onerous<br />

Forms of Proxy means the BLUE Form of Proxy and the WHITE Form of Proxy<br />

FSA means the Financial Services Authority<br />

FSMA means the Financial Services and Markets Act 2000<br />

General Meeting means the general meeting of <strong>Evolution</strong> <strong>to</strong> be held at the offices of Jones Day at 21 Tudor<br />

Street, London EC4Y 0DJ on 27 Oc<strong>to</strong>ber 2011 at 11.05 a.m. or as soon thereafter as the<br />

Court Meeting has concluded or been adjourned (or any adjournment thereof), notice of<br />

which is set out at Part X of this document<br />

General Meeting Resolution means the special resolution set out in the Notice of General Meeting in Part X of this<br />

document<br />

holder includes a person entitled <strong>by</strong> transmission<br />

Implementation Agreement means the implementation agreement between <strong>Investec</strong> and <strong>Evolution</strong> dated 9 September<br />

2011<br />

<strong>Investec</strong> means <strong>Investec</strong> <strong>plc</strong>, a company incorporated in England and Wales with registered<br />

number 3633621 whose registered office is at 2 Gresham Street, London EC2V 7QP<br />

<strong>Investec</strong> Bank means <strong>Investec</strong> Bank <strong>plc</strong>, a company incorporated in England and Wales with registered<br />

number 489604 whose registered office is at 2 Gresham Street, London EC2V 7QP<br />

65


<strong>Investec</strong> Direc<strong>to</strong>rs means the direc<strong>to</strong>rs of <strong>Investec</strong>, whose names are set out in paragraph 2.2 of Part VI<br />

(Additional In<strong>for</strong>mation) of this document<br />

<strong>Investec</strong> <strong>Group</strong> means <strong>Investec</strong>, <strong>Investec</strong> Limited and their respective subsidiaries<br />

<strong>Investec</strong> Investment Banking means <strong>Investec</strong> Investment Bank, a division of <strong>Investec</strong> Bank <strong>plc</strong>, acting as financial<br />

adviser and joint corporate broker <strong>to</strong> <strong>Investec</strong><br />

<strong>Investec</strong> Limited means <strong>Investec</strong> Limited, registration number 1925/002833/06, a public company<br />

incorporated in South Africa<br />

<strong>Investec</strong> Shares means the ordinary shares of £0.0002 each in the share capital of <strong>Investec</strong><br />

<strong>Investec</strong> Wealth means <strong>Investec</strong> Wealth & Investment Limited, a company incorporated in England and<br />

Wales with registered number 02122340 whose registered office is at 2 Gresham Street,<br />

London EC2V 7QP<br />

JSE means JSE Limited, registration number 2005/022939/06, a public company incorporated<br />

in South Africa, licensed as a securities exchange in terms of the South African Securities<br />

Services Act, 36 of 2004<br />

JSOP means the <strong>Evolution</strong> 2010 Joint Share Ownership Plan<br />

Listing Rules means the rules and regulations made <strong>by</strong> the Financial Services Authority in its capacity<br />

as the UKLA under the Financial Services and Markets Act 2000, and contained in the<br />

UK Listing Authority’s publication of the same name<br />

London S<strong>to</strong>ck Exchange means London S<strong>to</strong>ck Exchange <strong>plc</strong><br />

New <strong>Evolution</strong> Shares means the new ordinary shares of 1 pence each in the capital of <strong>Evolution</strong> <strong>to</strong> be created<br />

in accordance with Clause 2.1 of the Scheme<br />

New <strong>Investec</strong> Shares means the new ordinary shares in the capital of <strong>Investec</strong> of £0.0002 each <strong>to</strong> be issued<br />

pursuant <strong>to</strong> the terms of the Offer<br />

Offer means the acquisition <strong>by</strong> <strong>Investec</strong> of the entire issued share capital of <strong>Evolution</strong> pursuant<br />

<strong>to</strong> the Scheme<br />

Offer Period means the period commencing on 3 August 2011<br />

Official List means the official list of the UK Listing Authority<br />

Overseas Shareholder means a holder of Scheme Shares with a registered address in a jurisdiction outside the<br />

United Kingdom or whom <strong>Investec</strong> reasonably believes <strong>to</strong> be a citizen, resident or national<br />

of a jurisdiction outside the United Kingdom<br />

Panel means the Panel on Takeovers and Mergers<br />

Publicly Announced fairly disclosed in any public announcement <strong>by</strong> <strong>Evolution</strong> <strong>to</strong> any regula<strong>to</strong>ry in<strong>for</strong>mation<br />

service or in its report and accounts <strong>for</strong> the years ended 31 December 2010<br />

Registrar or <strong>Evolution</strong>’s<br />

Registrar or Capita<br />

66<br />

means Capita Registrars Limited, a private limited company incorporated in England and<br />

Wales under number 02605568<br />

Registrar of Companies means the Registrar of Companies in England and Wales<br />

Resolutions means the resolutions set out in the Notice of Court Meeting and Notice of General<br />

Meeting in Parts IX and X of this document<br />

Restricted Jurisdiction means any such jurisdiction where local laws or regulations may result in significant risk<br />

of civil, regula<strong>to</strong>ry or criminal exposure if in<strong>for</strong>mation concerning the Offer is sent or made<br />

available <strong>to</strong> <strong>Evolution</strong> Shareholders in that jurisdiction (in accordance with Rule 30.3 of<br />

the City Code)<br />

Scheme means the Scheme of Arrangement set out in Part III (<strong>The</strong> Scheme of Arrangement) of<br />

this document in its present <strong>for</strong>m or with or subject <strong>to</strong> any modification, addition or<br />

condition approved or imposed <strong>by</strong> the Court and agreed <strong>to</strong> <strong>by</strong> <strong>Evolution</strong> and <strong>Investec</strong><br />

Scheme Court Order means the order of the Court sanctioning the Scheme under Part 26 of the Companies<br />

Act and confirming the Capital Reduction under section 641 of the Companies Act<br />

Scheme Record Time means 6.00 p.m. on the Business Day immediately prior <strong>to</strong> the Effective Date<br />

Scheme Shareholders means the registered holders of Scheme Shares


Scheme Shares means<br />

(i) the <strong>Evolution</strong> Shares in issue at the date of the Scheme;<br />

(ii) any <strong>Evolution</strong> Shares issued after the date of the Scheme and be<strong>for</strong>e the Voting<br />

Record Time; and<br />

(iii) any <strong>Evolution</strong> Shares issued at or after the Voting Record Time and at or prior <strong>to</strong> the<br />

Scheme Record Time either on terms that the original or any subsequent holders<br />

thereof shall be bound <strong>by</strong> the Scheme and/or in respect of which the original or any<br />

subsequent holders thereof are, or shall have agreed in writing <strong>to</strong> be, bound <strong>by</strong> the<br />

Scheme<br />

in each case, excluding any <strong>Evolution</strong> Shares beneficially owned <strong>by</strong> and/or registered in<br />

the name of <strong>Investec</strong> or a member of the <strong>Investec</strong> <strong>Group</strong><br />

Shareholder Meetings means the Court Meeting and the General Meeting, and “Shareholder Meeting” means<br />

either one of them<br />

SIP means the <strong>Evolution</strong> Share Incentive Plan<br />

Takeover Offer means the implementation of the Offer <strong>by</strong> means of a takeover <strong>offer</strong> under the City Code<br />

Third Party means a central bank, government or governmental, quasi-governmental, supranational,<br />

statu<strong>to</strong>ry, regula<strong>to</strong>ry, environmental or investigative body, court, trade agency, professional<br />

association, institution, employee representative body or any other such body or person<br />

whatsoever in any jurisdiction<br />

Third Party Transaction means (a) any <strong>offer</strong> (construed in accordance with the Code and whether or not subject<br />

<strong>to</strong> pre-conditions), possible <strong>offer</strong>, proposal or indication of interest from, or on behalf of,<br />

any person other than <strong>Investec</strong> or any person acting in concert with <strong>Investec</strong>, with a view<br />

<strong>to</strong> such person, directly or indirectly, acquiring (in one transaction or a series of<br />

transactions) (i) more than 30 per cent. of the issued share capital of <strong>Evolution</strong> or (ii) a<br />

material part of the business or assets of <strong>Evolution</strong> or <strong>Evolution</strong>’s <strong>Group</strong> or (b) the entering<br />

in<strong>to</strong>, <strong>by</strong> <strong>Evolution</strong> or any member of <strong>Evolution</strong>’s <strong>Group</strong>, of any transaction or series of<br />

transactions howsoever implemented that, in the case of (a)(ii) or (b) above, would be<br />

reasonably likely <strong>to</strong> preclude, impede, delay or prejudice the implementation of the Offer<br />

Trust means the <strong>Evolution</strong> Employees’ Share Trust constituted <strong>by</strong> a trust deed dated 13 March<br />

2002<br />

UK Listing Authority or UKLA means the Financial Services Authority acting in its capacity as the competent authority<br />

<strong>for</strong> the purposes of Part VI of FSMA<br />

United Kingdom or UK means the United Kingdom of Great Britain and Northern Ireland<br />

US or United States means the United States of America, its terri<strong>to</strong>ries and possessions, any State of the<br />

United States and the District of Columbia<br />

US Securities Act means the US Securities Act of 1933, as amended, and the rules and regulations<br />

promulgated thereunder<br />

Voting Record Time means 6.00 p.m. on the day which is two Business Days be<strong>for</strong>e the date of the Court<br />

Meeting or, if the Court Meeting is adjourned, 6.00 p.m. on the day which is two Business<br />

Days be<strong>for</strong>e the date of such adjourned meeting<br />

WdeB GSOP means the Williams de Broë Limited 2010 Growth Share Ownership Plan<br />

WHITE Form of Proxy means the WHITE <strong>for</strong>m of proxy or <strong>for</strong>m of direction <strong>for</strong> use <strong>by</strong> Shareholders in relation <strong>to</strong><br />

the General Meeting<br />

Wider <strong>Evolution</strong> <strong>Group</strong> means <strong>Evolution</strong>, its subsidiaries, subsidiary undertakings and associated undertakings<br />

and any other body corporate, partnership, joint venture or person in which <strong>Evolution</strong> and<br />

such undertakings (aggregating their interests) have a direct or indirect interest of 20 per<br />

cent. or more of the voting or equity capital or the equivalent<br />

Wider <strong>Investec</strong> <strong>Group</strong> means <strong>Investec</strong>, <strong>Investec</strong> Limited and their respective subsidiaries, subsidiary undertakings<br />

and any other body corporate, partnership, joint revenue or person in which <strong>Investec</strong>,<br />

<strong>Investec</strong> Limited and such undertakings (aggregating their interests) have a direct or<br />

indirect interest of 20 per cent. or more of the voting or equity capital or the equivalent<br />

67


Williams de Broë means Williams de Broë Limited, a company incorporated in England and Wales with<br />

registered number 02485266 whose registered office is at 4th Floor, 100 Wood Street,<br />

London EC2V 7AN<br />

ZAR South African rand<br />

Unless otherwise stated, all times referred <strong>to</strong> in this document are references <strong>to</strong> London time. References <strong>to</strong> the singular include the<br />

plural and vice versa.<br />

All references <strong>to</strong> legislation in this document are <strong>to</strong> the legislation of England and Wales unless the contrary is indicated. Any reference<br />

<strong>to</strong> any provision of any legislation shall include any amendment, modification, re-enactment or extension thereof.<br />

For the purposes of this document, “subsidiary”, “subsidiary undertaking”, “undertaking” and “associated undertaking” have the<br />

respective meanings given there<strong>to</strong> <strong>by</strong> the Companies Act.<br />

68


PART IX<br />

NOTICE OF COURT MEETING<br />

IN THE HIGH COURT OF JUSTICE<br />

CHANCERY DIVISION<br />

COMPANIES COURT No. 8266 of 2011<br />

REGISTRAR DERRETT<br />

IN THE MATTER OF THE EVOLUTION GROUP PLC<br />

- and -<br />

IN THE MATTER OF THE COMPANIES ACT 2006<br />

NOTICE IS HEREBY GIVEN that <strong>by</strong> an Order dated 29 September 2011 made in the above matters the Court has directed a meeting <strong>to</strong><br />

be convened of the holders of the Scheme Shares (as defined in the scheme of arrangement hereinafter mentioned) <strong>for</strong> the purpose of<br />

considering and, if thought fit, approving (with or without modification) a scheme of arrangement (the “Scheme”) proposed <strong>to</strong> be made<br />

between <strong>The</strong> <strong>Evolution</strong> <strong>Group</strong> <strong>Plc</strong> (the “Company”) and the holders of Scheme Shares (as defined in the Scheme), and that such<br />

meeting shall be held at the offices of Jones Day at 21 Tudor Street, London EC4Y 0DJ on 27 Oc<strong>to</strong>ber 2011 at 11.00 a.m. at which<br />

place and time all holders of the said shares are requested <strong>to</strong> attend.<br />

A copy of the said Scheme and a copy of the explana<strong>to</strong>ry statement required <strong>to</strong> be furnished pursuant <strong>to</strong> section 897 of the Companies<br />

Act 2006 are incorporated in the document of which this notice <strong>for</strong>ms part.<br />

Holders of Scheme Shares entitled <strong>to</strong> attend and vote at the meeting may vote in person at the said meeting or they may<br />

appoint another person, whether a member of the Company or not, as their proxy <strong>to</strong> attend and vote in their stead. A BLUE<br />

<strong>for</strong>m of proxy <strong>for</strong> use at the meeting is enclosed with this notice.<br />

Holders of Scheme Shares are entitled <strong>to</strong> appoint a proxy in respect of some or all of their shares. Holders of Scheme<br />

Shares are also entitled <strong>to</strong> appoint more than one proxy, provided that each proxy is appointed <strong>to</strong> exercise the rights<br />

attached <strong>to</strong> a different share or shares held <strong>by</strong> such holder. A space has been included in the BLUE <strong>for</strong>m of proxy <strong>to</strong> allow<br />

holders of Scheme Shares <strong>to</strong> specify the number of shares in respect of which that proxy is appointed. Holders of Scheme<br />

Shares who return the BLUE <strong>for</strong>m of proxy duly executed but leave this space blank shall be deemed <strong>to</strong> have appointed the<br />

proxy in respect of all their Scheme Shares.<br />

Holders of Scheme Shares who wish <strong>to</strong> appoint more than one proxy in respect of their shareholding should contact the<br />

Company’s registrar, Capita Registrars Limited at PSX, <strong>The</strong> Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU (the<br />

“Company’s Registrar”) <strong>for</strong> further BLUE <strong>for</strong>ms of proxy or pho<strong>to</strong>copy the <strong>for</strong>m of proxy as required. Such holders should also<br />

read the “Multiple Proxy Voting Instructions” set out in the BLUE <strong>for</strong>m of proxy, and note the principles that shall be applied<br />

in relation <strong>to</strong> multiple proxies.<br />

It is requested that BLUE <strong>for</strong>ms of proxy (<strong>to</strong>gether with any power of at<strong>to</strong>rney or authority under which they are signed, or a duly<br />

certificated copy of such power of at<strong>to</strong>rney or other authority) be lodged with the Company’s Registrar at PSX, <strong>The</strong> Registry,<br />

34 Beckenham Road, Beckenham, Kent BR3 4TU so as <strong>to</strong> be received <strong>by</strong> no later than 11.00 a.m. on 25 Oc<strong>to</strong>ber 2011, or in the<br />

case of an adjourned meeting, not less than 48 hours be<strong>for</strong>e the time appointed <strong>for</strong> the said meeting, but if <strong>for</strong>ms are not so lodged<br />

they may be handed <strong>to</strong> the Company’s Registrar or the Chairman at the meeting.<br />

Holders of Scheme Shares entitled <strong>to</strong> attend and vote at the meeting may appoint a proxy electronically <strong>by</strong> logging on <strong>to</strong> the website of<br />

Capita at www.capitashareportal.com and entering the voting ID, task ID and shareholder reference number shown on their <strong>for</strong>m of proxy.<br />

Full details of the procedure <strong>to</strong> be followed <strong>to</strong> appoint a proxy electronically are given on the website. In<strong>for</strong>mation is also included in the<br />

instructions included on the Form of Proxy.<br />

Holders of Scheme Shares entitled <strong>to</strong> attend and vote at the meeting who hold their shares through CREST may appoint a proxy using<br />

the CREST electronic proxy appointment service.<br />

Completion of the BLUE <strong>for</strong>m of proxy or the appointment of a proxy or proxies electronically or through CREST shall not prevent a holder<br />

of Scheme Shares from attending and voting at the meeting or any adjournment thereof.<br />

In the case of joint holders, the vote of the senior who tenders a vote, whether in person or <strong>by</strong> proxy, shall be accepted <strong>to</strong> the exclusion<br />

of the vote(s) of the other joint holder(s) and <strong>for</strong> this purpose, seniority shall be determined <strong>by</strong> the order in which the names stand in the<br />

register of members of the Company in respect of the joint holding.<br />

As an alternative <strong>to</strong> appointing a proxy, any holder of Scheme Shares which is a corporation may vote <strong>by</strong> a corporate representative in<br />

accordance with the Companies Act 2006.<br />

Entitlement <strong>to</strong> attend and vote at the meeting or any adjournment thereof and the number of votes which may be cast thereat shall be<br />

determined <strong>by</strong> reference <strong>to</strong> the register of members of the Company at 6.00 p.m. on the day which is two business days be<strong>for</strong>e the date<br />

of the meeting or adjourned meeting (as the case may be). In each case, changes <strong>to</strong> the register of members of the Company after such<br />

time shall be disregarded.<br />

69


By the said Order, the Court has appointed Martin Gray or, failing him, Alex Snow or, failing him, any other direc<strong>to</strong>r of the Company, <strong>to</strong><br />

act as Chairman of the said meeting and has directed the Chairman <strong>to</strong> report the result thereof <strong>to</strong> the Court.<br />

<strong>The</strong> Scheme will be subject <strong>to</strong> the subsequent sanction of the Court.<br />

Dated 3 Oc<strong>to</strong>ber 2011.<br />

70<br />

Bird & Bird LLP<br />

15 Fetter Lane<br />

London EC4A 1JP<br />

United Kingdom<br />

Solici<strong>to</strong>rs <strong>for</strong> the Company


PART X<br />

NOTICE OF GENERAL MEETING<br />

THE EVOLUTION GROUP PLC<br />

(Registered in England and Wales No. 3359425)<br />

NOTICE IS HEREBY GIVEN that a GENERAL MEETING of the Company shall be held at the offices of Jones Day at 21 Tudor Street, London<br />

EC4Y 0DJ on 27 Oc<strong>to</strong>ber 2011 at 11.05 a.m. (or as soon thereafter as the Court Meeting (as defined in the document of which this<br />

Notice <strong>for</strong>ms part) has concluded or been adjourned) <strong>for</strong> the purpose of considering and, if thought fit, passing the following resolution<br />

which shall be proposed as a special resolution:<br />

THAT:<br />

SPECIAL RESOLUTION<br />

<strong>for</strong> the purpose of giving effect <strong>to</strong> the scheme of arrangement dated 3 Oc<strong>to</strong>ber 2011 between the Company and the holders of Scheme<br />

Shares (as defined in the said scheme of arrangement), a print of which has been produced <strong>to</strong> this meeting and <strong>for</strong> the purposes of<br />

identification signed <strong>by</strong> the Chairman thereof, in its original <strong>for</strong>m or subject <strong>to</strong> any modification, addition or condition agreed <strong>by</strong> the<br />

Company and <strong>Investec</strong> <strong>plc</strong> (“<strong>Investec</strong>”) and approved or imposed <strong>by</strong> the Court (the “Scheme”):<br />

(1) the share capital of the Company be reduced <strong>by</strong> cancelling and extinguishing all of the Scheme Shares;<br />

(2) subject <strong>to</strong> and <strong>for</strong>thwith upon the reduction of capital referred <strong>to</strong> in paragraph (1) above taking effect and notwithstanding anything<br />

<strong>to</strong> the contrary in the articles of association of the Company:<br />

(a) the share capital of the Compa ny be increased <strong>to</strong> its <strong>for</strong>mer amount <strong>by</strong> the creation of such number of new ordinary shares of<br />

1 pence in the capital of the Company (the “New <strong>Evolution</strong> Shares”) each as shall be equal <strong>to</strong> the aggregate of the number<br />

of Scheme Shares cancelled pursuant <strong>to</strong> paragraph (1) above;<br />

(b) the reserve arising in the books of account of the Company as a result of the said reduction of capital be capitalised and applied<br />

in paying up in full at par the New <strong>Evolution</strong> Shares so created, such New <strong>Evolution</strong> Shares <strong>to</strong> be allotted and issued credited<br />

as fully paid <strong>to</strong> <strong>Investec</strong> and/or its nominee(s); and<br />

(c) the direc<strong>to</strong>rs of the Company be generally and unconditionally authorised <strong>for</strong> the purposes of section 551 of the Companies<br />

Act 2006 <strong>to</strong> allot the New <strong>Evolution</strong> Shares referred <strong>to</strong> in paragraph (a) above, provided that (1) the maximum aggregate<br />

nominal amount of the shares which may be allotted under this authority shall be the aggregate nominal amount of the said<br />

New <strong>Evolution</strong> Shares created pursuant <strong>to</strong> paragraph (a) above, (2) this authority shall expire on the fifth anniversary of the date<br />

of this resolution and (3) this authority shall be in addition and without prejudice <strong>to</strong> any other authority under the said section<br />

551 previously granted and in <strong>for</strong>ce on the date on which this resolution is passed;<br />

(3) with effect from the passing of this resolution, the articles of association of the Company be amended <strong>by</strong> the adoption and inclusion<br />

of the following new article 166:<br />

“166 SCHEME OF ARRANGEMENT<br />

(a) In this Article 166, the “Scheme” means the scheme of arrangement dated 3 Oc<strong>to</strong>ber 2011 between the Company and the<br />

holders of Scheme Shares (as defined in the Scheme) under Part 26 of the Companies Act 2006 in its original <strong>for</strong>m or with or<br />

subject <strong>to</strong> any modification, addition or condition approved or imposed <strong>by</strong> the Court and agreed <strong>by</strong> the Company and <strong>Investec</strong><br />

<strong>plc</strong> (“<strong>Investec</strong>”) and (save as defined in this Article) expressions defined in the Scheme shall have the same meanings in this<br />

Article.<br />

(b) Notwithstanding any other provision of these Articles, if the Company issues any ordinary shares in the capital of the Company<br />

(other than <strong>to</strong> <strong>Investec</strong> or its nominee(s)) after the adoption of this Article and be<strong>for</strong>e the Scheme Record Time, such shares<br />

shall be issued subject <strong>to</strong> the terms of the Scheme (and shall be Scheme Shares <strong>for</strong> the purposes thereof) and the holder or<br />

holders of such shares shall be bound <strong>by</strong> the Scheme accordingly.<br />

(c) Subject <strong>to</strong> the Scheme becoming effective, if any ordinary shares in the capital of the Company are issued <strong>to</strong> any person<br />

(a “New Member”) (other than under the Scheme or <strong>to</strong> <strong>Investec</strong> or its nominee(s)) on or after the Effective Date (the<br />

“Post-Scheme Shares”), they shall be immediately transferred <strong>to</strong> <strong>Investec</strong> (or as it may direct) in consideration of (subject as<br />

hereinafter provided) the allotment and issue or transfer <strong>to</strong> the New Member of such number of <strong>Investec</strong> Shares (the<br />

“Consideration Shares”) as that New Member would have been entitled <strong>to</strong> under the Scheme <strong>for</strong> those Post-Scheme Shares<br />

had they been Scheme Shares, provided that if the Company is advised that the allotment and/or issue or transfer of<br />

Consideration Shares pursuant <strong>to</strong> this Article would or may infringe the laws of a jurisdiction outside the United Kingdom or<br />

would or may require <strong>Investec</strong> <strong>to</strong> comply with any governmental or other consent or any registration, filing or other <strong>for</strong>mality with<br />

which <strong>Investec</strong> is unable <strong>to</strong> comply or compliance with which <strong>Investec</strong> regards as unduly onerous, the Company may, in its sole<br />

discretion, determine that such Consideration Shares shall be sold, in which event the Company shall appoint a person <strong>to</strong> act<br />

pursuant <strong>to</strong> this Article and such person shall be authorised on behalf of such holder <strong>to</strong> procure that any shares in respect of<br />

71


72<br />

which the Company has made such determination shall, as soon as practicable following the allotment, issue or transfer of such<br />

shares, be sold.<br />

(d) <strong>The</strong> Consideration Shares allotted and issued or transferred <strong>to</strong> a New Member pursuant <strong>to</strong> paragraph (c) of this Article shall be<br />

credited as fully paid and shall rank pari passu in all respects with all other <strong>Investec</strong> Shares in issue at that time (other than as<br />

regards any dividend or other distribution payable <strong>by</strong> reference <strong>to</strong> a record date preceding the date of allotment) and shall be<br />

subject <strong>to</strong> the Articles of Association of <strong>Investec</strong>.<br />

(e) <strong>The</strong> number of Consideration Shares <strong>to</strong> be allotted and issued <strong>to</strong> a New Member pursuant <strong>to</strong> paragraph (c) of this Article may<br />

be adjusted <strong>by</strong> the direc<strong>to</strong>rs of the Company, in such manner as the audi<strong>to</strong>rs of the Company may determine, on any<br />

reorganisation of or material alteration (including, without limitation, any sub-division and/or consolidation) <strong>to</strong> the share capital<br />

of either the Company or <strong>Investec</strong> effected after the close of business on the Effective Date.<br />

(f) No fraction of a Consideration Share shall be allotted <strong>to</strong> a New Member pursuant <strong>to</strong> this Article, but any fraction of a<br />

Consideration Share <strong>to</strong> which a New Member would otherwise have become entitled shall be rounded down <strong>to</strong> the nearest<br />

whole number of Consideration Shares (which may be zero).<br />

(g) To give effect <strong>to</strong> any transfer of Post-Scheme Shares, the Company may appoint any person as at<strong>to</strong>rney <strong>for</strong> the New Member<br />

<strong>to</strong> transfer the Post-Scheme Shares <strong>to</strong> <strong>Investec</strong> and/or its nominee(s) and do all such other things and execute and deliver all<br />

such documents as may in the opinion of the at<strong>to</strong>rney be necessary or desirable <strong>to</strong> vest the Post-Scheme Shares in <strong>Investec</strong><br />

or its nominee(s) and pending such vesting <strong>to</strong> exercise all such rights attaching <strong>to</strong> the Post-Scheme Shares as <strong>Investec</strong> may<br />

direct. If an at<strong>to</strong>rney is so appointed, the New Member shall not thereafter (except <strong>to</strong> the extent that the at<strong>to</strong>rney fails <strong>to</strong> act<br />

in accordance with the directions of <strong>Investec</strong>) be entitled <strong>to</strong> exercise any rights attaching <strong>to</strong> the Post-Scheme Shares unless so<br />

agreed <strong>by</strong> <strong>Investec</strong>. <strong>The</strong> at<strong>to</strong>rney shall be empowered <strong>to</strong> execute and deliver as transferor a <strong>for</strong>m of transfer or other instrument<br />

or instruction of transfer on behalf of the New Member (or any subsequent holder) in favour of <strong>Investec</strong> and the Company may<br />

give a good receipt <strong>for</strong> the consideration <strong>for</strong> the Post-Scheme Shares and may register <strong>Investec</strong> as holder thereof and issue <strong>to</strong><br />

it certificates <strong>for</strong> the same. <strong>The</strong> Company shall not be obliged <strong>to</strong> issue a certificate <strong>to</strong> the New Member <strong>for</strong> the Post-Scheme<br />

Shares.<br />

(h) <strong>The</strong> purchaser shall settle the consideration due under paragraph (c) of this Article within five business days of the issue of the<br />

Post-Scheme Shares <strong>to</strong> the New Member.<br />

(i) Notwithstanding any other provision of these Articles, neither the Company nor the Direc<strong>to</strong>rs shall register the transfer of any<br />

Scheme Shares effected between the Scheme Record Time and the Effective Date.”;<br />

(4) with effect from the passing of this resolution:<br />

(a) one share of the Company be reclassified as a Deferred Share of 1 pence, such Deferred Share <strong>to</strong> have the rights set out in<br />

the articles of association of the Company as amended pursuant <strong>to</strong> paragraph (b) below;<br />

(b) the articles of association of the Company be altered <strong>by</strong> the adoption and inclusion of the following new Article 167:<br />

“167 <strong>The</strong> Deferred Share so designated <strong>by</strong> special resolution of the Company passed on the same date as the date of adoption<br />

of this Article shall have all the rights of an ordinary share as set out in these Articles, save that:<br />

(i) the holder of the Deferred Share shall not be entitled <strong>to</strong> receive a dividend or other distribution or <strong>to</strong> have any other right<br />

<strong>to</strong> participate in the profits of the Company;<br />

(ii) the holder of the Deferred Share shall have no right <strong>to</strong> attend or vote at any general meeting of the Company; and<br />

(iii) on a return of capital or winding-up of the Company, the holder of the Deferred Share shall be entitled, subject <strong>to</strong> the<br />

payment <strong>to</strong> the holders of all other classes of shares of the amount paid up or credited as paid up on such shares, <strong>to</strong><br />

repayment of the amount paid up or credited as paid up on the Deferred Share, but shall have no further or other right <strong>to</strong><br />

participate in the assets of the Company.”;<br />

(c) the Direc<strong>to</strong>rs be generally and unconditionally authorised pursuant <strong>to</strong> and in accordance with section 551 of the Companies<br />

Act 2006 <strong>to</strong> allot the said Deferred Share provided that (1) this authority shall expire on the fifth anniversary of the date of this<br />

resolution and (2) this authority shall be in addition and without prejudice <strong>to</strong> any authority under the said section 551 previously<br />

granted and in <strong>for</strong>ce on the date on which this resolution is passed; and<br />

(d) pursuant <strong>to</strong> and during the period of the said authority the Direc<strong>to</strong>rs be empowered <strong>to</strong> allot the said Deferred Share wholly <strong>for</strong><br />

cash as if section 561(1) of the said Act did not apply <strong>to</strong> any such allotment; and


(5) the direc<strong>to</strong>rs of the Company be authorised <strong>to</strong> take all such action as they may consider necessary or appropriate <strong>for</strong> carrying the<br />

Scheme in<strong>to</strong> effect.<br />

By order of the Board<br />

3 Oc<strong>to</strong>ber 2011<br />

Tony Lee<br />

Company Secretary<br />

<strong>The</strong> <strong>Evolution</strong> <strong>Group</strong> <strong>Plc</strong><br />

Registered office<br />

9th Floor<br />

100 Wood Street<br />

London EC2V 7AN<br />

73


74<br />

NOTES TO THE NOTICE OF GENERAL MEETING<br />

Entitlement <strong>to</strong> attend and vote<br />

1. Pursuant <strong>to</strong> Regulation 41 of the Uncertificated Securities Regulations 2001, the Company specifies that only those members<br />

registered on the Company’s register of members at 6.00 p.m. on 25 Oc<strong>to</strong>ber 2011 or if this meeting is adjourned, at 6.00 p.m.<br />

two business days be<strong>for</strong>e the date of the adjourned meeting, shall be entitled <strong>to</strong> attend and vote at the meeting. Changes <strong>to</strong> the<br />

register of members after 6.00 p.m. on 25 Oc<strong>to</strong>ber 2011 shall be disregarded in determining the rights of any person <strong>to</strong> vote at the<br />

meeting.<br />

Website giving in<strong>for</strong>mation regarding the meeting<br />

2. In<strong>for</strong>mation regarding the meeting, including the in<strong>for</strong>mation required <strong>by</strong> section 311A of the Companies Act 2006, is available from<br />

www.evg<strong>plc</strong>.com.<br />

Attending in person<br />

3. Shareholders who wish <strong>to</strong> attend the meeting in person should note that the meeting will be held at 11.05a.m. on 27 Oc<strong>to</strong>ber 2011<br />

(or as soon thereafter as the Court Meeting (as defined in the document of which this Notice <strong>for</strong>ms part) has concluded or been<br />

adjourned) at the offices of Jones Day at 21 Tudor Street, London EC4Y 0DJ. Shareholders who wish <strong>to</strong> attend in person are asked<br />

<strong>to</strong> please detach and bring with them the attendance slip attached <strong>to</strong> the WHITE Form of Proxy <strong>to</strong> assist in admission <strong>to</strong> the meeting.<br />

Appointment of proxies<br />

4. If you are a member of the Company at the time set out in note 1 above, you are entitled <strong>to</strong> appoint a proxy <strong>to</strong> exercise all or any<br />

of your rights <strong>to</strong> attend, speak and vote at the meeting and you should have received a WHITE proxy <strong>for</strong>m with this notice of meeting.<br />

You can only appoint a proxy using the procedures set out in these notes and the notes <strong>to</strong> the WHITE proxy <strong>for</strong>m.<br />

5. If you are a person who has been nominated under section 146 of the Companies Act 2006 <strong>to</strong> enjoy in<strong>for</strong>mation rights, “Nominated<br />

persons”.<br />

• You may have a right under an agreement between you and the member of the Company who has nominated you <strong>to</strong> have<br />

in<strong>for</strong>mation rights (“Relevant Member”) <strong>to</strong> be appointed or <strong>to</strong> have someone else appointed as a proxy <strong>for</strong> the meeting;<br />

• If you either do not have such a right or if you have such a right but do not wish <strong>to</strong> exercise it, you may have a right under an<br />

agreement between you and the Relevant Member <strong>to</strong> give instructions <strong>to</strong> the Relevant Member as <strong>to</strong> the exercise of voting<br />

rights; and<br />

• Your main point of contact in terms of your investment in the Company remains the Relevant Member (or, where applicable,<br />

your cus<strong>to</strong>dian or broker) and you should continue <strong>to</strong> contact them (and not the Company) regarding any changes or queries<br />

relating <strong>to</strong> your personal details and your interest in the Company (including any administrative matters). <strong>The</strong> only exception <strong>to</strong><br />

this is where the Company expressly requests a response from you.<br />

6. A proxy does not need <strong>to</strong> be a member of the Company but must attend the meeting <strong>to</strong> represent you. Details of how <strong>to</strong> appoint<br />

the Chairman of the meeting or another person as your proxy using the WHITE proxy <strong>for</strong>m are set out in the notes <strong>to</strong> the WHITE proxy<br />

<strong>for</strong>m. If you wish your proxy <strong>to</strong> speak on your behalf at the meeting you will need <strong>to</strong> appoint your own choice of proxy (not the<br />

Chairman) and give your instructions directly <strong>to</strong> them.<br />

7. You may appoint more than one proxy provided each proxy is appointed <strong>to</strong> exercise rights attached <strong>to</strong> different shares. You may not<br />

appoint more than one proxy <strong>to</strong> exercise rights attached <strong>to</strong> any one share. To appoint more than one proxy, each different proxy<br />

appointment <strong>for</strong>m must be received <strong>by</strong> the Company’s Registrar, Capita, PSX, <strong>The</strong> Registry, 34 Beckenham Road, Beckenham, BR3<br />

4TU no later than 48 hours be<strong>for</strong>e the time appointed <strong>for</strong> the meeting.<br />

8. A vote withheld is not a vote in law, which means that the vote will not be counted in the calculation of votes <strong>for</strong> or against the<br />

resolution. If either you select the ‘Discretionary’ option or no voting indication is given, your proxy will vote or abstain from voting<br />

at his or her discretion. Your proxy will vote (or abstain from voting) as he or she thinks fit in relation <strong>to</strong> any other matter which is<br />

put be<strong>for</strong>e the meeting.<br />

Appointment of proxy using hard copy proxy <strong>for</strong>m<br />

9. <strong>The</strong> notes <strong>to</strong> the proxy <strong>for</strong>m explain how <strong>to</strong> direct your proxy how <strong>to</strong> vote on each resolution or withhold their vote.<br />

To appoint a proxy using the proxy <strong>for</strong>m, the <strong>for</strong>m must be:<br />

• completed and signed;<br />

• sent or delivered <strong>to</strong> the Company’s Registrar; and<br />

• received <strong>by</strong> the Company’s Registrar no later than 48 hours be<strong>for</strong>e the time appointed <strong>for</strong> holding the meeting.<br />

In the case of a member which is a Company, the WHITE proxy <strong>for</strong>m must be executed under its common seal or signed on its behalf<br />

<strong>by</strong> an officer of that Company or an at<strong>to</strong>rney <strong>for</strong> that Company.<br />

Any power of at<strong>to</strong>rney or any other authority under which the WHITE proxy <strong>for</strong>m is signed (or a duly certified copy of such power or<br />

authority) must be included with the WHITE proxy <strong>for</strong>m.


Electronic appointment of proxies<br />

10. As an alternative <strong>to</strong> completing the hard copy WHITE proxy <strong>for</strong>m, you can appoint a proxy electronically <strong>by</strong> using the share portal<br />

service at www.capitashareportal.com. For an electronic proxy <strong>to</strong> be valid, your appointment must be received <strong>by</strong> Capita no later<br />

than 48 hours be<strong>for</strong>e the time appointed <strong>for</strong> holding the meeting.<br />

Appointment of proxies through CREST<br />

11. CREST members who wish <strong>to</strong> appoint a proxy or proxies <strong>by</strong> utilising the CREST electronic proxy appointment service may do so <strong>for</strong><br />

the meeting and any adjournment(s) thereof <strong>by</strong> utilising the procedures described in the CREST Manual. CREST Personal Members<br />

or other CREST sponsored members, and those CREST members who have appointed a voting service provider(s), should refer <strong>to</strong><br />

their CREST sponsor or voting service provider(s), who will be able <strong>to</strong> take the appropriate action on their behalf.<br />

In order <strong>for</strong> a proxy appointment made <strong>by</strong> means of CREST <strong>to</strong> be valid, the appropriate CREST message (a CREST Proxy Instruction)<br />

must be properly authenticated in accordance with Euroclear UK & Ireland Limited’s (EUI) specifications and must contain the<br />

in<strong>for</strong>mation required <strong>for</strong> such instructions, as described in the CREST Manual. <strong>The</strong> message must be transmitted so as <strong>to</strong> be<br />

received <strong>by</strong> the issuer’s agent (ID is RA10) no later than 48 hours be<strong>for</strong>e the time appointed <strong>for</strong> holding the meeting. For this<br />

purpose, the time of receipt will be taken <strong>to</strong> be the time (as determined <strong>by</strong> the timestamp applied <strong>to</strong> the message <strong>by</strong> the CREST<br />

Applications Host) from which the issuer’s agent is able <strong>to</strong> retrieve the message <strong>by</strong> enquiry <strong>to</strong> CREST in the manner prescribed <strong>by</strong><br />

CREST.<br />

CREST members and, where applicable, their CREST sponsors or voting service providers should note that EUI does not make<br />

available special procedures in CREST <strong>for</strong> any particular messages. Normal system timings and limitations will there<strong>for</strong>e apply in<br />

relation <strong>to</strong> the input of CREST Proxy Instructions. It is the responsibility of the CREST member concerned <strong>to</strong> take (or, if the CREST<br />

member is a CREST personal member or sponsored member or has appointed a voting service provider(s), <strong>to</strong> procure that his CREST<br />

sponsor or voting service provider(s) take(s)) such action as shall be necessary <strong>to</strong> ensure that a message is transmitted <strong>by</strong> means<br />

of the CREST system <strong>by</strong> any particular time. In this connection, CREST members and, where applicable, their CREST sponsors or<br />

voting service providers are referred, in particular, <strong>to</strong> those sections of the CREST Manual concerning practical limitations of the<br />

CREST system and timings.<br />

<strong>The</strong> Company may treat as invalid a CREST Proxy Instruction in the circumstances set out in Regulation 35(5) (a) of the Uncertificated<br />

Securities Regulations 2001.<br />

Appointment of proxy <strong>by</strong> joint members<br />

12. In the case of joint holders, where more than one of the joint holders purports <strong>to</strong> appoint a proxy, only the appointment submitted<br />

<strong>by</strong> the most senior holder will be accepted. Seniority is determined <strong>by</strong> the order in which the names of the joint holders appear in<br />

the Company’s register of members in respect of the joint holding (the first-named being the most senior).<br />

Changing proxy instructions<br />

13. To change your proxy instructions simply submit a new proxy appointment using the methods set out above. <strong>The</strong> cut-off time <strong>for</strong><br />

receipt of proxy appointments (see above) also applies in relation <strong>to</strong> amended instructions; any amended proxy appointment<br />

received after the relevant cut-off time will be disregarded.<br />

Where you have appointed a proxy using the hard WHITE proxy <strong>for</strong>m and would like <strong>to</strong> change the instructions using another hard<br />

copy WHITE proxy <strong>for</strong>m, please contact the Company’s Registrar.<br />

If you submit more than one valid proxy appointment, the appointment received last be<strong>for</strong>e the latest time <strong>for</strong> the receipt of proxies<br />

will take precedence.<br />

Termination of proxy appointments<br />

14. In order <strong>to</strong> revoke a proxy instruction you will need <strong>to</strong> in<strong>for</strong>m the Company <strong>by</strong> sending a signed hard copy notice clearly stating your<br />

intention <strong>to</strong> revoke your proxy appointment <strong>to</strong> the Company’s Registrar. In the case of a member which is a company, the revocation<br />

notice must be executed under its common seal or signed on its behalf <strong>by</strong> an officer of the company or an at<strong>to</strong>rney <strong>for</strong> the company.<br />

Any power of at<strong>to</strong>rney or any other authority under which the revocation notice is signed (or a duly certified copy of such power or<br />

authority) must be included with the revocation notice.<br />

<strong>The</strong> revocation notice must be received <strong>by</strong> Capita no later than 48 hours be<strong>for</strong>e the time appointed <strong>for</strong> holding the meeting.<br />

If you attempt <strong>to</strong> revoke your proxy appointment but the revocation is received after the time specified then, subject <strong>to</strong> the<br />

paragraph directly below, your proxy appointment will remain valid.<br />

Appointment of a proxy does not preclude you from attending the meeting and voting in person. If you have appointed a proxy and<br />

attend the meeting in person, your proxy appointment will au<strong>to</strong>matically be terminated.<br />

Issued shares and <strong>to</strong>tal voting rights<br />

15. As at 30 September 2011, the Company’s issued share capital comprised 232,680,307 ordinary shares of 1 pence each. Each<br />

ordinary share carries the right <strong>to</strong> one vote at a general meeting of the Company and, there<strong>for</strong>e, the <strong>to</strong>tal number of voting rights in<br />

the Company as at 30 September 2011 is 232,680,307.<br />

75


Questions at the meeting<br />

16. Under section 319A of the Companies Act 2006, the Company must answer any question you ask relating <strong>to</strong> the business being<br />

dealt with at the meeting unless:<br />

76<br />

• Answering the question would interfere unduly with the preparation <strong>for</strong> the meeting or involve the disclosure of confidential<br />

in<strong>for</strong>mation;<br />

• <strong>The</strong> answer has already been given on a website in the <strong>for</strong>m of an answer <strong>to</strong> a question; or<br />

• It is undesirable in the interests of the Company or the good order of the meeting that the question be answered.


80<br />

Printed <strong>by</strong> Royle corporate print

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!